Download - Heart Failure Society of America

14th Annual 

Scientific Meeting 

2010 Program 

September 12 – 15, 2010 

San Diego Convention Center 

San Diego, CA 

www.hfsa.org

Table of Contents 

President’s Message. ..................................... 2 

About the HFSA......................................... 3 

Society Officers and Council. .............................. 4 

Scientific Program Committee. ............................. 5 

Meeting Content ......................................... 5 

General Meeting Information ............................... 6 

Complimentary Food Events................................ 8 

2010 HFSA Satellite/Scientific Program Activity Supporters....... 9 

2010 HFSA Corporate Members............................. 9 

Liability Statement ....................................... 9 

CME Information ....................................... 10 

Disclosure Information ................................... 11 

Scientific Program Learning Objectives ...................... 11 

2010 Abstract Reviewers.................................. 12 

2010 HFSA Faculty...................................... 14 

Program-at-a-Glance..................................... 21 

September 12: (Sunday) 

Satellite Symposia..................................... 27 

Special Scientific Session............................... 30. 

Satellite Symposia..................................... 31 

September 13: (Monday) 

Morning Scientific Sessions ............................. 32 

Oral Abstract Session .................................. 39 

How To Sessions...................................... 40 

Afternoon Scientific Sessions............................ 41 

Monday Posters....................................... 50 

September 14: (Tuesday) 

Morning Scientific Sessions ............................. 82 

Oral Abstract Session .................................. 94 

How To Sessions...................................... 95 

Award Presentations ................................... 96 

Afternoon Scientific Sessions............................ 96 

Tuesday Posters ..................................... 104 

September 15: (Wednesday) 

Morning Scientific Sessions ............................ 135 

Exhibitors and Exhibit Floor Plan.......................... 146 

Clinical Trial Row...................................... 148 

Exhibitor Descriptions................................... 149 

Author Index.......................................... 160 

San Diego Convention Center Floor Plans ................... 200 

Notes................................................ 201 

1

President’s Message 

On behalf of the Executive 

Council and the Program 

Committee of the Heart Failure 

Society of America it is my 

pleasure to welcome you to the 

14th Annual Scientific Meeting. 

The Program Committee has 

put together a very exciting 

program that should be of great 

interest to you in your clinical 

and research activities. 

The program has been carefully 

planned to provide state of 

the art information about 

heart failure for the expert 

covering basic science to 

clinical practice. This year’s program includes simultaneous symposia, 

how-to sessions, oral abstract sessions, debates, poster sessions, and 

late-breaking clinical trials. Areas where there have been new advances 

and topics, including ontroversial issues, are included as part of the 

program. Some of the sessions will focus on a bench-to-bedside 

approach; it is our hope that you will choose to attend sessions out 

of your main areas of interest and benefit from this unique aspect of 

our meeting which offers a broad view of what is happening in heart 

failure. The Hyde Park session, which has become a tradition for this 

program, gives the audience an opportunity to sit back, relax, enjoy, 

and laugh a little while the presenters provide novel insights into 

important issues in the care of heart failure patients. 

We view our meeting’s success not only by the knowledge gained, but 

also by the enjoyment that attendees have in gaining it. We hope you 

find this year’s program to be informative and rewarding. As always 

we welcome and encourage your feedback. 

I hope you enjoy San Diego, leave energized, and take home new ideas 

that will enhance your professional goals. The 2011 annual scientific 

meeting will be held in Boston, and we look forward to seeing you 

again. 

Douglas L. Mann, MD 

President 

Heart Failure Society of America 

2008-2010 

About the HFSA 

The Heart Failure Society of America (HFSA) represents the first 

organized effort by heart failure experts from the Americas to provide 

a forum for all those interested in heart failure research and patient care. 

The HFSA is dedicated to: 

Promoting research related to all aspects of heart failure and to provide 

a forum for presentation of basic, clinical, and population-based research. 

Educating health care professionals through programs, publications 

and other media in the areas of basic science, clinical medicine, patient 

management, and social, ethical and economic issues to enable them to 

diagnose and treat heart failure and concomitant medical conditions more 

effectively. 

Encouraging primary and secondary preventive measures to reduce the 

incidence of heart failure; to serve as a resource for government, private 

industry, and health care providers to facilitate the establishment of 

programs and policies that will better serve the patient. 

Enhancing quality and duration of life in those with heart failure. 

Promoting and facilitating the formal training of physicians, scientists, 

and allied health care providers in the field of heart failure. 

Society Membership Information 

Membership in the Society is open to all health care professionals 

with an interest in cardiovascular medicine. For information about the 

HFSA or to become a member, call or write: 

Heart Failure Society of America, Inc. 

Court International 

Suite 240 South 

2550 University Avenue West 

St. Paul, MN 55114 

phone: 651-642-1633 

fax: 651-642-1502 

e-mail: info@hfsa.org 

Interested participants can also visit the HFSA exhibit booth (#501) or 

visit the HFSA web site at www.hfsa.org. 

2 3

Officers: 

President: 

Vice-President: 

Secretary: 

Treasurer: 

Immediate Past President: 

Members: 

Executive Council 


St. Louis, MO 

Barry M. Massie, MD 

San Francisco, CA 

Mariell L. Jessup, MD 

Philadelphia, PA 

Inder S. Anand, MD, PhD 

Minneapolis, MN 

Barry H. Greenberg, MD 

San Diego, CA 

J. Malcolm O. Arnold, MD 

London, ON, Canada 

John C. Burnett, Jr., MD 

Rochester, MN 

John Chin, MD 

Sacramento, CA 

Thomas Force, MD 


Steven R. Houser, PhD 


Sharon A. Hunt, MD 

Stanford, CA 

JoAnn Lindenfeld, MD 

Denver, CO 

Mandeep R. Mehra, MD 

Baltimore, MD 

Mariann R. Piano, RN, PhD 

Chicago, IL 

Randall C. Starling, MD 

Cleveland, OH 

Clyde W. Yancy, MD 

Dallas, TX 

Michael R. Zile, MD 

Charlotte, SC 

2010 Scientific Program Committee 

Walter J. Koch, PhD (co-chair) 

Christopher M. O’Connor, MD (co-chair) 

Nancy M. Albert, RN, PhD 

Burns C. Blaxall, PhD 

Horng H. Chen, MB, BCh 

Wilson S. Colucci, MD 

James P. Daubert, MD 

Prakash C. Deedwania, MD 

Carla S. Dupree, MD, PhD 

Justin A. Ezekowitz, MB, BCh 

James C. Fang, MD 

G. Michael Felker, MD 

Roger J. Hajjar, MD 

Joshua M. Hare, MD 

Tamara B. Horwich, MD 

Corrine Y. Jurgens, RN, PhD 

Carmelo A. Milano, MD 

Ayan R. Patel, MD 

Peipei Ping, PhD 

Stuart D. Russell, MD 

Randall C. Starling, MD, MPH 

Mark A. Sussman, PhD 

Mary N. Walsh, MD 

David J. Whellan, MD, MHS 

Matthew J. Wolf, MD, PhD 

Meeting Content: 

The 2010 HFSA Annual Scientific Meeting provides a forum for 

the open exchange and discussion of research results and scientific 

advancements in the field of heart failure; however HFSA makes no 

representation or warranty as to the truth, originality, or accuracy 

of the information presented. Nor are the views expressed by the 

individual speakers necessarily the views of HFSA. HFSA supports 

the ACCME’s policy on evidence-based content and encourages 

faculty to adhere to these standards when preparing a presentation. 

Ex Officio Members: 

Jay N. Cohn, MD 


Allen Farber, Esq 

Washington, DC 

Isabella Liang, PhD 

Bethesda, MD 

Alice M. Mascette, MD 

Bethesda, MD 

4 5

General Meeting Information 

San Diego, CA 

All activities listed in this program book will take place at the San 

Diego Convention Center. See page 200 for floor plan of meeting 

space. 

CME Accreditation/Registration 


Court International, Suite 240 South 



651-642-1633; fax: 651-642-1502 

Registration Hours 

Meeting Registration Desk, San Diego Convention Center 

(2nd floor, Ballroom 6 Lobby). 

Saturday, September 11: 

9:00 AM-4:00 PM 

Sunday, September 12: 

8:30 AM-5:00 PM 

Monday, September 13: 

7:00 AM-5:00 PM 

Tuesday, September 14: 

7:00 AM-5:00 PM 

Wednesday, September 15: 

7:00 AM-10:00 AM 

What’s Included in Registration Fees 

The registration fee includes admission to satellite programs, scientific 

sessions, poster sessions and receptions, exhibit hall, and the Opening 

Reception. 

Scientific Meeting Evaluation 

There are two ways to complete the scientific meeting evaluation 

form: (1) complete the evaluation form found in your congress bag 

and return to the HFSA Meeting Registration Desk; OR (2) complete 

the form on-line after the meeting (attendees to be notified by e-mail 

with instructions). 

E-Mail From the Exhibit Floor (Booth #525) 

During the meeting, computers will be available in the Exhibit Hall for 

attendees to check their e-mail. Please note your e-mail account must be 

accessible through a web-based browser, e.g., Internet Explorer. 

Wireless Available: An educational grant has been provided by Otsuka 

for wireless access in HFSA meeting space and exhibit hall hot spots. 

No Smoking Policy 

HFSA prohibits smoking in all areas of the meeting and all hotel meeting 

rooms hosting HFSA functions. Thank you for your cooperation. 

Speaker Ready Room – Room 10 (San Diego Convention Center) 

Sunday, September 12 

9:00 AM-6:00 PM 

Monday, September 13 

7:00 AM-6:00 PM 

Tuesday, September 14 

7:00 AM-6:00 PM 

Wednesday, September 15 

7:00 AM-NOON 

Press Room – Room 9 (San Diego Convention Center) 


10:00 AM-5:00 PM 


7:00 AM-5:00 PM 


7:00 AM-5:00 PM 


7:00 AM-NOON 

Exhibit Hall Dates and Hours 

Exhibits: The exhibits are located in the Sails Pavilion (Upper Level) 

San Diego Convention Center. See page 147 for list of exhibitors and 

location. 





6:00 PM-8:00 PM 

9:30 AM-7:00 PM 

9:30 AM-7:00 PM 

CLOSED 

Clinical Trial Row: Located in the HFSA Exhibit Hall (Sails Pavilion, 

upper level, SDCC). This provides an opportunity for attendees to learn 

more about ongoing clinical trials in heart failure. These boards have 

been rented by groups supporting clinical trials. The HFSA assumes no 

responsibility or liability for information posted about a clinical trial on 

these boards. 

Poster Sessions 

Poster Sessions will be held in the HFSA Exhibit Hall (Sails Pavilion, 

upper level, SDCC) as follows: 

Poster Display: 


9:30 AM-7:00 PM 


Presenters at 

their Posters: 

5:45 PM-6:45 PM 

Annual Business Meeting: 

The Annual Business Meeting of the HFSA will be held on 

Wednesday, September 15, 8:15 AM, Room 4. 

Questions? 

Look for staff wearing golf shirts with the HFSA logo. 

Special Needs 

The HFSA strives to hold meetings that are accessible to all. 

Please tell us what you require to help make your participation 

more enjoyable and meaningful. Contact Gudrun Echterhoff, Global 

Meetings & Incentives at gudrun@global-mtgs.com (201-850-7607). 

6 7

General Meeting Information (continued) 

Complimentary Food Events 

The following complimentary food events will be offered. All food 

events will take place in the San Diego Convention Center, Sails 

Pavilion, unless otherwise noted. 

SUNDAY, September 12 

Opening Reception 

(Wine & Hors d’oeuvres) 

MONDAY, September 13 

Continental Breakfast 

Meeting foyer area 

Refreshment Break 


Poster Session and Reception 


TUESDAY, September 14 





Poster Session and Reception 


WEDNESDAY, September 15 





6:00 PM-8:00 PM 

7:30 AM-8:30 AM 

10:00 AM-10:30 AM 

3:30 PM-4:00 PM 

5:30 PM-7:00 PM 

7:30 AM-8:30 AM 

10:00 AM-10:30 AM 

3:30 PM-4:00 PM 

5:30 PM-7:00 PM 

7:30 AM-8:30 AM 

10:00 AM-10:30 AM 

2010 HFSA Satellite/Scientific Program 

Activity Supporters 

Actelion 

Lippincott Williams 

Medtronic, Inc. 

Otsuka America Pharmaceuticals, Inc. 

Thoratec Corporation 

Support for the following scientific session was provided after 

planning was complete and speakers had confirmed: 

Controversies in Mechanical Cardiac Support (Thoratec) 

2010 HFSA Corporate Members 

Boston Scientific Corporation 

Medtronic, Inc. 

Merck & Co., Inc. 

Ortho-McNeil 

Otsuka America Pharmaceuticals, Inc. 

St. Jude Medical 

Thoratec Corporation 

Liability Statement 

Disclaimer: The Heart Failure Society of America (HFSA) cannot 

accept, and hereby specifically disclaims, any liability for death, 

injury, any loss, cost or expense suffered or incurred by any person 

if such loss is caused by, arises from or results from the act, default 

or omission of any person other than an employee or agent of HFSA. 

In particular, neither HFSA nor its agents can accept, and hereby 

specifically disclaims, any liability for losses arising from, caused by, 

or resulting from, the provision or non-provision of services provided 

by the hotels, companies, or transport operators. Neither HFSA nor 

its agents can accept, and hereby specifically disclaims, liability for 

losses suffered by reason of war including threat of war, riots and 

civil strife, terrorist activity, natural disaster, weather, fire, flood, 

drought, technical, mechanical or electrical breakdown within any 

premises visited by delegates and/or participants in connection with 

the meeting, industrial disputes, government action, regulations or 

technical problems that affect or may affect the services provided in 

connection with the meeting. HFSA is not able to warrant and does 

not warrant that a particular person will appear as a speaker. As a 

condition to any participation in or attendance at the Annual Scientific 

Meeting or any function associated or affiliated herewith, each 

attendee and participant accepts the foregoing disclaimer. 

8 9

CREDIT STATEMENTS 

Scientific Program and 

Special Sunday Scientific Session 

Physicians: The Heart Failure Society of America is accredited by the 

Accreditation Council for Continuing Medical Education to provide 

continuing medical education for physicians. 

The Heart Failure Society of America designates the Scientific 

Program for a maximum of 19 AMA PRA Category 1 Credits 

and the Sunday Excellence in Basic Science Session for a maximum 

of 2.75 AMA PRA Category 1 Credits. Physicians should only claim 

credit commensurate with the extent of their participation 

in the activity. 

Nurses: This program has been approved by the American Association 

of Critical Care Nurses (AACN) for 19 contact hours, Synergy CERP 

Category A, File number 00016043. 

Satellite Symposia 

September 12 (Sunday) 

Physicians: The Heart Failure Society of America (HFSA) is 

accredited by the Accreditation Council for Continuing Medical 

Education to provide continuing medical education for physicians. 

The HFSA designates each satellite program as an educational activity 

for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians 

should only claim credit commensurate with the extent of their 

participation in each program. 

Nurses: This program has been designed to meet Minnesota Board of 

Nursing continuing education requirements and is acceptable for 2.0 

contact hours of continuing education. 

CME Certificates Available On-Site 

CME certificates (scientific and satellite sessions) for physicians 

and nurses will be available on-site. Please visit the CME kiosk 

in registration area to print your CME certificate(s). 

Presenter/Planner Disclosure Information 

The Heart Failure Society of America has a disclosure policy that 

requires presenters and planners to disclose whether or not they have 

relevant financial relationships with any commercial interest. 

Disclosure information for speakers and poster presenters is provided 

in a booklet included in all Congress Bags. Speakers will also 

address disclosures at the beginning of their presentation(s). 

Scientific Program Learning Objectives 

Following this meeting, participants will be able to: 

1. Describe the epidemiology of HF, including environmental factors, 

and implement strategies for the prevention of HF. 

2. Describe current knowledge about the scientific basis of HF at the 

levels of cardiovascular physiology, neurohormones, tissue factors, 

and molecular biology and genetics. 

3. Identify the findings of basic science and current clinical trials and 

their implications for current and future HF therapy. 

4. Implement optimal guideline-based therapeutic options for HF, 

including pharmacologic agents, non-pharmacologic options, such 

as diet and exercise; and devices. 

5. Manage comorbidities including hypertension, diabetes, and 

cognitive issues. 

6. Demonstrate awareness of psychosocial, economic and ethical 

issues in the treatment of patients with HF. 

7. Implement strategies for effective management of the patient with 

HF, incorporating the family, encouraging self-care, and employing 

the medical home model. 

8. Engage in performance measurement and other site-based research. 

Session objectives are listed at the end of each session in the program 

book. Learning objectives for satellite symposia are listed after each 

presentation. 

All main entrances to meeting rooms for the scientific sessions 

and the satellite programs will be “gated” to capture attendee 

information. This is the only information that will be used to 

verify attendance for credit certificates. Please make sure you 

enter each session through a gated entrance. 

10 11


Cleveland, OH 

Larry A. Allen, MD 

Denver, CO 




West Henrietta, NY 

John P. Boehmer, MD 

Hershey, PA 

Bikyem Bozkurt, MD 

Houston, TX 

Javed Butler, MD, MPH 

Atlanta, GA 


Rochester, MN 


Durham, NC 

David DeNofrio, MD 

Boston, MA 

Anita Deswal, MD, MH 

Houston, TX 

Mark H. Drazner, MD 

Dallas, TX 


Chapel Hill, NC 

James C. Fang, MD 

Cleveland, OH 

David S. Feldman, MD, PhD 



Durham, NC 

Maureen P. Flattery, RN, NP 

Richmond, VA 

Gregg C. Fonarow, MD 

Los Angeles, CA 

A. Martin Gerdes, PhD 

Sioux Falls, SD 

Jalal K. Ghali, MD 

Detroit, MI 

Michael M. Givertz, MD 

Boston, MA 

Steven Goldman, MD 

Tucson, AZ 

2010 Abstract Reviewers 

Stephen S. Gottlieb, MD 

Baltimore, MD 


New York, NY 


Miami, FL 

Ayesha Hasan, MD 

Columbus, OH 

Paul J. Hauptman, MD 

St. Louis, MO 

Edward P. Havranek, MD 

Denver, CO 

Paul A. Heidenreich, MD 

Palo Alto, CA 

Adrian F. Hernandez, MD 

Durham, NC 

Ray E. Hershberger, MD 

Miami, FL 

Katherine J. Hoercher, RN 

Cleveland, OH 








Stony Brook, NY 

David E. Lanfear, MD 

Detroit, MI 

Carl V. Leier, MD 

Columbus, OH 

Terry A. Lennie, RN, PhD 

Lexington, KY 

Wayne C. Levy, MD 

Seattle, WA 

Ronglih Liao, PhD 

Boston, MA 


Denver, CO 

Kenneth B. Margulies, MD 




Alan B. Miller, MD 

Jacksonville, FL 

Judith E. Mitchell, MD 

New York, NY 

Mark A. Munger, PharmD 

Salt Lake City, UT 

Myung H. Park, MD 

Baltimore, MD 

Soon J. Park, MD 

Rochester, MN 


Boston, MA 

J. Herbert Patterson, PharmD 


Kismet D. Rasmusson, FNP 

Murray, UT 

Thomas S. Rector, PhD 


Margaret M. Redfield, MD 

Rochester, MN 

Joseph G. Rogers, MD 

Durham, NC 


Baltimore, MD 

Hani N. Sabbah, PhD 

Detroit, MI 

Douglas B. Sawyer, MD, PhD 

Nashville, TN 

Leslie A. Saxon, MD 


Douglas D. Schocken, MD 

Durham, NC 

Marc A. Silver, MD 

Oak Lawn, IL 

John A. Spertus, MD, MPH 

Kansas City, MO 

Francis G. Spinale, MD 

Charleston, SC 

William C. Stanley, PhD 

Baltimore, MD 


Cleveland, OH 

William G. Stevenson, MD 

Boston, MA 


San Diego, CA 

W.H. Wilson Tang, MD 

Cleveland, OH 

Hector O. Ventura, MD 

New Orleans, LA 


Indianapolis, IN 

Yibin Wang, PhD 


Cheryl A. Westlake, RN, PhD 

San Clemente, CA 

David J. Whellan, MD 


Suzanne J. Wingate, RN, PhD 

Gaithersburg, MD 


Durham, NC 



12 13

2010 HFSA Faculty 

14th Annual Scientific Meeting 

William T. Abraham, MD 

The Ohio State University 

Columbus, OH 

Michael A. Acker, MD 

University of Pennsylvania 


Kirkwood F. Adams, Jr., MD 

The University of North Carolina 


Patricia A. Adams, BSN 

Duke University 


Philip B. Adamson, MD 

Oklahoma Heart Hospital 

Oklahoma City, OK 


Cleveland Clinic Foundation 

Cleveland, OH 

Larry A. Allen, MD, MHS 

University of Colorado 

Denver, CO 


Minneapolis VAMC 


Mark E. Anderson, MD, PhD 

University of Iowa 

Iowa City, IA 

Rebecca L. Angerstein, MA, MSN 

Norton, OH 

Stefan D. Anker, MD, PhD 

Charité Hospital 

Berlin, Germany 

J. Malcolm O. Arnold, MD 

University Hospital 

London, ON, Canada 

Euan A. Ashley, MD, PhD 

Stanford University 

Stanford, CA 

Troy A. Baudino, PhD 

Texas A&M 

Temple, TX 

Richard C. Becker, MD 


Durham, NC 

Donald M. Bers, PhD 

University of California, Davis 

Davis, CA 

Kirsten Bibbins-Domingo, MD 

University of California 

San Francisco 



University of Rochester 

Rochester, NY 

Rolf Bodmer, PhD 

Sanford-Burnham Medical 

Research Institute 

La Jolla, CA 

John P. Boehmer, MD 

Milton Hershey Medical Center 

Hershey, PA 

Kathryn H. Bowles, RN, PhD 



Eugene Braunwald, MD 

Brigham and Women’s Hospital 

Boston, MA 

Michael R. Bristow, MD, PhD 


Denver, CO 

Joan Heller Brown, PhD 

University of California, 

San Diego 

La Jolla, CA 

John C. Burnett, Jr., MD 

Mayo Clinic & Foundation 

Rochester, MN 

Javed Butler, MD, MPH 

Emory University 

Atlanta, GA 

Alfred E. Buxton, MD 

Brown University 

Providence, RI 

Thomas P. Cappola, MD, ScM 



Peter E. Carson, MD 

Washington VAMC 


Kanu Chatterjee, MB 

University of Iowa 

Iowa City, IA 



Rochester, MN 

Ju Chen, PhD 


San Diego 

La Jolla, CA 

John Chin, MD 

Sutter Memorial Hospital 

Sacramento, CA 

Karen L. Christman, PhD 


San Diego 

San Diego, CA 

Misook L. Chung, RN, PhD 

University of Kentucky 

Lexington, KY 

Andrew J.S. Coats, MD 

University of Sydney 

Sydney, Australia 

Jay N. Cohn, MD 

University of Minnesota 


Sean P. Collins, MD 

University of Cincinnati 

Cincinnati, OH 

Wilson S. Colucci, MD 

Boston University 

Boston, MA 

Gianluigi Condorelli, MD, PhD 


San Diego 

San Diego, CA 

Simon J. Conway, PhD 

Indiana University 


Kevin Costa, PhD 

Mount Sinai School of Medicine 

New York, NY 



Durham, NC 

Prakash C. Deedwania, MD 

VA Central California 

Health Care System 

Fresno, CA 

Frederica del Monte, MD, PhD 

Beth Israel Deaconess 

Medical Center 

Boston, MA 

Teresa De Marco, MD 


San Francisco 


David DeNofrio, MD 

Tufts Medical Center 

Boston, MA 

Wolfgang H. Dillmann, MD 


San Diego 

La Jolla, CA 

Gerald W. Dorn, II, MD 

Washington University 

St. Louis, MO 

Kathleen A. Dracup, RN, DNSc 


San Francisco 



University of North Carolina 


Uri Elkayam, MD 

University of Southern California 


Ronald Evans, PhD 

The Salk Institute 

La Jolla, CA 

Justin A. Ezekowitz, MB, BCh 

University of Alberta 

Edmonton, AB, Canada 

James C. Fang 


Cleveland, OH 

Arthur M. Feldman, MD, PhD 

Thomas Jefferson University 




Durham, NC 

Mona Fiuzat, PharmD 


Durham, NC 

Jerome L. Fleg, MD 

National Institutes of Health 

Bethesda, MD 

14 15

Gregg C. Fonarow, MD 

UCLA 


Thomas Force, MD 



Paul R. Forfia, MD 



Michael B. Fowler, MD 


Stanford, CA 

Gary S. Francis, MD 



Jalal K. Ghali, MD 

Harper University Hospital 

Detroit, MI 

Mihai Gheorghiade, MD 

Northwestern University 

Chicago, IL 

Michael M. Givertz, MD 


Boston, MA 

Steven Goldman, MD 

VA Medical Center 

Tucson, AZ 

Steven R. Goldsmith, MD 

Minnesota Medical Research 

Foundation 


Roberta A. Gottlieb, MD 

San Diego State University 

San Diego, CA 

Stephen S. Gottlieb, MD 

University of Maryland 

Baltimore, MD 

Barry H. Greenberg, MD 


San Diego 

San Diego, CA 


Mount Sinai Medical Center 

New York, NY 


University of Miami 

Miami, FL 

Paul J. Hauptman, MD 

St. Louis University 

St. Louis, MO 

Paul A. Heidenreich, MD, MS 

VA / Stanford University 

Palo Alto, CA 

Ray E. Hershberger, MD 

University of Miami 

Miami, FL 

J. Thomas Heywood, MD 

Scripps Clinic 

La Jolla, CA 

Katherine J. Hoercher, RN 


Cleveland, OH 


UCLA 



Temple University 


Nancy Houston-Miller, RN, PhD 


Stanford, CA 

Jonathan G. Howlett, MD 

University of Calgary 

Calgary, AB, Canada 

Sharon A. Hunt, MD 


Stanford, CA 

Paul A. Insel, MD 


San Diego 

San Diego, CA 

James L. Januzzi, MD 

Massachusetts General Hospital 

Boston, MA 




Nan Marie Jokerst, PhD 


Durham, NC 

Bodh I. Jugdutt, MD, MSc, DM 

University of Alberta 



Stony Brook University 

Stony Brook, NY 

Daniel P. Kelly, MD 

Sanford-Burnham Institute for 

Medical Research at Lake Nona 

Orlando, FL 

Dalane W. Kitzman, MD 

Wake Forest University 

Winston-Salem, NC 

Kirk U. Knowlton, MD 


San Diego 

San Diego, CA 

Jon A. Kobashigawa, MD 

Cedars-Sinai Heart Institute 


Walter J. Koch, PhD 



Marvin A. Konstam, MD 


Boston, MA 

Evangelia G. Kranias, PhD 

University of Cincinnati 


David E. Lanfear, MD 

Henry Ford Hospital 

Detroit, MI 

Kenneth P. Laurita, PhD 

Case Western Reserve University 

Cleveland, OH 

Carl V. Leier, MD 

The Ohio State University 

Columbus, OH 

Terry A. Lennie, RN, MS, PhD 


Lexington, KY 

Annarosa Leri, MD 


Boston, MA 

Wayne C. Levy, MD 

University of Washington 

Seattle, WA 

Eldrin F. Lewis, MD 


Boston, MA 

Ronglih Liao, PhD 


Boston, MA 

Stephen B. Liggett, MD 


Baltimore, MD 



Denver, CO 

Peter P. Liu, MD 

University of Toronto 

Toronto, ON, Canada 

Douglas W. Losordo, MD 


Chicago, IL 

Donna M. Mancini, MD 

Columbia University 

New York, NY 



St. Louis, MO 

Kenneth B. Margulies, MD 



Daniel B. Mark, MD, MPH 


Durham, NC 



San Francisco 


Paul J. Mather, MD 



Michael A. Mathier, MD 

University of Pittsburgh 

Pittsburgh, PA 

Mathew S. Maurer, MD 


New York, NY 

Vallerie V. McLaughlin, MD 

University of Michigan 

Ann Arbor, MI 

Elizabeth M. McNally, MD, PhD 

University of Chicago 

Chicago, IL 

Dennis M. McNamara, MD 

University of Pittsburgh 


Mandeep R. Mehra, MD 


Baltimore, MD 

16 17

Donald R. Menick, PhD 

Medical University of 

South Carolina 


Carmelo A. Milano, MD 


Durham, NC 

Alan B. Miller, MD 

University of Florida 

Jacksonville, FL 

Leslie W. Miller, MD 


Roger M. Mills, MD 

Ortho-McNeill 

Whitehouse Station, NJ 

Stephen Moelter, PhD 

University of the Sciences 


Christine S. Moravec, PhD 


Cleveland, OH 

Gregory E. Morley, PhD 

New York University 

New York, NY 

Debra K. Moser, RN, DNSc 


Lexington, KY 

Patrick Most, MD 



Mark A. Munger, PharmD 

University of Utah 

Salt Lake City, UT 

Srinivas Murali, MD 

Allegheny General Hospital 


Anthony J. Muslin, MD 


St. Louis, MO 

Christopher M. O’Connor, MD 


Durham, NC 

Milton Packer, MD 

University of Texas Southwestern 

Dallas, TX 

Peter S. Pang, MD 


Chicago, IL 

Nazareno Paolocci, MD 

Johns Hopkins University 

Baltimore, MD 

Myung H. Park, MD 


Baltimore, MD 

Soon J. Park, MD 


Rochester, MN 

Kevin Kit Parker, PhD 

Harvard University 

Boston, MA 



Boston, MA 

J. Herbert Patterson, PharmD 

University of North Carolina 


Marc A. Pfeffer, MD, PhD 


Boston, MA 

Mariann R. Piano, RN, PhD 

University of Illinois 

Chicago, IL 

Ileana L. Piña, MD 

Case Western University 

Cleveland, OH 

Peipei Ping, PhD 

UCLA 


Bertram Pitt, MD 


Ann Arbor, MI 

Piotr Ponikowski, MD, PhD 

Medical University 

Wroclaw, Poland 

Kenneth D. Poss, PhD 


Durham, NC 

Susan J. Pressler, RN, DNS 


Ann Arbor, MI 

Kismet D. Rasmusson, RN, FNP 

Intermountain Medical Center 

Murray, UT 

Margaret M. Redfield, MD 


Rochester, MN 

Carolyn Miller Reilly, RN, PhD 

Emory University 

Atlanta, GA 

Michael W. Rich, MD 


St. Louis, MO 

Barbara J. Riegel, RN, DNSc 



Jeffrey Robbins, PhD 

Cincinnati Children’s Hospital 



Howard A. Rockman, MD 


Durham, NC 

Joseph G. Rogers, MD 


Durham, NC 

Anthony Rosenzweig, MD 

Beth Israel Deaconess 


Boston, MA 

Robert S. Ross, MD 

VA Healthcare San Diego 

San Diego, CA 

Pilar Ruiz-Lozano, PhD 

Sanford-Burnham Medical 

Research Institute 

La Jolla, CA 


Johns Hopkins University 

Baltimore, MD 

Oliver A. Ryder, PhD 

Institute for Conservation Research 

San Diego Zoo 

San Diego, CA 

Hani N. Sabbah, PhD 

Henry Ford Health System 

Detroit, MI 

Junichi Sadoshima, PhD, MD 

UMDNJ Medical School 

Newark, NJ 

Leslie A. Saxon, MD 

University of Southern California 


Douglas D. Schocken, MD 


Durham, NC 

Marc J. Semigran, MD 

Massachusetts General Hospital 

Boston, MA 

Shey-Shing Sheu, PhD 

University of Rochester 

Rochester, NY 

Ralph Snyderman, MD 


Durham, NC 

Scott D. Solomon, MD 


Boston, MA 

George Sopko, MD, MPH 

National Institutes of Health 

Bethesda, MD 

Didier Y. R. Stainier, PhD 


San Francisco 




Cleveland, OH 

D. Eric Steidley, MD 


Phoenix, AZ 

Lynne Warner Stevenson, MD 


Boston, MA 

Norman L. Stockbridge, MD, PhD 

Food and Drug Administration 

Silver Spring, MD 

Mark D. Sullivan, MD, PhD 


Seattle, WA 


San Diego State University 

San Diego, CA 

W.H. Wilson Tang, MD 


Cleveland, OH 

Anne L. Taylor, MD 


New York, NY 

Doris A. Taylor, PhD 



John R. Teerlink, MD 

San Francisco VAMC 


18 19

Rong Tian, PhD, MD 


Seattle, WA 

Patricia A. Uber, PharmD 


Baltimore, MD 

James E. Udelson, MD 


Boston, MA 

Eric J. Velazquez, MD 


Durham, NC 

Hector O. Ventura, MD 

Ochsner Medical Center 

New Orleans, LA 

Francisco J. Villarreal, MD, PhD 


San Diego 

San Diego, CA 

Kenneth Walsh, PhD 

Boston University 

Boston, MA 


The Care Group 


Yibin Wang, PhD 

UCLA 


R. Clinton Webb, PhD 

Medical College of Georgia 

Augusta, GA 

J. Marcus Wharton, MD 




David J. Whellan, MD, MHS 



Bruce L. Wilkoff, MD 


Cleveland, OH 

Mark A. Winchester, MD 


Durham, NC 

Ronald M. Witteles, MD 


Stanford, CA 



Durham, NC 

Mary A. Woo, RN, DNSc 

UCLA 






20 21 

Sunday-September 12, 2010 HFSA 14th Annual Scientific Meeting – September 12-15, 2010 – San Diego, CA 

Ballroom 6A Ballroom 6B Room 6C Room 6D Room 5AB 

Satellite Symposium 

2010 Update: Tips and 

Pearls in Pulmonary 

Hypertension (PH) for the 

Heart Failure Clinician 

1:00-3:00 PM Satellite Symposium 

Heart Failure Device 

Diagnosis: What, When, 

How, and Where 

3:00-4:00 PM 

Special Scientific Session 

Excellence in Basic 

Science (featured speaker: 

Ronald Evans, PhD) 

3:15 - 6:00 PM 

4:00-6:00 PM Satellite Symposium 

Cardio-Renal Connections 

in Heart Failure: From 

Pathophysiology to 

Therapy 

6:00 PM Opening Reception 14 th Annual Scientific Meeting - Poster-Exhibit Area (Exhibit Hall) Sails Pavilion, San Diego Convention Center

Monday-September 13, 2010 HFSA 14th Annual Scientific Meeting – September 12-15, 2010 – San Diego, CA 


7:30 AM Continental Breakfast available in foyer areas 

8:00 AM Welcome/Opening Remarks 

2010 HFSA Lifetime Achievement Award 

8:20 AM President’s Remarks 

8:30 AM Opening Plenary Session 

Novel Technologies and Models in Cardiovascular 

Disease 

10:00 AM Coffee Break – Exhibit Hall (Posters displayed 9:30 AM-7:00 PM) 

10:30 AM Late Breaking 

Clinical Trials I 

Nursing Investigator 

Award Session 

JNC New Investigator 

Clinical/Integrative 

Physiology Session 

JNC New Investigator 

Basic Science Session 

Monday-September 13, 2010 HFSA 14th Annual Scientific Meeting – September 12-15, 2010 – San Diego, CA 


NOON Lunch Break – Exhibit Hall opens at 9:30 AM; see page 33 for Monday posters; visit posters until 7:00 PM 

12:30-1:30 PM How To Sessions (6) See 

page 40 for locations 

2:00 PM Symposium 

Atrial Fibrillation (AF) 

in Heart Failure: The 

Chicken or the Egg? 

Symposium 

What Is the Future 

of Biomarkers and 

Personalized Medicine in 

Heart Failure? 

Symposium 

Cardiac Tissue 

Engineering 

3:30 PM Coffee Break – Exhibit Hall (Posters displayed 9:30 AM-7:00 PM) 

4:00 PM Guideline Session 

2010 HFSA HF Guidelines: 

What Is New and Why It Is 

Important 

Symposium 

Ventricular 

Tachyarrhythmias (VT) 

and Sudden Cardiac 

Death: Can We Prevent 

Them in the Heart Failure 

Patient? 

5:30 PM Wine and Hors d’oeuvres in Poster Area Exhibit Hall (presenters at their posters 5:45-6:45 PM) 

7:00 PM Exhibits Close (Exhibit Hall re-opens Tuesday 9:30 AM-7:00 PM) 

Symposium 

Aging and Heart Failure: 

Bench to Bedside 

Symposium 

Genes as Guides to 

Diagnosis and Treatment 

of Cardiomyopathies 

Oral Abstract Session 

Leading Translational 

Research 

Symposium 

Calcium Signaling and 

Heart Failure 

Symposium 

Model Organisms of 

Cardiomyopathy and 

Aging 

22 

23

Tuesday-September 14, 2010 HFSA 14th Annual Scientific Meeting – September 12-15, 2010 – San Diego, CA 



Symposium 

Novel Concepts in 

Hypertrophic Gene 

Transcription 

Symposium 

Surveillance of Patients 

with HF: How Do We Do 

It, When Do We Stop? 

Symposium 

Prevention of Heart 

Failure Progression: 

New Insights for Stage B 

Management 

Symposium 

Hypertension and HF: 

From Bench to Bedside 

8:30 AM Symposium 

A Reassessment of 

Dyspnea as a Critical 

Endpoint in Acute Heart 

Failure Trials 

24 

10:00 AM Coffee Break – Exhibit Hall (Posters displayed 9:30 AM-7:00 PM) 

Symposium 

Innovations in 

Cardiomyocyte Signaling 

Symposium 

Metabolic Pathways in the 

Failing Heart 

Symposium 

Controversies in 

Mechanical Cardiac 

Support 

10:30 AM Case Discussion Symposium 

Patient Education: 

Strategies that Work 

Tuesday-September 14, 2010 HFSA 14th Annual Scientific Meeting – September 12-15, 2010 – San Diego, CA 


NOON Lunch Break – Exhibit Hall opens at 9:30 AM; see page 87 for Tuesday posters; visit posters until 7:00 PM 

Oral Abstract Session 

Leading Clinical Research 

12:30-1:30 PM How To Sessions (6) See 

page 95 for locations 

1:45 PM Announcement of Awards 

Symposium 

Novel Participants in 

Cardiomyopathy and HF 

Symposium 

Guidelines, Performance 

Measures, and the Practice 

of Medicine: Mind the 

Gap 

2:00 PM Hyde Park Session Symposium 

Comorbidities in Heart 

Failure 

25 

3:30 PM Coffee Break – Exhibit Hall (Posters displayed 9:30 AM-7:00 PM) 

Symposium 

The Cardiac Fibroblast 

as the Forgotten Cell in 

Cardiac Development and 

Disease 

Symposium 

Latest Developments 

in Stem Cell and Gene 

Therapy in Heart Failure 

Symposium 

Cognition and Heart 


4:00 PM Debate Session 

LVADs in Class III HF: Should We Be Moving 

Treatment Upstream?; Should 30-Day Heart Failure 

Readmission Be a Measure of Quality of Care? 

5:30 PM Wine and Hors d’oeuvres in poster/exhibit area (presenters at their posters 5:45-6:45 PM) 

7:00 PM Exhibits Close

Wednesday-September 15, 2010 HFSA 14th Annual Scientific Meeting – September 12-15, 2010 – San Diego, CA 

Ballroom 6A Ballroom 6B Room 6C Room 6D Room 4 


8:15 AM HFSA Annual Business 

Meeting (Room 3) 

Symposium 

Just say NO: Nitric Oxide 

Enhancement for Heart 


Symposium 

Designing the Medical 

Home for Heart Failure 

Patients 

Symposium 

Common Dilemmas of the 

Failing Right Ventricle in 

Pulmonary Hypertension: 

Are We Getting Better at 

Treating It? 

8:30 AM Late Breaking Clinical 

Trials II 

26 

10:00 AM Coffee Break in meeting foyer areas 

Symposium 

Update on Cardiac 

Transplantation 

Symposium 

The Other 

Cardiomyopathies: 

Diagnosis and Management 

Symposium 

Heart Failure Readmissions: 

The 2010 Challenge 

10:30 AM Symposium 

M&M from Heart Failure 

Trials 

12:00 PM Scientific Meeting adjourned. 15 th Annual Scientific Meeting: September 18-21, 2011, Boston, MA

Welcome to the 

14th Annual 


September 12 – 15, 2010 

San Diego Convention Center 

San Diego, CA 

www.hfsa.org 

27

Sept. 12 

Sunday 

PM 

SATELLITE SYMPOSIUM 


1:00-3:00 PM 

Room 6A 



1:00-3:00 PM 

Room 6B 

Sept. 12 

Sunday 

PM 

sunday 

Heart Failure Device Diagnostics: What, When, 

How, and Where 

2010 Update: Tips and Pearls in Pulmonary 

Hypertension (PH) for the Heart Failure Clinician 

Sunday 

Chair: 

David J. Whellan, Philadelphia, PA 

1:00 Introduction 


1:05 Background on Heart Failure Device Diagnostics: 

What Are We Looking At? 

J. Thomas Heywood, La Jolla, CA 

Learning Objective: Identify potential data elements 

available from current heart failure devices. 

1:25 Clinical Trial Results Overview: 

When Have Diagnostics Been Evaluated? 

Philip B. Adamson, Oklahoma City, OK 

Learning Objective: Describe how to integrate the data into 

the every day management of heart failure. 

1:45 Implementation in Clinical Practice: How Can This 

Information Be Used Now? 

Nancy M. Albert, Cleveland, OH 

Learning Objective: Define what changes in heart failure 

diagnostic data are predictive of clinical events. 

2:05 The Future of Diagnostics: Where Are We Going? 

Gregg C. Fonarow, Los Angeles, CA 

Learning Objective: Discuss the current level of evidence 

for the use of diagnostic and future rends in diagnostics. 

2:25 Case Studies with Panel Discussion 

Faculty 

2:50 Questions and Answers 

Supported by an educational grant from Medtronic, Inc. 

Chair: 

Vallerie V. McLaughlin, Ann Arbor, MI 

1:00 Welcome and Introduction 


1:05 Perilous Pathways in PAH: Pathogenic Mediators and 

Treatment Targets 

Milton Packer, Dallas, TX 

Learning Objectives: List factors to consider in the 

differential diagnosis of acute decompensated HF and discuss 

pharmacologic and non-pharmacologic treatment options 

1:25 Questions and Answers with Audience Response 

1:35 Hemodynamic Assessment of PH: Echocardiography 

vs. Catheterization 

Paul R. Forfia, Philadelphia, PA 

Learning Objectives: Apply an evidenced-based approach 

to diagnosis of PAH and PH secondary to HF, with a 

focus on echocardiography vasodilator testing, and right 

heart catheterization; Review the utilization of right heart 

catheterization parameters for the diagnosis of PAH 


2:05 Treatment of PAH: Establishing Goals to Optimize Outcomes 


Learning Objectives: Employ state-of-the-art evidence-based 

treatment algorithms to optimize parenteral and oral therapies 

and assess implications of emerging clinical data for future 

management plans; Identify pathogenic mediators of PAH, 

with a focus on the endothelin and prostacyclin pathways; and 

appraise implications in terms of treatment targets 


2:35 Evaluation and Management of Acute Decompensated 

Right Heart Failure 

Teresa De Marco, San Francisco, CA 

Learning Objectives: Identify pathophysiologic insights and 

therapeutic approaches that have evolved in HF that might 

apply in managing the cardiopulmonary complications of PAH 


Supported by an educational grant from Actelion 

This program is not part of the scientific program 

as planned by the HFSA Scientific Program 

Committee. 

28 



Committee. 

29

Sept. 12 

Sunday 

PM 

SPECIAL SCIENTIFIC SESSIoN 


3:15-6:00 PM 

Room 5AB 



4:00-6:00 PM 

Room 6A 

Sept. 12 

Sunday 

PM 

sunday 

Excellence in Basic Science 

Moderator: Walter J. Koch, Philadelphia, PA 

3:15 Nuclear Receptor Signaling 

The 4th Distinguished Lecture in Basic Science 

Ronald Evans, La Jolla, CA 

(Award to be presented immediately following lecture) 

4:00* SR Modulating Proteins 

Evangelia G. Kranias, Cincinnati, OH 

4:30* GSK3α Regulates β-Adrenergic Responsiveness, 

Post-MI Remodeling, and Cardiomyocyte Proliferation 

Thomas Force, Philadelphia, PA 

5:00* T-type Calcium Channels and Cardiac Function 

Steven R. Houser, Philadelphia, PA 

5:30* Cardiac Stem Cells 

Mark A. Sussman, San Diego, CA 

*25 minute presentation, 5 minute audience discussion 

Chair: 

Cardio-Renal Connections in Heart Failure: 

From Pathophysiology to Therapy 

G. Michael Felker, Durham, NC 

4:00 Welcome and Introduction 


4:10 Pathophysiology of the Cardio-Renal Syndrome 

in Heart Failure 

John C. Burnett, Jr., Rochester, MN 

Learning Objective: Discuss the pathophysiology of worsening 

renal function in heart failure, including the role of congestion, 

neurohumoral activation, natriuretic peptides, and renal injury. 


4:35 Hyponatremia in Heart Failure: Pathophysiology, 

Clinical Implications and Treatment Options 

James E. Udelson, Boston, MA 

Learning Objective: Discuss the pathophysiology of 

hyponatremiain heart failure, its clinical implications, and 

therapeutic options. 

Sunday 

Learning Objective: Describe current knowledge about 

nuclear receptor signaling, SR modulating proteins, GSK3α, 

T-type calcium channels, and cardiac stem cells and their 

role in heart failure and heart failure treatment. 


5:00 Implications of Emerging Renal Biomarkers for Heart 

Failure Management 

James L. Januzzi, Boston, MA 

Learning Objective: Describe emerging biomarkers of renal 

function and injury such as Cystatin C and NGAL and their 

potential clinical uses in the management of patients with 

heart failure. 


5:25 Worsening Renal Function in ADHF: Marker or Mediator? 

John R. Teerlink, San Francisco, CA 

Learning Objective: Discuss epidemiologic data linking 

worsening renal function (WRF) to outcomes in heart 

failure, and discuss impact of recent clinical trials (e.g., 

PROTECT, DOSE) on the current understanding of the 

importance of WRF. Discuss potential therapeutic options 

for preventing or treating WRF in patients with ADHF. 

This program is part of the scientific program 


Committee. 


5:50 Panel Discussion and Final Remarks 

Supported by an educational grant from Otsuka America 

Pharmaceuticals 

6:00 Opening Reception 

2010 HFSA Annual Scientific Meeting 

Exhibit Hall (Sails Pavilion) 



Committee. 

30 

31

Sept. 13 

Monday 

AM 

OPENING PLENARY SESSION 


8:00-10:00 AM 

Ballrooms 6A-6B 

POSTERS DISPLAYED 


9:30 AM-7:00 PM 


Sept. 13 

Monday 

AM 

8:00 Welcome and Opening Remarks 

Walter J. Koch, Philadelphia, PA 

Christopher M. O’Connor, Durham, NC 

PRESENTERS AT POSTERS 5:45 PM-6:45 PM 

8:05 2010 HFSA Lifetime Achievement Award: Eugene 

Braunwald 

Presented by Marc A. Pfeffer, Boston, MA 

Categories Poster # 

Cardiovascular Physiology 024-047 

Monday 

8:15 Special Presentation to Douglas L. Mann, 

HFSA President 2008-2010 

Barry H. Greenberg, San Diego, CA 

Cardiovascular Structure 071-076 

Monday 

8:20 President’s Remarks 

Douglas L. Mann, St. Louis, MO 

Neurohormones/Cytokines 082-092 

Novel Technologies and Models in Cardiovascular Disease 

Molecular Biology and Genetics 104-116 

Moderators: Douglas L. Mann, St. Louis, MO 


8:30 Nanotechnology and its Application to Cardiovascular 

Disease: Microsystems for Disease Evaluation 

Nan Marie Jokerst, Durham, NC 

Surgery, Transplantation, Devices 129-153 

Electrophysiology/Arrhythmias 179-190 

Clinical Trials 203-215 

8:55 Comparative Genomics and Human Disease: 

Some Recent Contributions from Zoos 

Oliver A. Ryder, San Diego, CA 

Cardiovascular Pharmacology 229-235 

9:20 Personalized Medicine: From Theory to Practice 

Ralph Snyderman, Durham, NC 

Epidemiology, Prevention 244-254 

9:45 Panel Discussion 

Outcomes 266-297 

Learning Objective: Describe new technologies and disease 

models in heart failure. 

Clinical Care/Management Strategies 331-360 

Listing for Monday posters begins on page 50 

Listing for Tuesday posters begins on page 104 

10:00 Coffee Break 

Refreshments served in Exhibit Hall (Sails Pavilion) 

32 

33

Sept. 13 

Monday 

AM 

LATE BREAKING CLINICAL TRIALS 


10:30 AM-NOON 




10:30 AM-NOON 


Sept. 13 

Monday 

AM 

Late Breaking Clinical Trials I 

Late Breaking Clinical Trials I (cont.) 

Monday 

Moderators: Carl V. Leier, Columbus, OH 

Marc A. Pfeffer, Boston, MA 

10:30 CUPID 1: MYDICAR ® in Patients with Advanced Heart 

Failure Continue to Show Significant Improvement in 

Clinical Outcomes Compared to Optimal Therapy 9 

Months Post-Dose 

Barry H. Greenberg, Mariell L. Jessup, Krisztina M. Zsebo, 

Alex Yaroshinsky, Roger J. Hajjar, University of California, San 

Diego, CA 

10:40 Commentary 

Michael R. Bristow, Denver, CO 

10:45 Audience Questions 

10:48 NEXT-HEART Tai Chi Exercise Improves Quality 

of Life in Patients with Chronic Heart Failure in a 

Randomized Controlled Trial 

Gloria Yeh, EP McCarthy, PM Wayne, LW Stevenson, MJ 

Wood, DE Forman, RB Davis, RS Phillips. Beth Israel 

Deaconess Medical Center, Boston, MA 


Ileana L. Piña, Cleveland, OH 


11:06 Economic Impact of Monitoring Heart Transplant 

Recipients with Gene Expression Profiling to Detect 

Rejection: An IMAGE Analysis 

Paul A. Heidenreich, JJ Teuteberg, AG Kfoury, RC Starling, 

MC Deng, TP Cappola, A Kao, AS Anderson, WG Cotts, GA 

Ewald, DA Baran, RC Bogaev, B Elashoff, H Baron, J Yee, HA 

Valantine. VA Palo Alto Health Care System, Palo Alto, CA 


Mandeep R. Mehra, Baltimore, MD 


11:24 Ventricular Elastic Support Therapy (VEST) in Stage C 

Heart Failure: Analysis from the PEERLESS-HF Study 

William T. Abraham, Maria Rosa Costanzo, Simon Maybaum, 

Alan Bank, Inderjit Anand, Barry Rayburn, Russell Ivanhoe. 

The Ohio State University, Columbus, OH 


Eric J. Velazquez, Durham, NC 


11:42 The PEARL-HR (Multicenter, Randomized, Double- 

Blind, Placebo-Controlled, Parallel Group, Multiple- 

Dose To Evaluate the Effects of RLY5016 in Heart 

Failure Patients) Trial 

Bertram Pitt, I-Zu Huang, Stefan Anker, David Bushinsky, 

Dalane Kitzman, Faiez Zannad, and for the PEARL-HF 

Investigators University of Michigan, Ann Arbor, MI 




Learning Objective: Describe the results of recent trials and 

discuss their implications for the care of patients with heart 

failure. 

Monday 

(continued next page) 





34 

35

Sept. 13 

Monday 

AM 

NURSING INVESTIGATOR SESSION 


10:30 AM-NOON 

Room 6C 

JNC NEW INVESTIGATOR SESSION 


10:30 AM-NOON 

Room 6D 

Sept. 13 

Monday 

AM 

Monday 

Nursing Research Award 

Moderators: Kathleen A. Dracup, San Francisco, CA 

Mariann R. Piano, Chicago, IL 

10:30* Impact of Caregiving on Family Caregivers 011 

of Patients with Heart Failure 

Boyoung Hwang, Kathleen Dracup, University of 

California, San Francisco, CA 

10:48* Cognitive Impairment Patterns in Chronic 012 


Lisa C. Bauer, Julene K. Johnson, Bunny J. Pozehl, 

University of California, San Francisco, CA 

11:06* Trends in Dyspnea Predict 12-Month 013 

Outcomes in Patients with Heart Failure 

Tsuey-Yuang Huang, Shiow-Li Hwang, Ming-Feng 

Tsai, Fu-Tien Chiang, Chun-Li Wang, Feng-Chun Tsai, 

Chun-Chi Chen, Chih-Yuan Fang, Kelvin Hsieh, 

Kuan-Rau Chiou, Terry A. Lennie, Debra K. Moser, 

Chang Gung Institute of Technology, Taoyuan, Taiwan 

11:24* Heart Failure Disease Management: 014 

Will It Reduce the Incidence of Device Shocks? 

Tamra L. Ward, Madhu Reddy, Jennifer Campbell, 

Andrew De Nazareth, Nathan Almeida, Dennis 

Esterbrooks, Claire Hunter, Creighton University, 

Omaha, NE 

11:42* Quality of Life Is Improved in Uninsured 015 

Heart Failure Patients in Disease Management 

Programs in Public Hospitals 

Aurelia Macabasco-O’Connell, Tracy Finegan, Jennifer 

Galindo, Gisele Munoz, Andrene Schonberg, Robert 

Bryg, Charles McKay, University of California, Los 

Angeles, CA. 


Learning Objective: Discuss results of recent research and 

their implications for the care of patients with heart failure. 

Jay N. Cohn New Investigator Award: 

Clinical/Integrative Physiology 

Moderators: Inder S. Anand, Minneapolis, MN 

Eugene Braunwald, Boston, MA 

10:30* Partial Recovery of Myocyte Contractile 006 

Function with Left Ventricular Assist Device 

Support in Patients with Nonischemic Cardiomyopathy 

Amrut V. Ambardekar, (2009-10 HFSA Reseach Fellow), John 

S. Walker, Lori A. Walker, Joseph C. Cleveland, Jr., Brian D. 

Lowes, Peter M. Buttrick, University of Colorado, Denver, 

CO 

10:48* Right Ventricular and Pulmonary Vascular 007 

Response Patterns to Exercise Predict Exercise 

Capacity and Outcomes in Heart Failure 

Gregory D. Lewis, Ryan M. Murphy, Ravi Shah, Paul P. 

Pappagianopoulos, Rajeev Malhotra, Kenneth D. Bloch, 

David M. Systrom, Marc. J. Semigran, Massachusetts 

General Hospital, Boston, MA 

11:06* Ventricular Assist Device Implantation Corrects 008 

Myocardial Lipotoxicity, Reverses Insulin Resistance 

and Normalizes Cardiac Metabolism in Advanced 


P. Christian Schulze, Aalap Chokshi, Michael Chew, 

Parvati Singh, Tuba Khawaja, Raffay Khan, Faisal 

Cheema, Sang-Woo Pak, Hiroo Takayama, Yoshifumi 

Naka, Ira Goldberg, Columbia University, New York, NY 

11:24* The Novel Dual Natriuretic Peptide Receptor 009 

Activator CD-NP Decreases Fibrosis and Improves 

Diastolic Dysfunction Produced by Mild Renal 

Insufficiency 

Fernando L. Martin, Jeson Sangarlingham, Paul M. McKie, 

Josef Korinek, Elise A. Oehler, Gerald E. Harders, Horng H. 

Chen, John C. Burnett, Mayo Clinic, Rochester, MN 

11:42* A Genetic Variant of the ANP Gene Is Associated 010 

with a Lower Cardiometabolic Risk Profile in the 

General USA Population 

Valentina Cannone, Guido Boerrigter, Lisa C. Costello- 

Boerrigter, Alessandro Cataliotti, Kent R. Bailey, Brian 

Lahr, Denise M. Heublein, Richard J. Rodeheffer, Timothy 

M. Olson, John C. Burnett, Mayo Clinic, Rochester, MN 

Monday 


Learning Objective: Discuss results of recent research and 


36 

37

Sept. 13 

Monday 

AM 

JNC NEW INVESTIVATOR SESSION 


10:30 AM-NOON 

Room 5AB 

ORAL ABSTRACT SESSION 


12:30-1:30 PM 

Room 5AB 

Sept. 13 

Monday 

PM 

Monday 

Jay N. Cohn New Investigator Award: 

Basic Science 

Moderators: Wilson S. Colucci, Boston, MA 

Hani N. Sabbah, Detroit, MI 

10:30* Myocardial Recovery Is Associated with Molecular 001 

Hysteresis in a Model of Conditional Transgenesis 

Veli K. Topkara, Wei Wang, Huei-Ping Tzeng, Feng Gao, 

Amanda Camp, Charles Gu, Jeffery Robbins, Philip M. Barger, 

Douglas L. Mann, Washington University, St. Louis, MO 

10:48* The Pharmacokinetics of Molecular Cardiac 002 

Surgery with Recirculating Delivery (MCARD) 

Results in Robust Cardiac-Specific βARKct Gene 

Delivery to Ovine Myocardium 

Anthony S. Fargnoli, M. Sumaroka, J. Swain, M. Katz, C. 

Tomasulo, W.J. Koch, J. Rabinowitz, C.R. Bridges, Thomas 

Jefferson University, Philadelphia, PA 

11:06* Clinical Heterogeneity of Cardiomyocytes 003 

Due to Mutations in Myopalladin Gene 

Enkhsaikhan Purevjav, Takuro Arimura, Sibylle Augustin, 

Shinichi Nunoda, Jaquelin Varela, Micaela Morgado, Debra 

L. Kearney, William McKenna, Neil E. Bowles, Michael J. 

Ackerman, Akinori Kimura, Jeffrey A. Towbin, Cincinnati 

Children’s Hospital Medical Center, Cincinnati, OH 

11:24* Loss of PHD Prolyl Hydroxylase Activity in 004 

Cardiomyocytes Phenocopies Ischemic 

Cardiomyopathy 

Javid Moslehi, Yoji Andy Minamishima, Robert Padera, 

Ronglih Liao, William G. Kaelin, Brigham and Women’s 

Hospital, Boston, MA 

11:42* Growth Hormone Releasing Hormone 005 

Agonist Improves Cardiac Performance in the 

Chronic Model of Myocardial Infarction (MI) in Rats 

Rosemeire M. Kanashiro-Takeuchi, Lauro M. Takeuchi, Raul 

Dulce, Adriana V. Treuer, Qinghua Hu, Norman L. Block, 

Andrew V. Schally, Joshua M. Hare, University of Miami, 

Miami, FL 

Leading Translational Research 

Moderators: Horng H. Chen, Rochester, MN 

David E. Lanfear, Detroit, MI 

12:30* Chronic Rapamycin Therapy Ameliorates 020 

Hypertrophy and Systolic Dysfunction in Severe 

Chronic Heart Failure Due to Pressure Overload 

Kalkidan Bishu, Selma Mohammed, Tomahito Ohtani, 

Sudhir Kushwaha, Xiaolei Xu, Ozgur Ogut, Margaret 

Redfield, Mayo Clinic, Rochester, MN 

12:45* Loss of PI3Kγ Enhances cAMP-Dependent 021 

MMP Remodeling of N-Cadherin Adhesion 

Complexes and Extracellular Matrix in Response 

to Biomechanical Stress 

Danny Guo, Zamaneh Kassiri, Josef M. Penninger, 

Gavin Y. Oudit, University of Alberta, Edmonton, Canada 

1:00* Myocardial Pronatriuretic Peptide Convertase 022 

Furin in the Presence and Absence of Experimental 


Tomoko Ichiki, Brenda K. Huntley, Horng H. Chen, 

Michihisa Jougasaki, John C. Burnett, Jr., Mayo Clinic, 

Rochester, MN 

1:15* The Right Ventricular Hypertrophic Response 023 

Does Not Mirror the Left Ventricle 

Sushma Reddy, Mingming Zhao, Viswanathan Rajagopalan, 

Giovanni Fajardo, Zhumur Ghosh, Joseph Wu, Daniel 

Bernstein, Stanford University, Palo Alto, CA 


Learning Objective: Discuss the results of recent research 

bridging the gap between basic science and clinical care. 

Monday 


Learning Objective: Discuss results and implications of 

basic science research in heart failure. 

38 

39

Sept. 13 

Monday 

PM 

Monday 

HOW TO SESSIONS 


12:30-1:30 PM 

Location 

1. How to Prevent Heart Failure Room 1AB 

Carla S. Dupree, Chapel Hill, NC 

J. Herbert Patterson, Chapel Hill, NC 

Mark A. Winchester, Durham, NC 

Learning Objective: Implement strategies to prevent the 

development of heart failure. 

2. How to Transition from Hospital to Home Room 7AB 

Kathryn H. Bowles, Philadelphia, PA 

Paul A. Heidenreich, Stanford, CA 

Learning Objective: Effectively transition patients with 

heart failure from hospital to home using patient-centered 

care strategies. 

3. How to Evaluate Supplements and Noncardiac Drug Room 2 

Interactions in Heart Failure Patients 

Alan B. Miller, Jacksonville, FL 

Mark A. Munger, Salt Lake City, UT 

Learning Objective: Counsel patients with heart failure 

on their use of supplements and identify potential 

supplement-drug interactions. 

4. How to Manage LVAD Complications Room 3 

James C. Fang, Cleveland, OH 

Carmelo A. Milano, Durham, NC 

D. Eric Steidley, Phoenix, AZ 

SYMPOSIUM 


2:00-3:30 PM 

Ballroom 6A 

Atrial Fibrillation (AF) in Heart Failure: 

The Chicken or the Egg? 

Moderator: Leslie A. Saxon, Los Angeles, CA 

2:00 Pharmacotherapy for Atrial Fibrillation in 

Heart Failure Patients 

Prakash C. Deedwania, Fresno, CA 

2:20 Anticoagulation in AF in CHF Patients 

Richard G. Becker, Durham, NC 

2:40 Managing AF in Heart Failure: Role of Catheter 

Ablation 

J. Marcus Wharton, Charleston, SC 

3:00 Registries in Atrial Fibrillation: What Do They Tell Us? 



Sept. 13 

Learning Objective: Describe the roles of catheter ablation, 

pharmacotherapies, and anticoagulation in the management 

of AF in patients with heart failure. 

Monday 

PM 

Monday 

Learning Objective: Anticipate potential complications in 

patients with LVADs and employ effective strategies in their 

management. 

5. How to Manage Peripartum Cardiomyopathy Room 8 

Uri Elkayam, Los Angeles, CA 

Dennis M. McNamara, Pittsburgh, PA 

Learning Objective: Manage patients with peripartum 

cardiomyopathy using evidence-based therapies. 

6. How to Do Site-Based Research Including Securing Room 4 

Research Grants for Your Heart Failure Practice 

Patricia A. Adams, Chapel Hill, NC 

George Sopko, Bethesda, MD 

Learning Objective: Develop a plan for site-based heart 

failure research and the submission of effective grant 

proposals. 



40 

41

Sept. 13 

Monday 

PM 

SYMPOSIUM 


2:00-3:30 PM 

Ballroom 6B 

SYMPOSIUM 


2:00-3:30 PM 

Room 6C 

Sept. 13 

Monday 

PM 

Monday 

What Is the Future of Biomarkers and 

Personalized Medicine in Heart Failure? 

Moderator: John C. Burnett, Jr., Rochester, MN 

2:00* Risk Stratification with Biomarkers: Individual or 

Multimarker Panels? 

James L. Januzzi, Boston, MA 

2:18* Transcriptomics in Heart Failure: Translational Science 

and Clinical Applications 

Thomas P. Cappola, Philadelphia, PA 

2:36* The Use of Biomarkers in Clinical Trials 


2:54* Pharmacogenetic Discovery in Clinical Trials 

Michael R. Bristow, Denver CO 

3:12* Integration of Omics 

Stephen B. Liggett, Baltimore, MD 

*15 minute presentations, 3 minute discussion 

Learning Objective: Discuss the potential uses of 

biomarkers in heart failure research and risk stratification 

and recent developments in personalized medicine. 

Cardiac Tissue Engineering 

Moderator: Roger J. Hajjar, New York, NY 

2:00 Decellularized Natural Matrix for Cardiac Organ 

Engineering 

Doris A. Taylor, Minneapolis, MN 

2:20 Biologically Inspired Injectable Matrix for Cardiac 

Tissue Engineering 

Karen L. Christman, La Jolla, CA 

2:40 Engineered Cardiac Tissues for In Vitro Evaluation of 

Myocardial Repair Strategies 

Kevin Costa, New York, NY 

3:00 Engineered Substrates for Controlling Cardiodmyocyte 

Remodeling In Vitro 

Kevin Kit Parker, Cambridge, MA 


Learning Objective: Describe current knowledge and 

practice in cardiac tissue engineering for research and 

myocardial repair. 

Monday 





42 

43

Sept. 13 

Monday 

PM 

SYMPOSIUM 


2:00-3:30 PM 

Room 6D 

SYMPOSIUM 


2:00-3:30 PM 

Room 5AB 

Sept. 13 

Monday 

PM 

Aging and Heart Failure: Bench to Bedside 

Calcium Signaling and Heart Failure 

Moderator: Kenneth B. Margulies, Philadelphia, PA 

Moderator: Shey-Shing Sheu, Rochester, NY 

2:00 Biology of Aging in the Cardiac Patient 

Bodh I. Jugdutt, Edmonton, AB, Canada 

2:00* Plasma Membrane CA2+ Signaling 

Mark E. Anderson, Iowa City, IA 

Monday 

2:20 Aging and Diastolic Heart Failure 

Jerome L. Fleg, Bethesda, MD 

2:40 How to Assess Frailty in the Elderly 

Dalane W. Kitzman, Winston-Salem, NC 

2:22* Novel Targets to Modulate SR CA2+ Signaling 

Patrick Most, Philadelphia, PA 

2:44* Mitochondrial CA2+ Signaling and Myocyte Death 

Roberta A. Gottlieb, San Diego, CA 

Monday 

3:00 Pharmacotherapy in the Elderly 

Michael W. Rich, St. Louis, MO 

3:07* Nuclear Calcium and Hypertrophic Gene Regulation 

Donald M. Bers, Davis, CA 


*20 minute presentation, 2-3 minute audience discussion 

Learning Objective: Effectively manage elderly patients 

with heart failure, including those with preserved EF, 

mindful of complications such as frailty. 

Learning Objective: Describe current research in calcium 

signaling and the role of calcium signaling in heart failure. 





44 

45

Sept. 13 

Monday 

PM 

guideline Session 


4:00-5:30 PM 

Ballroom 6B 

SYMPOSIUM 


4:00-5:30 PM 

Room 6C 

Sept. 13 

Monday 

PM 

Monday 

2010 HFSA HF Guidelines: What Is New and 

Why It Is Important? 

Moderators: JoAnn Lindenfeld, Denver, CO 

Randall C. Starling, Cleveland, OH 

4:00 Evaluation of Patients for Ventricular Dysfunction and 


W.H. Wilson Tang, Cleveland, OH 

4:07 Management of Asymptomatic Patients with Reduced 

Left Ventricular Ejection Fraction 


4:15 Questions and Comments 

4:25 Heart Failure in Patients with Left Ventricular Systolic 

Dysfunction 

Justin A. Ezekowitz, Edmonton, AB, Canada 


4:50 Evaluation and Management of Patients with Acute 

Decompensated Heart Failure 

Sean P. Collins, Cincinnati, OH 


5:15 Panel Discussion and Questions 

Nancy M. Albert, Cleveland, OH 

Sean P. Collins, Cincinnati, OH 

Justin A. Ezekowtiz, Edmonton, AB, Canada 

J. Herbert Patterson, Chapel Hill, NC 


Learning Objective: Identify changes in practice 

recommendations and implement them in the care of 

patients with heart failure. 

Ventricular Tachyarrhythmias (VT) and 

Sudden Cardiac Death: Can We Prevent Them 

in the Heart Failure Patient? 

Moderator: John P. Boehmer, Hershey, PA 

4:00 Epidemiology and Risk Stratification of Sudden Death 

Alfred E. Buxton, Providence, RI 

4:20 Pharmacotherapy of VT 

Leslie A. Saxon, Los Angeles, CA 

4:40 Device Therapy and Ablative Strategies for VT 

Management 

James P. Daubert, Durham, NC 

5:00 ICD Shocks Lead to Heart Failure 

Bruce L. Wilkoff, Cleveland, OH 


Learning Objective: Describe pharmacologic, device, and 

ablative treatment options for VT and the role of VT in the 

sudden death of patients with heart failure. 

Monday 

5:30 Poster Session and Reception 


Presenters at their Posters 5:45-6:45 PM 

Refreshments and Hors d’oeuvres served 

46 





47

Sept. 13 

Monday 

PM 

SYMPOSIUM 


4:00-5:30 PM 

Room 6D 

SYMPOSIUM 


4:00-5:30 PM 

Room 5AB 

Sept. 13 

Monday 

PM 

Genes as Guides to Diagnosis and Treatment 

of Cardiomyopathies 

Model Organisms of Cardiomyopathy 

and Aging 

Moderator: Thomas Force, Philadelphia, PA 

Moderator: Kirk U. Knowlton, San Diego, CA 

Monday 

4:00 Dilated Cardiomyopathy Genes: 30+ and Counting 

Ray E. Hershberger, Miami, FL 

4:20 Clinical Perspective in HCM 

Elizabeth M. McNally, Chicago, IL 

4:00* Drosophila as a Model of Heart Disease and Aging 

Rolf Bodmer, La Jolla, CA 

4:22* Genetic Screens for Identifying Cardiomyopathy Genes 

Matthew J. Wolf, Durham, NC 

Monday 

4:40 Myosin-Binding Protein C and HCM 

Jeffrey Robbins, Cincinnati, OH 

4:45* Zebrafish as a Model of Cardiovascular Disease 

Didier Y. R. Stainier, San Francisco, CA 

5:00 Functional Genomics in HCM Patients 

Gerald W. Dorn, II, St. Louis, MO 

5:07* Cardiac Regeneration Using Zebrafish as a Model 

Kenneth D. Poss, Durham, NC 



Learning Objective: Describe the role of genetics in the 

diagnosis and treatment of hypertrophic cardiomyopathy. 

Learning Objective: Discuss model organisms being used 

for research in cardiomyopathy and aging. 









48 

49

Sept. 13 

Monday 

Posters 

Posters 

Cardiovascular Physiology 

Posters 


Sept. 13 

Monday 

Posters 

Monday 

P024 

P025 

P026 

P027 

P028 

P029 

RGS4 Inhibits Gi-Mediated Cardiac Survival Pathways 

Anthony J. Muslin 1 , Xiaohua Jin 1 , Yoram Etzion 1 ; 1 Center for 

Cardiovascular Research, Washington University School of 

Medicine, Saint Louis, MO 

Loss of ACE2 Accelerates Pressure Overload- 

Induced Myocardial Oxidative Stress and Ventricular 

Dysfunction 

Jiu-Chang Zhong 1 , Fung L. Chow 1 , Xiu-hua Wang 1 , Zamaneh 

Kassiri 1 , Gavin Y. Oudit 1 ; 1 Department of Medicine, University of 

Alberta; Mazankowski Alberta Heart Institute, Edmonton, AB, 

Canada 

Mesenchymal Stem Cells Enhance Contractile Function 

of Myocyte-Depleted Engineered Cardiac Tissues 

Irene C. Turnbull 1 , Gregory W. Serrao 1 , Damian Ancukiewicz 1 , 

Quentin R. Youmans 1 , Lahouaria Hadri 1 , Roger J. Hajjar 1 , 

Hina W. Chaudhry 1 , Kevin D. Costa 1 ; 1 Cardiovascular Research 

Center, Mount Sinai School of Medicine, New York, NY 

Enhancing cGMP with Sildenafil and BNP Acutely 

Reduces Diastolic Stiffness in Experimental Diastolic 


Kalkidan Bishu 1 , Selma Mohammed 1 , Ahmed Abdalrhim 1 , 

Tomohito Ohtani 1 , Ozgur Ogut 1 , Wolfgang Linke 2 , John C. 

Burnett 1 , Margaret M. Redfield 1 ; 1 Cardiovascular Division, Mayo 

Clinic, Rochester, MN; 2 Institute of Physiology, Ruhr-University 

Bochum, Bochum, Germany 

The Aging Heart Is at Risk for Excessive Structural 

Remodeling and Heart Failure Post Myocardial 

Infarction 

S. Jeson Sangaralingham 1 , Fernando L. Martin 1 , Diego Bellavia 1 , 

Elise A. Oehler 1 , Paul M. McKie 1 , Tomoko Ichiki 1 , Gerald E. 

Harders 1 , Horng H. Chen 1 , John C. Burnett, Jr. 1 ; 1 Cardiovascular 

Diseases, Mayo Clinic, Rochester, MN 

Pressure Overload-Induced Heart Failure Is Associated 

with an Increased Enzymatic O-GlcNAcylation of 

Calcium Handling Proteins 

Jorge Suarez 1 , Mary O. Oyeleye 1 , Wenlong Han 1 , Wolfgang H. 

Dillmann 1 ; 1 Medicine, University of California, San Diego, La 

Jolla, CA 

P030 

P031 

P032 

P033 

P034 

P035 

Cancer Cachexia Therapy: A Matter of Helping the 

Heart? 

Jochen Springer 1,2 , Anika Tschirner 1,2 , Aleksandra Grzesiak 3 , 

Elena Kaschina 3 , Stephan von Haehling 1,2 , Stefan D. 

Anker 1,4 ; 1 Center for Cardiovascular Research, Charite Medical 

School, Berlin, Germany; 2 Applied Cachexia Research, Charite 

Medical School, Berlin, Germany; 3 Institute of Pharmacology, 

Center for Cardiovascular Research, Charite Medical School, 

Berlin, Germany; 4 Centre for Clinical and Basic Research, 

IRCCS San Raffaele, Rome, Italy 

Adiponectin and Myocardial Performance in Chronic 

Systolic Heart Failure: Potential Role in Compensation 

for Endothelial Dysfunction 

Kevin Shrestha 1 , Richard W. Troughton 2 , Allen G. Borowski 1 , 

Allan L. Klein 1 , W.H. Wilson Tang 1 ; 1 Cleveland Clinic, 

Cleveland, OH; 2 Christchurch School of Medicine and Health 

Sciences, Christchurch, New Zealand 

Is N-Terminal (NT) Pro Brain Natriuretic Peptide (BNP) 

Level Normalized by Successful Heart Transplantation 

in Infants and Children? 

James Y. Coe 1 , Connie Prosser 2 , Cathy Revers 2 ; 1 Pediatric 

Cardiology, University of Alberta, Edmonton, AB, Canada; 

2 

Clinical Laboratory Medicine, University of Alberta Hospitals, 


Invasive Optimization of the LV Lead Position, 

Atrioventricular and Interventricular Intervals during 

Cardiac Resynchronization- Role of the VV Interval 

Determined by the Long Term Follow up in the 

Prospective Randomized Study 

Dusan Z. Kocovic 1 , Nancy Britton 1 , Steven Rothman 1 , Heiman 

Mark 1 , Scott Cox 1 ; 1 Cardiology, Lankenau Hospital, Wynnewood, 

PA 

Sex Differences In Hypertrophic Remodeling and Heart 

Failure in Mice Lacking Natriuretic Peptide Receptor A 

Selma F. Mohammed 1 , Robert D. Simari 1 , John C. Burnett, Jr. 1 , 

Margaret M. Redfield 1 ; 1 Cardiovascular Diseases, Mayo Clinic, 

Rochester, MN 

Chronic Canine Study Demonstrating the Feasibility of a 

New Passive Fixation Pericardial Lead Placed by a Non- 

Surgical Percutaneous Subxiphoid Approach 

Kevin Morgan 1 , Anna Raskin 1 , Dorab Sethna 1 , Stephanie Toy 1 , 

Steve Conger 1 , Vivian Wong 1 , Joyce Tao 1 ; 1 St Jude Medical, 

Sylmar, CA 

Monday 

50 

51

Sept. 13 

Monday 

Posters 

Posters 


Posters 


Sept. 13 

Monday 

Posters 

Monday 

P036 

P037 

P038 

P039 

Human Preclinical Systolic and Diastolic Dysfunction 

Is Characterized by Impaired Cardiorenal Endocrine 

Response to Acute Volume Overload 

Paul M. McKie 1 , Sherry L. Benike 1 , Lynn K. Harstad 1 , Elise A. 

Oehler 1 , Lisa C. Costello-Boerrigter 1 , John A. Schirger 1 , Robert 

A. Simari 1 , Margaret M. Redfield 1 , John C. Burnett 1 , Horng H. 

Chen 1 ; 1 Mayo Clinic, Rochester 

Relationship between Symptomatic Dyspnea and 

Renal Function in Patients with Acute Heart Failure 

Syndromes: Results from the URGENT-Dyspnoea Study 

(Ularitide Global Evaluation in Acute Decompensated 

Heart Failure) 

Kori Sauser 1 , Peter Pang 1 , D. Mark Courtney 1 , Judd 

Hollander 2 , Sean P. Collins 3 , Alan Storrow 4 , Richard M. 

Nowak 5 , Miguel Tavares 6 , Alexandre Mebazaa 7 , Mihai 

Gheorghiade 1 ; 1 Northwestern University, Chicago, IL; 2 University 

of Pennsylvania, Philadelphia, PA; 3 University of Cincinnati, 

Cincinnati, OH; 4 Vanderbilt University, Nashville, TN; 5 Henry 

Ford Hospital, Detroit, MI; 6 Hospital Geral de Santo Antonio, 

Porto, Portugal; 7 University Paris Diderot; Hopital Lariboisiere, 

Paris, France 

Differences in Accuracy of Doppler-Estimated 

Pulmonary Vascular Resistance Relate to the Degree 

of Left Atrial Pressure Contribution to Pulmonary 

Hypertension 

Anthony F. Yu 1 , Yan Wang 1 , Lucas Marzec 1 , James N. 

Kirkpatrick 1 , Paul R. Forfia 1 ; 1 Medicine/Cardiovascular Division, 

University of Pennsylvania, Philadelphia, PA 

Novel Large Animal Model of Acute Experimental 

Hypertensive Heart Failure 

Paul M. McKie 1 , S. Jeson Sangaralingham 1 , Tomoko Ichiki 1 , 

Alessandro Cataliotti 1 , Guido Boerrigter 1 , Horng H. Chen 1 , John 

C. Burnett 1 ; 1 Mayo Clinic, Rochester 

P042 

P043 

P044 

P045 

Renal Effects of Conivaptan, Furosemide and the 

Combination in Patients with Heart Failure 

Steven R. Goldsmith 1 , Shari A. Mackedanz 2 , David T. 

Gilbertson 3 , Suzanne K. Swan 4 ; 1 Department of Medicine, 

Hennepin County Medical Center, Minneapolis, MN; 2 Research, 

Minneapolis Medical Research Foundation, Minneapolis, 

MN; 3 Chronic Disease Research Grants, Minneapolis Medical 

Research Foundation, Minneapolis, MN; 4 Research, Davita 

Clinical Research, Minneapolis, MN 

Angiotensin Converting Enzyme 2 Suppresses 

Pathological Hypertrophy, Myocardial Fibrosis and 

Diastolic Dysfunction 

Gavin Y. Oudit 1 , Jiuchang Zhong 1 , Ratnadeep Basu 1 , Danny 

Guo 1 , Josef M. Penninger 2 , Zamaneh Kassiri 1 ; 1 Medicine, 

Mazankowski Alberta Heart Institute, University of Alberta, 

Edmonton, AB, Canada; 2 IMBA, Vienna, Austria 

Reverse or Inverted Tako-Tsubo Cardiomyopathy 

(Reverse Left Ventricular Apical Ballooning Syndrome) 

Presents at a Younger Age Compared to Mid or Apical 

Variant and Is Always Associated with Triggering Stress 

Radhakrishnan Ramaraj 1,3 , Mohammad R. Movahed 1,2,3 ; 1 Internal 

Medicine, University of Arizona, Tucson, AZ; 2 Cardiology, 

University of Arizona, Tucson, AZ; 3 Internal Medicne, 

Cardiology, Southern Arizona VA Health Care System, Tucson, 

AZ 

Effects of Short-Term Right Ventricular Apical Pacing 

on Ventricular Function and Dyssinchrony in Patients 

with Sick Sinus Syndrome and Normal Ventricular 

Function 

Cesar A. Belziti 1 , Gustavo Maid 1 , Pablo Oberti 1 , Raul Perez 

Etchepare 1 , Mariano Falconi 1 , Rodolfo Pizarro 1 , Javier Victorica 1 , 

Norberto Vulcano 1 , Hernan C. Doval 1 ; 1 Cardiology, Hospital 

Italiano de Buenos Aires, Buenos Aires, Argentina 

Monday 

P040 

P041 

Increase in Infarct Wall Thickness by a Bio-Inert 

Injectable Material Is Insufficient for Improving Cardiac 

Function after Myocardial Infarction 

Aboli A. Rane 1 , Joyce S. Chuang 1 , Diane Hu 1 , Yusu Gu 1 , Kirk L. 

Peterson 1 , Jeffrey H. Omens 1 , Karen L. Christman 1 ; 1 University of 

California San Diego, La Jolla 

Myocardial Cystatin C Production in Hypertensive 

Heart Disease and Systolic Heart Failure 

Stephen J. Morrissy 1 , Wendy Sweet 2 , Christine Moravec 2 , 

W.H.Wilson Tang 2 ; 1 Internal Medicine, Cleveland Clinic, 

Cleveland, OH; 2 Cardiology, Cleveland Clinic, Cleveland, OH 

P046 

P047 

Dynamic Changes in Right Ventricular Systolic Function 

in Heart Failure 

Maya Guglin 1 , Sameer Verma 1 ; 1 Cardiology, University of South 

Florida, Tampa, FL 

Long-Term Survival and Cardiac Function Following 

Fulminant Myocarditis Requiring Percutaneous 

Extracorponeal Cardio-Pulmonary Support 

Hiroki Ishida 1 , Hiroshi Wada 1 , Kenichi Sakakura 1 , Norifumi 

Kubo 1 , Nahoko Ikeda 1 , Yoshitaka Sugawara 1 , Junya Ako 1 , Shinichi 

Momomura 1 ; 1 Division of Cardiovascular Medicine, Saitama 

Medical Center, Jichi Medical University, Saitama, Japan 

52 

53

Sept. 13 

Monday 

Posters 

Posters 

Cardiovascular Structure 

Posters 

Neurohormones/Cytokines 

Sept. 13 

Monday 

Posters 

Monday 

P071 

P072 

P073 

P074 

P075 

Improved Left Ventricular End-Systolic Myocardial Wall 

Stress Following Chronic Baroreflex Activation with the 

Rheos® System in Resistant Hypertension 

Dimitrios Georgakopoulos 1 , Abraham Kroon 2 , David S. Bach 3 , 

Christopher L. Kaufman 1 , William T. Abraham 4 , William C. 

Little 5 , Michael R. Zile 6 ; 1 CVRx Inc., Minneapolis; 2 Maastricht 

University, Maastricht, Netherlands; 3 University of Michigan, 

Ann Arbor; 4 The Ohio State University, Columbus; 5 Wake 

Forest University, Winston Salem; 6 Medical University of South 

Carolina, Charlston 

Reverse Cardiac Remodeling: Implication of the Etiology 

Raymond Yau 1 , Denise Petersen 2 , Sylvia Westrom 2 , Sharon 

Fabbri 2 , Jun R. Chiong 2 ; 1 Cardiology, Baylor College of 

Medicine, Houston, TX; 2 Loma Linda University Medical 

Center, Loma Linda, CA 

Racial Differences in Blood Volumes in Patients with 

Heart Failure and a Preserved Ejection Fraction 

(HFPEF): Implications for Diagnosing Anemia 

Bassel Noumi 1 , Sergio Teruya 1 , Stephen Helmke 1 , Mathew S. 

Maurer 1 ; 1 Medicine, Columbia University, New York, NY 

Assessment of Cardiac Fiber Orientation, Function, 

and Morphology in a Swine Model of Dilated 

Cardiomyopathy Using MRI 

Michael D. Eggen 1 , Michael G. Bateman 2,3 , Christopher D. 

Rolfes 2,3 , Stephen A. Howard 2,3 , Cory M. Swingen 4 , Paul A. 

Iaizzo 2,3 ; 1 CRDM, Medtronic, Minneapolis, MN; 2 Surgery, 

University of Minnesota, Minneapolis, MN; 3 Biomedical 

Engineering, University of Minnesota, Minneapolis, MN; 

4 

Medicine, University of Minnesota, Minneapolis, MN 

In the Setting of Preserved Left Ventricular Systolic 

Function, Is There an Association between Left 

Ventricular Mass and Ischemic Burden on Stress 

Myocardial Perfusion Imaging? 

Renee P. Bullock-Palmer 1 , Meriam F. Caboral 1 , Girardin Jean- 

Louis 1 , Judith E. Mitchell 1 ; 1 Cardiology, Kings County Hospital 

Center- SUNY Downstate Medical Center, Brooklyn, NY 

P082 

P083 

P084 

P085 

Hepcidin Does Not Mediate Anemia in Chronic Heart 

Failure Patients and Is Suppressed in Chronic Heart 


Vijay G. Divakaran 1 , Sachin Mehta 1 , David Yao 1 , Saamir 

Hassan 1 , Douglas L. Mann 3 , Vahid Afshar-Kharghan 2 ; 1 Section 

of Cardiology, Baylor College of Medicine, Houston, TX; 

2 

Division of Hematology, The University of Texas MD 

Anderson Cancer Center, Houston, TX; 3 Section of Cardiology, 

Washington University in St. Louis, St. Louis, MO 

Prognostic Value of MR-proADM and Troponin in 

Patients with Acute Dyspnea: The Biomarkers in Acute 

Heart Failure (BACH) Trial 

Lori B. Daniels 1 , Pam Taub 1 , Paul Clopton 1,2 , Frank Peacock 3 , 

Richard Nowak 4 , Stefan D. Anker 5 , Alan Maisel 1,2 ; 1 UC San 

Diego, La Jolla, CA; 2 VA San Diego, La Jolla, CA; 3 Cleveland 

Clinic, Cleveland, OH; 4 Henry Ford, Detroit, MI; 5 Charite 

Campus Virchow-Klinikum, Berlin, Germany 

Urinary NGAL Levels Predict Acute Kidney Injury 

in Emergency Department Patients with Acute Heart 


Sean Collins 1 , Matthew Sperling 1 , Alan Storrow 2 , Gregory 

Fermann 1 , David Maron 2 , John McPherson 2 , Allen Naftilan 2 , 

Sue Roll 1 , Karen Miller 2 , Christopher Lindsell 1 ; 1 University of 

Cincinnati, Cincinnati; 2 Vanderbilt University, Nashville 

Potential Renal Biomarkers in Experimental Left 

Ventricular Dysfunction 

Fernando L. Martin 1 , Brenda K. Huntley 1 , Paul M. McKie 1 , S. 

Jeson Sangaralingham 1 , Tomoko Ichiki 1 , Gerald E. Harders 1 , 

Horng H. Chen 1 , John C. Burnett 1 ; 1 Cardiovascular Diseases, 

Mayo Clinic, Rochester, MN 

P086 The Non-Failing Human Heart Secretes ProBNP 1-108 

Fima Macheret 1 , Fernando L. Martin 1 , Tomoko Ichiki 1 , Denise 

M. Heublein 1 , Brenda K. Huntley 1 , Catherine Larue 2 , Amir 

Lerman 1 , John C. Burnett 1 ; 1 Cardiorenal Research, Mayo Clinic, 

Rochester, MN; 2 Bio-Rad Laboratories, Marnes-la-Coquette, 

France 

Monday 

P076 

Heat Energy for Heart Failure Treatment 

Tofy Mussivand;, University of Ottawa Heart Institute, Ottawa, 

ON 

P087 

Relationship of Plasma Neutrophil Gelatinase-Associated 

Lipocalin (NGAL) and Anemia in Chronic Systolic Heart 

Failure beyond Renal Insufficiency 

Kevin Shrestha 1 , Richard W. Troughton 2 , Allen G. Borowski 1 , 

Allan L. Klein 1 , W.H. Wilson Tang 1 ; 1 Cardiovascular Medicine, 

Cleveland Clinic, Cleveland, OH; 2 Christchurch School of 

Medicine and Health Sciences, Christchurch, New Zealand 

54 

55

Sept. 13 

Monday 

Posters 

Posters 


Posters 


Sept. 13 

Monday 

Posters 

Monday 

P088 

P089 

P090 

Biased Agonism/Antagonism of β-Arrestin Activation by 

the Angiotensin II Type 1 Receptor: A Study of Sartans 

and Angiotensin II Analogs Using Aldosterone Turnover 

as a Readout 

Anastasios Lymperopoulos 1 , Giuseppe Rengo 2 , Vassiliki 

Magafa 3 , Paul Cordopatis 3 , Walter J. Koch 4 ; 1 Dept. of Pharm. 

Sciences, Nova Southeastern University College of Pharmacy, 

Ft. Lauderdale, FL; 2 Cardiology Division, Fondazione 

“Salvatore Maugeri”, IRCCS, Telese Terme (BN), Italy; 3 Dept. 

of Pharmacy, University of Patras, Patras, Greece; 4 Dept. of 

Medicine, Thomas Jefferson University, Philadelphia, PA 

Differential Anti-Fibrotic Effects of Vardenafil and 

Fasudil in the Heart and Kidney of Diabetic Rats 

Brenda K. Huntley 1 , Syed Ameenuddin 1 , Horng H. 

Chen 1 ; 1 Cardiorenal Research, Mayo Clinic, Rochester, MN 

The Activation of Natural Killer T Cells Ameliorates 

Post-Infarct Heart Failure in Mice 

Mochamad Ali Sobirin 1 , Shintaro Kinugawa 1 , Taisuke Ono 1 , 

Kagami Hirabayashi 1 , Tadashi Suga 1 , Takashi Yokota 1 , Naoki 

Ishimori 1 , Kazuya Iwabuchi 2 , Hiroyuki Tsutsui 1 ; 1 Cardiovascular 

Medicine, Hokkaido University Graduate School of Medicine, 

Sapporo, Hokkaido, Japan; 2 Immunobiology, Institute for 

Genetic Medicine, Hokkaido University, Sapporo, Hokkaido, 

Japan 

P092 

P104 

Changes in Plasma Biomarkers of Inflammation, 

Oxidative Stress and Thrombosis Following De Novo 

Cardiac Transplantation: Effects of Immunosuppressive 

Therapy 

Michel White 1 , Bernard Cantin 2 , Haissam Haddad 3 , Jon 

Kobashigawa 4 , Heather Ross 5 , Intiaz Ali 6 , Debra Isaac 7 , 

Renzo Cecere 8 , Shao-Hua Wang 9 , Peter Pflugfelder 10 , Rhian 

Touyz 11 ; 1 Montreal Heart Institute/Université de Montréal, 

Montreal, QC, Canada; 2 Hôpital Laval, Québec, QC, Canada; 

3 

University of Ottawa Heart Institute, Ottawa, ON, Canada; 

4 

University of California at Los Angeles, Los Angeles; 

5 

Toronto General Hospital, Toronto, ON, Canada; 6 QEII Health 

Sciences Centre, Halifax, NS, Canada; 7 Foothills Medical 

Centre, Calgary, Canada; 8 Royal Victoria Hospital, Montreal, 

QC, Canada; 9 University of Alberta Hospital, Edmonton, AB, 

Canada; 10 London Health Sciences Center, London, ON, Canada; 

11 

University of Ottawa, Ottawa, ON, Canada 

Molecular Biology and Genetics 

Nox4 Regulates Cellular Survival by Modulating 

FOXO3A Activity and SIRT1 Expression 

Lihong Cheng 1 , Atsuko Tanaka 1 , Calin Chiribau 1 , Qianhong 

Qin 1 , Dan Sorescu 1 ; 1 Division of Cardiology, Emory University, 

Atlanta, GA 

Monday 

P091 

Plasma Renin Activity (PRA) on Admission Predicts 

Diuretic Resistance and Mortality in Decompensated 

Heart Failure (HF) Patients with Renal Dysfunction 

(RD) 

Tomohito Ohtani 1 , Selma F. Mohammed 1 , Kalkidan G. 

Bishu 1 , Horng H. Chen 1 , John C. Burnett, Jr. 1 , Margaret 

M. Redfield 1 ; 1 Cardiovascular Diseases, Mayo Clinic and 

Foundation, Rochester, MN 

P105 

P106 

Bnip3 Induced Autophagy Contributes to Adverse 

Ventricular Remodeling 

Sarah A. Foyil 1 , Xiucui Ma 1 , Joseph A. Hill 2 , Gerald W. Dorn, 

II 1 , Abhinav Diwan 1 ; 1 Washington University, St. Louis; 2 UT 

Southwestern, Dallas 

Nuclear Translocation of GRK5 Following Hypertrophic 

Stimuli Is a Calmodulin-Dependent Process 

Jessica I. Gold 1 , Jeffrey S. Martini 1 , J. Kurt Chuprun 1 , Walter 

J. Koch 1 ; 1 Center of Translational Medicine, Thomas Jefferson 

University, Philadelphia, PA 

P107 

Dual Loss of PI3Kα and PI3Kγ Leads to a Paradoxical 

Increase in AKT Activation and Physiological 

Hypertrophy 

Danny Guo 1 , Ratnadeep Basu 1 , Fung L. Chow 1 , Xiuhua Wang 1 , 

Zamaneh Kassiri 1 , Gavin Y. Oudit 1 ; 1 Univ of Alberta, Edmonton, 

Canada 

P108 

Age-Related Cardiac Dysfunction Is Associated with 

Enhanced Oxidative Stress in Senescence-Prone Mice 

Joshua D. Lovelock, Atsuko Tanaka, Torahiro Matsuda, Zhe 

Jiao, Qianhong Qin, Alana L. Reed, Brian H. Crawford, Mary 

B. Wagner, Roy L. Sutliff, Dan Sorescu;Medicine, Emory 

University, Atlanta, GA 

56 

57

Sept. 13 

Monday 

Posters 

Posters 


Posters 


Sept. 13 

Monday 

Posters 

Monday 

P109 

P110 

P111 

Genetic Deletion of the Collagen Receptor, DDR2, in 

Mice Leads to Slower Deposition of Fibrillar Collagen by 

Cardiac Fibroblasts 

Seon Ju Yeo 1 , Barry H. Greenberg 1 , Randy T. 

Cowling 1 ; 1 Medicine/Cardiology, UCSD, San Diego, CA 

Elevated Intramuscular Triglycerides Are Associated 

with Suppression of PDK4, Enhanced Glucose Oxidation 

and Muscle Fiber Atrophy in Animals with Chronic Left 

Ventricular Dysfunction 

Aalap Chokshi 1 , Raffay Khan 1 , John Morrow 1 , Chad Trent 1 , 

Steven Marx 1 , Ira Goldberg 1 , P. Christian Schulze 1 ; 1 Medicine, 

Columbia University Medical Center, New York, NY 

Deletion of NADPH Oxidase Homologue Nox2 

Accelerates Age-Related Cardiac Remodeling in Mice 

Atsuko Tanaka, Torahiro Matsuda, Zhe Jiao, Joshua D. 

Lovelock, Lihong Cheng, Qianhong Qin, Dan Sorescu;Internal 

Medicine, Emory University, Atlanta, GA 

P116 

P129 

NPPA Genotype Is Associated with Aldosterone 

Breakthrough in Heart Failure 

Larisa H. Cavallari 1 , Shitalben R. Patel 1 , Yana Blekhman 1 , 

Vicki L. Groo 1 , Thomas D. Stamos 2 ; 1 Department of Pharmacy 

Practice, University of Illinois at Chicago, Chicago, IL; 

2 

Department of Medicine, University of Illinois at Chicago, 

Chicago, IL 

Surgery, Transplantation, Devices 

Predictive Value of the Seattle Heart Failure Model 

in Patients Undergoing Left Ventricular Assist Device 

Placement 

Eric S. Ketchum 1 , Daniel P. Fishbein 1 , Nahush A. Mokadam 2 , 

Edward D. Verrier 2 , Gabriel S. Aldea 2 , Shauna Andrus 2 , Kenneth 

W. Kenyon 1 , Wayne C. Levy 1 ; 1 Cardiology/Internal Medicine, 

University of Washington, Seattle, WA; 2 Cardiothoracic Surgery, 

University of Washington, Seattle, WA 

Monday 

P112 

P113 

P114 

P115 

Overexpression of C-Reactive Protein Exacerbates 

Pressure Overload-Induced Left Ventricular 

Hypertrophy and Fibrosis in Association with Enhanced 

Inflammatory Response 

Toshiyuki Nagai 1 , Toshihisa Anzai 1 , Yoshinori Mano 1 , Hidehiro 

Kaneko 1 , Atsushi Anzai 1 , Yuichiro Maekawa 1 , Tsutomu 

Yoshikawa 1 , Keiichi Fukuda 1 ; 1 Cardiology, Keio University 

School of Medicine, Tokyo, Japan 

Defining the Role of the Transcription Factor TCF7L2 in 

Type 2 Diabetes 

Melissa K. Thomas, Cyprian Weaver, Bonnie LaCroix, Mila 

Prokunina-Olsson, Jennifer L. Hall;, Mass General Hospital, 

Boston, MA; Lillehei Heart Institute, University of Minnesota, 

Minneapolis, MN; , NCI, Bethesda, MD; Developmental 

Biology, University of Minnesota, Minneapolis, MN 

Myocardial Transcriptional Profiling Reveals a Distint 

Molecular Signature in Patients with Postpartum 

Cardiomyopathy 

Veli K. Topkara 1 ; 1 Cardiology, Washington University School of 

Medicine, St. Louis, MO 

Mitochondrial Respiratory Capacity in Diabetic Heart 

Failure Patients 

Dale J. Hamilton 1 , Luz E. Vela 3 , Heather L. Brasher 3 , Matthias 

Loebe 4 , Keith A. Youker 2 , Guillermo Torre-Amione 2 , William 

Widger 3 ; 1 Medicine, The Methodist Hospital & Research 

Institute, Houston, TX; 2 Cardiology, The Methodist Hospital & 

Research Institute, Houston, TX; 3 Biochemistry, University of 

Houston, Houston, TX; 4 Cardiovascular Thorasic Surgery, The 

Methodist Hospital, Houston, TX 

P130 

P131 

P132 

Novel Dynamic Heart Failure Risk Score Incorporating 

Implanted Device Diagnostic Parameters 

Shantanu Sarkar 1 , Jodi Koehler 1 , Holly Vitense 1 , Doug 

Hettrick 1 ; 1 Cardiac Rhythm and Disease Management, Medtronic 

Inc., Moundsview, MN 

Impact of Shock Energy and Ventricular Rhythm on the 

Success of First Shock Therapy – The ALTITUDE Study 

Group 

Yong-Mei Cha 1 , David L. Hayes 1 , Samuel J. Asirvatham 1 , Brian 

D. Powell 1 , David A. Cesario 2 , Michael Cao 2 , F. Roosevelt 

Gilliam, III 3 , Paul Jones 4 , Milan Seth 4 , Leslie A. Saxon 5 ; 1 Division 

of Cardiovascular Diseases, Mayo Clinic, Rochester, MN; 

2 

Cardiovascular Medicine, Keck School of Medicine, Los 

Angeles, CA; 3 Cardiology Associates of Northeast Arkansas, 

Jonesboro, AR; 4 Boston Scientific, St. Paul, MN; 5 University of 

Southern California, Los Angeles, CA 

Acute Left Ventricular Reconstruction with 

Circumferential Mid-Ventricular Intramyocardial 

Injections of Alginate Hydrogel in Dogs with Chronic 


Itamar Ilsar 1 , Mengjun Wang 1 , Michael S. Sabbah 1 , Ramesh C. 

Gupta 1 , Sharad Rastogi 1 , Sam Helgerson 2 , Norman Tarazona 2 , 

Randall J. Lee 3 , Hani N. Sabbah 1 ; 1 Henry Ford Hospital, Detroit, 

MI; 2 CardioPolymers, Inc., Laguna Hills, CA; 3 UCSF, San 

Francisco, CA 

58 

59

Sept. 13 

Monday 

Posters 

Posters 


Posters 


Sept. 13 

Monday 

Posters 

P133 

First Reported Experience with Percutaneous Placement 

of Axillary-Subclavian Intra-Aortic Balloon Pumps that 

Permit Ambulation for Patients with Advanced Heart 


Jerry D. Estep 1 , Nashwa Khalil 1 , Brian Bruckner 2 , Matthias 

Loebe 2 , Carlos Orrego 1 , Guillermo Torre-Amione 1 ; 1 Cardiology, 

The Methodist Hospital, Houston, TX; 2 Cardiovascular Thoracic 

Surgery, The Methodist Hospital, Houston, TX 

P139 

Impact of Chronic Right Ventricular Failure on 

Outcomes in Left Ventricular Assist Device Destination 

Therapy Patients 

Robert J. Brewer 1 , Hassan W. Nemeh 1 , Jeffrey A. Morgan 1 , 

Scott E. Henry 1 , Gaetano Paone 2 , Celeste Williams 1 , Cristina 

Tita 2 , David E. Lanfear 2 ; 1 Cardiac Surgery, Henry Ford Hospital, 

Detroit, MI; 2 Advanced Heart Failure Cardiology, Henry Ford 

Hospital, Detroit, MI 

Monday 

P134 

Hepatic Dysfunction and MELD Score Improve after 

Orthotopic Heart Transplantation and Predict Post- 

Transplantation Mortality 

Aalap Chokshi 1 , Faisal Cheema 2 , Ken Schaefle 2 , Tuba Khawaja 1 , 

Maryjane Farr 1 , Hiroo Takayama 2 , Yoshifumi Naka 2 , Donna 

Mancini 1 , P. Christian Schulze 1 ; 1 Medicine, Columbia University 

Medical Center, New York, NY; 2 Surgery, Columbia University 

Medical Center, New York, NY 

P140 

In Vivo Evaluation of a Biologically Active 

Cardiomyocyte Seeded Scaffold 

Jordan J. Lancaster 1 , Sarah A. Arnce 1 , Nicholle M. Johnson 1 , 

Elizabeth Juneman 1 , Hoang Thai 1 , Robert S. Kellar 2 , 

Jose Ek Vitorin 3 , Janis Burt 3 , Joseph J. Bahl 1 , Steven 

Goldman 1 ; 1 Cardiology, Southern Arizona VA Health Care 

System, Tucson, AZ; 2 Development Engineering Sciences, 

LLC., Flagstaff, AZ; 3 University of Arizona, Tucson, AZ 

Monday 

P135 

P136 

P137 

P138 

Cardiac Allograft Remodeling and Exercise Capacity 

after Heart Transplantation 

Eugenia Raichlin 2 , Malik A. Al-Omari 1 , Sudhir S. Kushwaha 1 , 

Brooks S. Edwards 1 , Alfredo L. Clavell 1 , Richard J. Rodeheffer 1 , 

Robert P. Frantz 1 , John A. Schirger 1 , Daly C. Daly 1 , Thomas G. 

Allison 1 , Naveen L. Pereira 1 ; 1 William J. von Liebig Transplant 

Center, Mayo Clinic, Rochester, MN; 2 Division of Cardiology, 

UNMC, Omaha, NE 

Motivation and Quality of Life in Patients with Left 

Ventricular Assist Device for Destination Therapy 

Colleen T. Gallagher, Laura A. Coyle, Antone J. Tatooles, 

Rebecca Stout, Moises F. Gaviria, Pat Pappas, Geetha 

Bhat;Center for Transplant and Mechanical Assist Device, 

Advocate Christ Medical Center, Oak Lawn, Il 

Is Left Ventricular Lead Position Associated with a 

Differential Outcome in Cardiac Resynchronization 

Therapy 

Kelly L. Brooke 1 , Tracy Webster 1 , David O. Hodge 1 , Heather 

J. Wiste 1 , David L. Hayes 1 , Yong-Mei Cha 1 ; 1 Division of 

Cardiovascular Diseases, Mayo Clinic, Rochester, MN 

Is There a Gender Difference in Outcomes of Cardiac 

Resynchronization Therapy? 

Kelly L. Brooke 1 , Tracy Webster 1 , David O. Hodge 1 , Heather 

Wiste 1 , David L. Hayes 1 , Yong-Mei Cha 1 ; 1 Cardiovascular 

Diseases, Mayo Clinic, Rochester, MN 

P141 

P142 

P143 

P144 

Abnormal Thyroid Function in Patients with Advanced 

Heart Failure Reverses after Heart Transplantation 

Sang-Woo Pak 1 , Sarah Cappleman 1 , Kenneth J. Schaefle 1 , 

Faisal H. Cheema 1 , Gebe George 1 , Hiroo Takayama 1 , Yoshifumi 

Naka 1 , Donna Mancini 2 , Christian P. Schulze 2 , Maryjane 

Farr 2 ; 1 Cardiothoracic Surgery, Columbia University, New York, 

NY; 2 Cardiology, Columbia University, New York, NY 

Surgical Management of Chemotherapy-Induced End- 

Stage Heart Failure 

Sang-Woo Pak 1 , Nir Uriel 2 , Robert Song 1 , Alex Kossar 1 , Paolo C. 

Colombo 2 , Hiroo Takayama 1 , Yoshifumi Naka 1 , Donna Mancini 1 , 

Ulrich Jorde 1 ; 1 Surgery, Columbia University, New York, NY; 

2 

Medicine, Columbia University, New York, NY 

Indications for Hospital Readmission in Patients with 

Left-Ventricular Assist Devices (LVADs): Outcomes in 

the Continuous-Flow Era 

Veli K. Topkara 1 , Sreekanth R. Kondareddy 1 , I-Wen 

Wang 2 , Douglas L. Mann 1 , Nader Moazami 3 , Gregory A. 

Ewald 1 ; 1 Cardiology, Washington University School of Medicine, 

St. Louis, MO; 2 Cardiothoracic Surgery, Washington University 

School of Medicine, St. Louis, MO; 3 Cardiothoracic Surgery, 

Minneapolis Heart Institute, Minneapolis, MN 

The Indication for Short Term Ventricular Assist Device 

Placement Influences Survival 

Berhane Worku 1 , Hiroo Takayama 1 , Danielle Van Patten 1 , Sang- 

Woo Pak 1 , Nir Uriel 2 , Amanda Alonso 1 , Yehuda Edo Paz 1 , Ulrich 

Jorde 2 , Yoshifumi Naka 1 ; 1 Cardiothoracic Surgery, Columbia 

University/New York Presbyterian Hospital, New York, NY; 

2 

Cardiology, Columbia University/New York Presbyterian 

Hospital, New York, NY 

60 

61

Sept. 13 

Monday 

Posters 

Posters 


Posters 


Sept. 13 

Monday 

Posters 

P145 

Altered Expression of Glycogen Synthase Kinase-3 

Beta at Different Stages of Remodeling and Reverse 

Remodeling of the Human Heart 

Wendy E. Sweet 1 , Jennifer Perpar 1 , Steven J. Schomisch 2 , 

Randall C. Starling 1 , Christine S. Moravec 1 ; 1 Kaufman Center for 

Heart Failure, and Dept of Cardiovascular Medicine, Cleveland 

Clinic, Cleveland, OH; 2 Dept of Surgery, Case Western Reserve 

University, Cleveland, OH 

P152 

Partial Mechanical Support in Ovine Postinfarction 

Chronic Heart Failure: Effect on Remodelling 

Jef H. Geens 1 , Piet Claus 2 , Steven Jacobs 1 , Michael Martin 3 , 

Veerle Leunens 1 , Ingrid Van Tichelen 1 , Filip R. Rega 1 , Daniel 

Burkhoff 3 , Bart Meyns 1 ; 1 Cardiac Surgery, University Hospitals 

Leuven, Leuven, Belgium; 2 Medical Imaging, University 

Hospitals Leuven, Leuven, Belgium; 3 CircuLite, Inc., 

Hackensack 

Monday 

P146 

LVAD Support as a Bridge to Transplant in the Morbidly 

Obese Needs a Long-Term Weight Loss Strategy 

Wilbert L. Jones 1 , Luis J. Garcia 1 , Alejandro R. Trevino 1 , Brian 

A. Bruckner 1 , Matthias Loebe 1 , George P. Noon 1 , Barbara 

Elias 1 , Carlos M. Orrego 1 , Guillermo Torre-Amione 1 , Jerry D. 

Estep 1 ; 1 DeBakey Heart and Vascular Center, The Methodist 

Hospital, Houston, TX 

P153 

Coping with a New Lease on Life after LVAD-DT 

Implantation: Value of Social Work and Palliative Care 

in the Pre-LVAD Assessment and Post-Implantation Care 

Monica R. Freeman 1 , Keith M. Swetz 1 , Abigale L. Ottenberg 1 , 

Paul S. Mueller 1 , Soon J. Park 1 ; 1 Mayo Clinic, Rochester, MN 

Electrophysiology/Arrhythmias 

Monday 

P147 

P148 

P149 

P150 

P151 

S3 Amplitude Measured Using a Modified Implanted 

CRT-D Device Is Correlated to Left Atrial Pressure 

during Acute Pulmonary Edema Induction in Canines 

Abhilash Patangay 1 , Pramodsingh H. Thakur 1 , Divya Srinivasan 1 , 

Lynne Swanson 1 ; 1 Boston Scientific Corporation, Arden Hills 

Cardiac Sympathetic Reserve and Response to Cardiac 

Resynchronization Therapy 

Tracy A. Webster 1 , Kelly L. Brooke 1 , David O. Hodge 1 , David L. 

Hayes 1 , Yong-Mei Cha 1 ; 1 Mayo Clinic, Rochester, MN 

Bridge to Weight Loss: Myth or Reality 

Dzifa Dordunoo 2 , Tasha Beck 1 , James O. Mudd 1 , Ashish 

Shah 2 , John V. Conte 2 , Tammy Bubb 2 , Pamela Meyer 2 , Susan 

Ullrich 2 , Marta M. Gilson 3 , Stuart D. Russell 1 ; 1 Medicine- 

Cardiology, Johns Hopkins Hospital, Baltimore, MD; 2 Surgery, 

Johns Hopkins Hospital, Baltimore, MD; 3 Surgery – Center 

for Surgery Trials and Outcomes Research, Johns Hopkins 

University, Baltimore, MD 

Paced QRS Durations Can Be Estimated from the CRT 

Device Interventricular Conduction Delays 

Robin Germany 1 , Christina Murray 1 , Brent Sakowski 2 , Alex 

Sambelashvili 2 , Michael Ujhelyi 2 ; 1 University of Oklahoma, 

Oklahoma City, OK; 2 Medtronic Inc., Mounds View, MN 

Long Term Left Ventricular Assist Device as Bridge to 

Heart Transplantation: De Facto Destination Therapy in 

Many? 

Nir Uriel 1 , Sang-Woo Pak 2 , Mauer Biscotti 2 , Bartlomiej 

Kachniarz 2 , Paolo C. Colombo 1 , Daniel Sims 1 , Hiroo Takayama 2 , 

Yoshifumi Naka 2 , Donna Mancini 1 , Ulrich P. Jorde 1 ; 1 Medicine, 

Columbia University, New York, NY; 2 Surgery, Columbia 

University, New York, NY 

P179 

P180 

P181 

P182 

P183 

Does Atrial Pacing Affect Atrial Tachyarrhythmia Mode 

Switches in Heart Failure Patients? 

Ulrika Birgersdotter-Green 1 , Patrick M. Hranitzky 3 , Stacia 

Merkel Kraus 2 , Kira Q. Stolen 4 , John D. Day; 1 Division of 

Cardiology, UCSD Medical Center, San Diego, CA; 2 The 

Integra Group, Brooklyn Park, MN; 3 Duke University Medical 

Center, Durham, NC; 4 Clinical Affairs, Boston Scientific CRM, 

St. Paul, MN; 5 Intermountain Medical Center, Murray, UT 

Wearable Defibrillators within a NYHA Class IV Heart 

Failure Population 

Nicole R. Bianco 1 , Brian L. Wilmer 1 , Steven J. 

Szymkiewicz 1 ; 1 ZOLL, Pittsburgh, PA 

Arrhythmia Prevalence in Tetralogy of Fallot Relates to 

Left-Sided Cardiac Dysfunction Rather than Right-Sided 

Craig S. Broberg 1 , Jamil Aboulhosn 2 , Michelle Gurvitz 2 , Joseph 

Kay 2 , Anne Valente 2 , Alexander Opotowsky 2 , Deborah Gersony 2 , 

Francois-Pierre Mongeon 2 , Stephen Cook 2 , Michael Earing 2 , 

Jennifer Ting 2 , George Lui 2 , Paul Khairy 2 ; 1 Cardiology, Oregon 

Health and Science University, Portland, OR; 2 Alliance for Adult 

Research in Congenital Cardiology (AARCC), Portland, OR 

Simplified Identification of Heart Failure Patients Who 

May Benefit from PVC Ablation 

Faisal Siddiqi 1 , Mukta Srivastava 1 , Magdi Saba 1 , Anastasios 

Saliaris 1 , Stephen Shorofsky 1 , Timm Dickfeld 1 ; 1 Cardiology, 

University of Maryland, Baltimore, MD 

Real World Experience with the Wearable External 

Defibrillator: A False Sense of Security? 

Faisal Siddiqi 1 , Kristin Thanavaro 1 , Timm Dickfeld 1 , Anastasios 

Saliaris 1 , Stephen Shorofsky 1 , Magdi Saba 1 ; 1 Cardiology, 

University of Maryland, Baltimore, MD 

62 

63

Sept. 13 

Monday 

Posters 

Posters 


Posters 


Sept. 13 

Monday 

Posters 

Monday 

P184 

P185 

P186 

P187 

P188 

Dedicated Anti-Arrhythmic Drug Service within a VA 

Center 

Amy C. Andrews, Kimberly A. Selzman, Stephen L. 

Wasmund;Electrophysiology Service, Salt Lake City VA 

Medical Center, Salt Lake City, UT; Cardiovascular Research 

and Training Institute, University of Utah Medical Center, Salt 

Lake City, UT 

Clinical Subtype of Atrial Fibrillation at the Time of 

Implantation and Subsequent Mortality among Veterans 

with Implantable Defibrillators 

Ryan Aleong 1 , William H. Sauer 1 , Cara N. Pellegrini 2 , Yanfei 

Yang 2 , Edmund Keung 2 , Paul Heidenreich 3 , John S. Rumsfeld 4,1 , 

Barry M. Massie 2 , Paul D. Varosy 4,1 ; 1 Medicine, University of 

Colorado Denver, Aurora, CO; 2 Medicine, San Francisco VAMC 

and UCSF, San Francisco, CA; 3 Medicine, Palo Alto VAMC 

and Stanford University, Palo Alto, CA; 4 Medicine, VA Eastern 

Colorado Health Care System, Denver, CO 

Comparison of Right and Left Unilateral Phrenic Nerve 

Stimulation in the Termination of Central Apnea Events 

Ayesha Hasan 1 , Dariusz Michalkiewicz 2 , Danuta Czarnecka 3 , 

Piotr Ponikowksi 4 , William T. Abraham 1 ; 1 The Ohio State 

University, Columbus; 2 Central Military Hospital, Warsaw, 

Poland; 3 Jagiellonian University, Krakow, Poland; 44 th Military 

Hospital, Wroclaw, Poland 

“Inappropriate” Shocks for Atrial Fibrillation/Flutter 

Detected by Remote Monitoring 

David A. Cesario 1 , Michael K. Cao 1 , Yongmei Cha 2 , Samuel J. 

Asirvatham 2 , Brian D. Powell 2 , Paul W. Jones 3 , F. Roosevelt 

Gilliam, III 4 , Leslie A. Saxon 1 ; 1 USC Keck School of Medicine, 

Los Angeles; 2 Mayo Clinic, Rochester; 3 Boston Scientific, St. 

Paul; 4 Cardiology Associates of Northeast Arkansas, Jonesboro 

Identification of the Pericardiophrenic Vein during 

Cardiac Procedures 

Dariusz Jagielski 1 , Ralph Augostini 2 , Ronald Berger 3 , Charles 

Henrikson 3 , George Crossley 4 , Edward Schloss 5 , Charles Love 2 , 

Dariusz Michalkiewicz 6 , Marek Jastrzebski 7 , Gabriel Yip 8 , Randy 

Westlund 9 , Nancy Johnson 9 ; 14 th Military Hospital, Wroclaw, 

Poland; 2 The Ohio State University Medical Center, Columbus, 

OH; 3 Johns Hopkins Medical Institutions, Baltimore, MD; 

4 

Baptist Hospital, Nashville, TN; 5 Christ Hospital, Cincinnati, 

OH; 6 Central Military Hospital, Warsaw, Poland; 7 Jagiellonian 

University, Krakow, Poland; 8 Prince of Wales Hospital, Shatin 

NT, Hong Kong; 9 Cardiac Concepts, Minnetonka, MN 

P189 

P190 

P203 

P204 

Preserved Right Ventricular Function Despite Low Left 

Ventricular Ejection Fraction Predicts Good Survival 

after Ablation for Recurrent Ventricular Tachycardia 

Amaar Ujeyl 1 , Keiichi Inada 1 , Katja Hillman 2 , Mahoto Kato 1 , 

Jens Seiler 1 , Usha Tedrow 1 , Lynne W. Stevenson 1 , William G. 

Stevenson 1 ; 1 Cardiovascular Division, Brigham and Women’s 

Hospital, Boston, MA; 2 Department of Economics, University of 

Hamburg, Hamburg, Germany 

Heart Failure Patients Admitted with Elevated Cardiac 

Troponin Post Implantable Cardioverter-Defibrillator 

Firing Carry the Highest Mortality Rates 

Emad F. Aziz 1 , Juan Pablo Cordova 1 , Balaji Pratap 1 , Manpreet 

Singh 1 , David Newman 2 , Dan Musat 1 , Eyal Herzog 1 ; 1 Cardiology, 

St. Luke’s-Roosevelt Hospital Center, New York, NY; 

2 

Emergency Medicine, St. Luke’s-Roosevelt Hospital Center, 

New York, NY 

Clinical Trials 

Reduction of MR Via Percutaneous Annuloplasty Is 

Associated with Significant Improvement in Exercise and 

QOL 

David G. Reuter 1 , Justina C. Wu 2 , Tomasz Siminiak 3 , Michael 

Haude 4 , Jerzy Sadowski 5 , Janusz Lipeicki 6 , Jean Fajadet 7 , 

Nawzer Mehta 1 , Uta C. Hoppe 8 ; 1 Cardiac Dimensions, Kirkland, 

WA; 2 BWH, Boston, MA; 3 Poznan Univ, Poznan, Poland; 

4 

Stadtische, Neuss, Germany; 5 John Paul II, Krakow, Poland; 

6 

Univ Hosp, Clermont-Ferrand, France; 7 Pasteur Clinic, 

Toulouse, France; 8 Univ of Cologne, Cologne, Germany 

The Influence of Bundle Branch Morphology on 

Outcomes with Cardiac Resynchronization in 

NYHA Class III/IV Heart Failure: Insights from the 

COMPANION Study 

Leslie A. Saxon 1 , Jonathan S. Steinberg 2 , Patrick Yong 3 , 

Elizabeth Galle 3 , John Boehmer 4 ; 1 USC Keck School of 

Medicine, Los Angeles, CA; 2 Columbia University, College of 

Physicians and Surgeons, New York, NY; 3 Boston Scientific 

Corporation, Saint Paul, MN; 4 Penn State University College of 

Medicine, Hershey, PA 

Monday 

64 

65

Sept. 13 

Monday 

Posters 

Posters 


Posters 


Sept. 13 

Monday 

Posters 

Monday 

P205 

Does the Effect of Beta-Blockers on Outcomes in Patients 

with Advanced Chronic Systolic Heart Failure Vary 

by Baseline Systolic Blood Pressure? Insights from the 

BEST Trial 

Michel White 1 , Ravi V. Desai 2 , Marjan Mujib 2 , Mustafa I. 

Ahmed 2 , Immaculada Aban 2 , Gregg Fonarow 3 , Prakash 

Deedwania 4 , Wilbert S. Aronow 5 , Finn Waagstein 6 , Ali 

Ahmed 7 ; 1 Montreal Heart Institute/Université de Montréal, 

Montreal, QC, Canada; 2 University of Alabama at Birmingham, 

Birmingham; 3 University of California at Los Angeles, Los 

Angeles; 4 University of California at San Francisco, Fresno; 

5 

New York Medical College, Valhalla; 6 Sahlgrenska University 

Hospital, Göteborg, Sweden; 7 University of Alabama at 

Birmingham, Alabama Veterans Affairs Medical Center, 

Birmingham 

P210 

Prognostic Value of Discharge Levels of N-Terminal Pro- 

Brain Natriuretic Peptide in 1301 Patients: A European 

Collaborative Study 

Khibar Salah 1 , Wouter E.M. Kok 1 , Luc W. Eurlings 2 , Paulo 

Bettencourt 3 , Joana M. Pimenta 3 , Luca Bettari 4 , Antonio Bayes- 

Genis 5 , Valerio Verdiani 6 , Jan G.P. Tijssen 1 ; 1 Heart Failure 

Research Center, Department of Cardiology, Academic Medical 

Center, Amsterdam, Netherlands; 2 Department of Cardiology, 

University Hospital Maastricht, Maastricht, Netherlands; 

3 

Department of Internal Medicine, Hospital S. João, Porto, 

Portugal; 4 Department of Experimental and Applied Cardiology, 

University of Brescia, Brescia, Italy; 5 Department of Cardiology, 

Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 6 Careggi 

University Hospital, Department of Internal Medicine and 

Emergency, Florence, Italy 

Monday 

P206 

P207 

P208 

P209 

Relationship between Intrathoracic Impedance, BNP and 

Six-Minute Hall Walk 

Sanjeev K. Gulati 1 , John McKenzie 2 , George H. Crossley 3 , 

Mary Anne Papp 4 , Jason Sims 5 , John Andriulli 6 ; 1 Sanger Heart & 

Vascular Institute, Charlotte, NC; 2 Glendale Memorial Hospital 

& Medical Center, Glendale, CA; 3 Mid-State Cardiology of St. 

Thomas Heart, Nashville, TN; 4 Medical College of Wisconsin, 

Milwaukee, WI; 5 Medtronic, Mounds View, MN; 6 Southern New 

Jersey Cardiac Specialists, Vorhees, NJ 

Association of Serum Bilirubin with Heart Failure 

Events but Not Coronary Events in Patients with Left 

Ventricular Systolic Dysfunction: Data from the Beta- 

Blocker Evaluation of Survival Trial (BEST) 

Larry Allen 1 , Mona Fiuzat 2 , Gordon Davis 3 , G. Michael Felker 2 , 

Michael Bristow 1,3 ; 1 University of Colorado Health Sciences 

Center, Aurora, CO; 2 Duke University Medical Center, Durham, 

NC; 3 ARCA biopharma, Inc, Broomfield, CO 

Effect of ACE Inhibitors on the Incidence of Cancer: 

Meta-Analysis of Randomized Controlled Trials 

Prasun Mishra 1 , Ilke Sipahi 2 , Sally Taylor 2 , Rebecca Boxer 2 , 

James C. Fang 2 ; 1 Internal Medicine, University Hospitals Case 

Medical Center, Cleveland, OH; 2 Cardiovascular Medicine, 

University Hospitals Case Medical Center, Cleveland, OH 

Tissue Doppler Global Function Index and Strain 

Imaging Estimation of Right Ventricular Function in 

Type 2 Diabetic Patients 

Angelina Stevanovic 1 , Anton Toncev 2 , Sinisa Dimkovic 2 , 

Milica Dekleva 2 , Nevena Punovic 1 , Dragana Toncev 2 , Nikola 

Sekularac 2 ; 1 Cardiology, Railway Health Care Institute, Belgrade, 

Serbia; 2 Cardiology, Zvezdara University Medical Center, 

Belgrade, Serbia 

P211 

P212 

P213 

P214 

Potential Interaction of Nesiritide with Clinical Variables 

Wayne C. Levy 1 , Mei L. Cheng 2 , Aldo P. Maggioni 3 , Inder 

Anand 4 , Clyde W. Yancy 5 , James B. Young 6 , Roger M. 

Mills 2 ; 1 University of Washington, Seattle, WA; 2 Scios Inc.; 

3 

Italian Association of Hospital Cardiologists, Florence, Italy; 

4 

University of Minnesota, Minneapolis, MN; 5 Baylor University 

Medical Center, Dallas, TX; 6 Cleveland Clinic, Cleveland, OH 

Prevalence of Sleep Disordered Breathing in ICD 

Patients 

Andrew J. Kaplan 1 , Philippe Mabo 2 , Enzo Aime 3 , A. Kowsar 4 , 

Pierre H. Siot 5 , Frederic Anselme 6 ; 1 Tri-City Cardiology 

Consultants, Mesa; 2 CH Pontchaillou, Rennes, France; 3 Ospedale 

San Donato, Milano, Italy; 4 Clinique du Colombier, Limoges, 

France; 5 Sorin CRM SAS, Clamart, France; 6 CHU de Rouen, 

Rouen, France 

Inadequate Self-Care Practices in Patients with 

Implantable Devices: Implications for Remote 

Monitoring 

Lisa D. Rathman 1 , Roy S. Small 1 , J. Thomas Heywood 2 , John A. 

Andriulli 3 , W.H. Wilson Tang 4 ; 1 Heart Failure Clinic, The Heart 

Group/Lancaster Heart and Stroke Foundation, Lancaster, PA; 

2 

Scripps Clinic Torrey Pines, La Jolla, CA; 3 UMDNJ, Voorhees, 

NJ; 4 Department of Cardiovascular Medicine, Cleveland Clinic, 

Cleveland, OH 

Initial Experience with Spinal Cord Stimulation (SCS) 

for the Treatment of Advanced Heart Failure 

Siller Jesus 2 , Kenneth M. Alo 2 , Guillermo Torre-Amione 1,2 ; 1 The 

Methodist DeBakey Heart & Vascular Center & Instituto de 

Cardiologia y Medicina Vascular, Cardiology; Tec de Monterrey, 

Houston, TX & Monterrey Mexico; 2 Instituto de Cardiologia y 

Medicina Vascular, Tec de Monterrey, Monterrey, Mexico 

66 

67

Sept. 13 

Monday 

Posters 

Posters 


Posters 

Cardiovascular Pharmacology 

Sept. 13 

Monday 

Posters 

Monday 

P215 

P229 

P230 

P231 

P232 

Exercise Training Improves Heart Rate Variability 

in Older Patients with Heart Failure: A Randomized, 

Controlled, Single-Blinded Study 

Khalil Murad 1 , Elsayed Z. Soliman 1 , Timothy M. Morgan 1 , 

David M. Fitzgerald 2 , Joel D. Eggebeen 2 , David C. Goff, Jr. 1 , 

Dalane W. Kitzman 2 ; 1 Public Health Sciences, Wake Forest 

University School of Medicine, Winston-Salem, NC; 2 Internal 

Medicine/Section of Cardiology, Wake Forest University School 

of Medicine, Winston-Salem, NC 


TRV120027, a β-Arrestin Biased Ligand at the 

Angiotensin II Type 1 Receptor, Produces Unique 

Pharmacology and Is a Novel Potential Therapy for 


Jonathan D. Violin 1 , David G. Soergel 1 , Scott M. DeWire 1 , 

Dennis Yamashita 1 , David Rominger 1 , Erin J. Whalen 1 , Maxine 

Gowen 1 , Michael W. Lark 1 ; 1 Trevena Inc, King of Prussia, PA 

Myocardial Specific BNP Gene-Delivery Improves 

Diastolic Function and Ventricular Structure in 

Spontaneous Hypertensive Rodents 

Diego Bellavia 1 , Alessandro Cataliotti 1 , Ikeda Iasuhiro 1 , Patricia 

A. Pellikka 2 , Margaret M. Redfield 1 , Elise Oehler 1 , Jason M. 

Tonne 1 , Francesco Pitrolo 3 , Fletcher A. Miller, Jr. 2 , John C. 

Burnett, Jr. 1 ; 1 Cardio-Renal Unit, Division of Cardiovascular 

Diseases, Mayo Clinic and Foundation, Rochester, MN; 

2 

Echocardiography Lab, Division of Cardiovascular 

Diseases, Mayo Clinic and Foundation, Rochester, MN; 

3 

Echocardiography Lab, Division of Cardiovascular Diseases, 

Ospedale Cervello, Palermo, Sicily, Italy 

Effect of the Selective Cardiac Myosin Activator, 

Omecamtiv Mecarbil, on Left Atrial Performance in 

Healthy Men 

M. Reza Habibzadeh 1 , Nelson B. Schiller 2 , Fady I. Malik 3 , 

Michael M. Chen 3 , Khalil G. Saikali 3 , Andrew A. Wolff 3 , 

Jonathan H. Goldman 4 , John R. Teerlink 2 ; 1 Cardiology, U 

Arizona, Tucson, AZ; 2 Cardiology, San Francisco VAMC/ 

UCSF, San Francisco, CA; 3 Cytokinetics, South San Francisco, 

CA; 4 ICON, Warrington, PA 

Intravenous Infusion of the Novel HNO Donor, 

CXL-1020, Improves Cardiac Mechano-Energetics: 

Comparison with Sodium Nitroprusside 

Carlos del Rio 1 , Anusak Kijtawornrat 1 , Yaowalak Panyasing 1 , 

Robert Hamlin 2 , John Reardon 3 , Reza Mazhari 3 ; 1 QTest Labs, 

Columbus, OH; 2 The Ohio State University, Columbus, OH; 

3 

Cardioxyl Pharmaceuticals, Inc., Chapel Hill, NC 

P233 

P234 

P235 

P244 

P245 

P246 

Cardiorenal Actions of TRV120027, a Novel, β-Arrestin- 

Biased Ligand at the Angiotensin II Type I Receptor, in 

Healthy and Heart Failure Canines: A Novel Therapeutic 

Strategy for Acute Heart Failure 

Guido Boerrigter 1 , Erin J. Whalen 2 , Michael Lark 2 , John C. 

Burnett 1 ; 1 Mayo Clinic, Rochester, MN; 2 Trevena, Inc., King of 

Prussia, PA 

Dobutamine Versus Milrinone in Left Ventricular 


Jeremy A. Mazurek 1 , Jason N. Salamon 2 ,Tuna Baykaner 1 , Ronald 

Zolty 2 ; 1 Department of Medicine, Jacobi Medical Center, Albert 

Einstein College of Medicine, Bronx, NY; 2 Department of 

Medicine, Division of Cardiology, Montefiore Medical Center, 

Albert Einstein College of Medicine, Bronx, NY 

Synthetic Human Calcitonin Gene Related Peptide in 

Action 

Asad Sheikh 1 , James Vacek 1 , Jeff Southard 2 , Pamela Gayheart- 

Walsten 3 , Ty Speece 3 , Keith Koehler 4 , Gary Schmitt 4 , Mary 

Fisher 4 , Lee Southard 2 ; 1 Department of Cardiovascular 

Medicine, University of Kansas, Kansas City, KS; 2 Vasogenix 

Pharmceuticals Inc, Lenexa, KS; 3 Xenometrics, Stilwell, KS; 

4 

Acceleration Laboratory Services, Lee’s Summit 

Epidemiology/Prevention 

Pro-B-Type Natriuretic Peptide Predicts Mortality and 

Cardiovascular Events in the General Community: 

Comparison to Other BNP Biomarkers 

Fima Macheret 1 , Paul McKie 1 , Guido Boerrigter 1 , Lisa Costello- 

Boerrigter 1 , Lahr Brian 2 , Denise Heublein 1 , Sandberg Sharon 1 , 

Alessandro Cataliotti 1 , Richard Rodeheffer 1 , John C. Burnett, 

Jr. 1 ; 1 Cardiorenal Research Laboratory, Mayo Clinic, Rochester, 

MN; 2 Division of Health Sciences, Mayo Clinic, Rochester, MN 

The Prevalence and Outcome of Diabetic 

Cardiomyopathy: A Population Based Study in Olmsted 

County, MN 

Aaron M. From 1 , Joshua Slusser 1 , Douglas Mahoney 1 , Richard 

Rodeheffer 1 , Horng H. Chen 1 ; 1 Mayo Clinic, Rochester, MN 

Association of NPPA rs5065 Genetic Variant with 

Increased Cardiovascular Risk in the General USA 

Population 

Valentina Cannone 1 , Guido Boerrigter 1 , Lisa C. Costello- 

Boerrigter 1 , Alessandro Cataliotti 1 , Kent R. Bailey 2 , Brian Lahr 2 , 

Denise M. Heublein 1 , Richard J. Rodeheffer 1 , Timothy M. 

Olson 3 , John C. Burnett 1 ; 1 Division of Cardiovascular Diseases, 

Mayo Clinic, Rochester, MN; 2 Division of Biostatistics, Mayo 

Clinic, Rochester, MN; 3 Division of Pediatric Cardiology, Mayo 

Clinic, Rochester, MN 

Monday 

68 

69

Sept. 13 

Monday 

Posters 

Posters 


Posters 


Sept. 13 

Monday 

Posters 

Monday 

P247 

P248 

P249 

P250 

P251 

Inciting Events in Takotsubo Cardiomyopathy: Is 

Emotional Stress Always the Culprit? 

Sarika K. Desai, Jayanta R. Das, Jerold Shinbane, Bojan Cercek, 

Suhail Dohad;Cardiovascular Thoracic Institute, University of 

Southern California Keck School of Medicine, Los Angeles, 

CA; Heart Institute, Cedars Sinai, Los Angeles, CA 

Trends in Heart Failure Epidemiology in a Midwestern 

State: Ruralness and Race over a Twelve-Year Period 

Eric S. Armbrecht 2 , Paul J. Hauptman 1 ; 1 Division of Cardiology, 

Saint Louis University, St. Louis, MO; 2 Center for Outcomes 

Research, Saint Louis University, St. Louis, MO 

Prevalence of Functional Iron Deficiency in Adults 

with Heart Failure and Associations with Anemia, 

Inflammation, and Mortality 

Ankit D. Parikh 1 , Sundar Natarajan 1,2 , Stuart R. Lipsitz 3 , Stuart 

D. Katz 4 ; 1 Medicine, New York University Langone Medical 

Center, New York, NY; 2 Internal Medicine, VA New York 

Harbor Healthcare System, New York, NY; 3 Division of General 

Internal Medicine, Brigham and Womens Hospital, Boston, MA; 

4 

Leon H Charney Division of Cardiology, New York University 

Langone Medical Center, New York, NY 

A Novel Index for Comparison of Diagnostic Accuracy of 

Stress Tests 

Maya Guglin 1 ; 1 Cardiology, University of South Florida, Tampa, FL 

Greater Adherence to the Mediterranean Diet 

Contributes to the Preservation of Left Ventricular 

Systolic Function and to the Long Term Favorable 

Prognosis of Patients after an Acute Coronary Event 

Christina Chrysohoou 1 , Panagiotis Aggelopoulos 1 , Christina 

M. Kastorini 1 , Ioanna Kehagia 1 , Evagelia Christoforatou 1 , 

Athanasios Tsiachris 1 , Christos Antoniou 1 , George Lazaros 1 , 

Christos Pitsavos 1 , Christodoulos Stefanadis 1 ; 1 First Department 

of Cardiology, Hippocrateion General Hospital, Athens, Attiki, 

Greece 

P253 

P254 

P266 

P267 

Use and Predictors of Heart Failure Disease 

Management Referral in Patients Hospitalized with 

Heart Failure: Insights from the American Heart 

Association – Get With the Guidelines Program 

Shahyar M. Gharacholou 1 , Anne S. Hellkamp 2 , Adrian F. 

Hernandez 2 , Eric D. Peterson 2 , Deepak L. Bhatt 3 , Clyde W. 

Yancy 4 , Gregg C. Fonarow 5 ; 1 Mayo Clinic, Rochester, MN; 

2 

Duke Clinical Research Institute, Durham, NC; 3 Brigham and 

Women’s Hospital, Boston, MA; 4 Baylor Heart and Vascular 

Institute, Dallas, TX; 5 University of California Los Angeles, Los 

Angeles, CA 

Omega 3 Supplementation Improves Left Ventricular 

Diastolic Function in Patients with Chronic Ischemic 


Christina Chrysohoou 1 , George Metallinos 1 , Stella Brili 1 , 

Evagelia Christoforatou 1 , Petros Arsenos 1 , Polychronis 

Dilaveris 1 , Christos Antoniou 1 , George Tsitsinakis 1 , Christos 

Pitsavos 1 , Christodoulos Stefanadis 1 ; 1 First Department of 

Cardiology, Hippocrateion General Hospital, Athens, Attiki, 

Greece 

Outcomes 

Medicare P4P Demonstration Project in Heart Failure: 

Is iIt Pay for Performance or Pay for Punishment? 

Jun R. Chiong 1 , Diane Garcia Gonzales 2 , Seth Wiafe 2 ; 1 Medicine 

– Cardiology, Loma Linda University, Loma Linda, CA; 2 School 

of Public Health, Loma Linda University, Loma Linda, CA 

Financial Impact of Pay for Performance on the US 

Hospitals 

Irma B. Ancheta 1 , Cynthia Battie 1 , Christine B. Ancheta 3 , Celso 

Perez 2 , Jun R. Chiong 2 ; 1 School of Nursing, University of North 

Florida, Jacksonville, FL; 2 Loma Linda University, Loma Linda, 

CA; 3 School of Public Health, University of South Florida, 

Tampa, FL 

Monday 

P252 

Racial/Ethnic Differences in Clinical Characteristics 

among Patients Hospitalized with Acute Decompensated 


Suleiman Daifallah 1 , Jareer Farah 2 , Sandip Zalawadiya 2 , 

Hammam Zmily 2 , Omaima Ali 2 , Jalal K. Ghali 2 ; 1 John D. Dingell 

VA Medical Center, Detroit, MI; 2 Wayne State University/ 

Detroit Medical Center, Detroit, MI 

P268 

Prognostic Importance of Serial Evaluation of Blood 

Urea Nitrogen in Ambulatory Patients with Chronic 

Systolic Heart Failure 

W.H. Wilson Tang 1 , Matthew Tong 2 , Yuping Wu 3 , Anil 

Jain 1 ; 1 Cleveland Clinic, Cleveland, OH; 2 Kettering Medical 

Center, Kettering, OH; 3 Mathematics, Cleveland State 


P269 

The Natural History of Preclinical Diastolic Dysfunction: 

A Population Based Study 

Mark W. Vogel 1 , Joshua P. Slusser 1 , David O. Hodge 1 , Horng H. 

Chen 1 ; 1 Mayo Clinic, Rochester, MN 

70 

71

Sept. 13 

Monday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 13 

Monday 

Posters 

Monday 

P270 

P271 

P272 

P273 

P274 

P275 

P276 

Low Rate of Heart Failure Hospitalization after 

Myocardial Infarction in the Occluded Artery Trial 

(OAT) 

Rahul Jhaveri 1 , Raban Jeger 2 , Harmony Reynolds 1 , Stuart Katz 1 , 

Elzbieta Zinka 3 , Sandra Forman 4 , Gervasio Lamas 5 , Judith 

Hochman 1 ; 1 NYU, NY, NY; 2 Cardiology University Hospital, 

Basel, Switzerland; 3 Voivode Hospital, Koszalin, Poland; 

4 

Maryland Medical Res Inst, Baltimore, MD; 5 Mt Sinai Medical 

Ctr, Miami, FL 

Validation of an Effective and Easily-Administered Walk 

Test Measure of Functional Status in Heart Failure 

Patients: Comparison of the 60 Foot and 6 Minute Walk 

Tests 

Kristie M. Harris 1 , Stephen S. Gottlieb 2 , Sari D. Holmes 1 , 

Andrew J. Wawrzyniak 1 , Sarah M. Godoy 1 , Britta L. Nylund 2 , 

Kerry S. Whittaker 1 , Nadine S. Bekkouche 1 , Joanne P. 

Marshall 2 , Willem J. Kop 2 , David S. Krantz 1 ; 1 Medical & Clinical 

Psychology, Uniformed Services University, Bethesda, MD; 

2 

Division of Cardiology, University of MD, Baltimore, MD 

Metformin Use and Mortality in Ambulatory Patients 

with Diabetes and Heart Failure 

David Aguilar 1,2 , Wenyaw Chan 3 , Biykem Bozkurt 1,2 , Kumudha 

Ramasubbu 1,2 , Anita Deswal 1,2 ; 1 Baylor College of Medicine, 

Houston, TX; 2 Michael E. Debakey Medical Center, Houston, 

TX; 3 University of Texas Health Science Center School of 

Public Health, Houston, TX 

Medication Adherence, Perceived Social Support, and 

Event-Free Survival in Patients with Heart Failure 

Jia-Rong Wu 1 , Debra K. Moser 1 , Misook Chung 1 , Terry A. 

Lennie 1 ; 1 College of Nursing, University of Kentucky, Lexington, 

KY 

Withdrawn 

Identifying Predictors of Diaphragmatic Stimulation in a 

CRT Patient Population 

John R. Onufer 1 , Ian F. Woollett 1 , Ashish L. Oza 2 , Stacey L. 

Neuman 2 ; 1 Cardiovascular Associates Ltd, Chesapeake, VA; 2 St. 

Jude Medical, Sylmar, CA 

Increased 90 Day Mortality in Patients with Elevated 

Neopterin: Secondary Results from the Biomarkers in 

the Acute Heart Failure (BACH) Study 

Salvatore Di Somma, Serena Gramaccini, Giulia Gagliano, 

Paul Clopton, Alan Maisel;Emergency Department, Azienda 

Ospedaliera Sant Andrea, Roma, Italy; Emergency Department, 

Azienda Ospedaliera Sant Andrea, Roma, Italy; Emergency 

Department, Azienda Ospedaliera Sant Andrea, Roma, Italy; VA 

Hospital, San Diego, CA; Cardiology, VA Hospital, San Diego, 

CA 

P277 

P278 

P279 

P280 

P281 

P282 

The Relationship between Serum Lipids and Survival in 

Patients Hospitalized with Heart Failure 

Mitja Lainscak 1 , Lea Majc-Hodoscek 2 , Stephan von Haehling 3 , 

Wolfram Doehner 3 , Stefan D. Anker 3 ; 1 Division of Cardiology, 

University Clinic Golnik, Golnik, Slovenia; 2 Department of 

Internal Medicine, General Hospital Murska Sobota, Murska 

Sobota, Slovenia; 3 Applied Cachexia Research, Division of 

Cardiology, Charite – Campus Virchow-Klinikum, Berlin, 

Germany 

Significant Tricuspid Regurgitation Predicts Mortality in 

Patients Hospitalized with Acutely Decompensated Heart 


Puja B. Parikh 1 , Smadar Kort 1 , Abhijeet Singh 1 , Roopali Parikh 1 , 

Alexander Osei-Bonsu 1 , Hal A. Skopicki 1 ; 1 Medicine, Stony 

Brook University Medical Center, Stony Brook, NY 

Heart Failure Symptoms Identified with Home 

Monitoring Predict Subsequent Shock and Death 

Paul A. Heidenreich 1 , John P. Boehmer 2 , David L. Hayes 3 , F.R. 

Gilliam 4 , John D. Day 5 , Paul W. Jones 6 , Milan Seth 6 , Leslie A. 

Saxon 7 ; 1 Stanford, Palo Alto, CA; 2 Penn St., Hershey, PA; 3 Mayo 

Clinic, Rochester, MN; 4 Cardiology Consultants, Jonesboro, 

AR; 5 Intermountain Medical Center, Salt Lake City, UT; 6 Boston 

Scientific, St. Paul, MN; 7 USC, Los Angeles, CA 

Therapeutics Effects on 6-minute Walk Distance as a 

Predictor of Therapeutic Effects on Mortality in Heart 

Failure Randomized Trials 

Benjamin S. Wessler 1 , Jessica L. Kelly 1 , Daniel G. Kramer 1 , 

Thomas A. Trikalinos 2 , David M. Kent 2 , Marvin A. Konstam 1 , 

James E. Udelson 1 ; 1 CardioVascular Center, Tufts Medical 

Center, Boston, MA; 2 Center for Clinical Evidence Synthesis, 

Institute for Clinical Research and Health Policy Studies, Tufts 

Medical Center, Boston, Ma 

Increase in Sequential Red Cell Distribution Width 

Portends Poor Prognosis in Ambulatory Heart Failure 

W.H. Wilson Tang 1 , Wilson Tong 2 , Anil Jain 1 ; 1 Cleveland Clinic, 

Cleveland, OH; 2 University of Cincinnati School of Medicine, 


Increased Morbidity in Chagas Cardiomyopathy 

Patients Compared to Other Nonischemic 

Cardiomyopathy Patients in US-Based Population 

Mahmoud Traina 1 , Salvador Hernandez 1 , Eva Padilla Garcia 1 , 

Yacen M. Elzawam 1 , Haneen Khamag 1 , Aiman M. Smer 1 , Jason 

Bradfield 1 , Sheba K. Meymandi 1 ; 1 Chagas Center of Excellence, 

Olive View-UCLA Medical Center, Sylmar, CA 

Monday 

72 

73

Sept. 13 

Monday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 13 

Monday 

Posters 

P283 

Cost of Heart Failure Admissions in Children in the 

United States 

Joseph W. Rossano 1 , David L.S. Morales 1 , Farhan Zafar 1 , Daniel 

E. Graves 1 , Biykem Bozkurt 1 , Antonio G. Cabrera 1 , Jack F. 

Price 1 , Jeffrey J. Kim 1 , William J. Dreyer 1 , Susan W. Denfield 1 , 

Jamie A. Decker 1 , John L. Jeffereis 1 ; 1 Pediatric Cardiology and 

Cardiac Surgery, Baylor College of Medicine/Texas Children’s 


P288 

Health Related Quality of Life Assessment in 

Pharmacological Clinical Trials: Rigor of Measurement 

and Reporting 

Sungwon Chang 1,2 , Phillip J. Newton 1 , Yenna Salamonson 2 , Peter 

S. MacDonald 3 , Patricia M. Davidson 1 ; 1 Curtin Health Innovation 

Research Institute, Curtin University of Technology, Sydney, 

NSW, Australia; 2 University of Western Sydney, Penrith, NSW, 

Australia; 3 St Vincent’s Hospital, Sydney, NSW, Australia 

Monday 

P284 

P285 

P286 

P287 

Peripartum Cardiomyopathy: Echocardiographic 

Characteristics and Medication Use in Patients with 

Versus without Recovery of Ventricular Function 

Kismet Rasmusson 1 , Rami Alharethi 1 , Deborah Budge 1 , Kim 

Brunisholz 1 , Benjamin Horne 1 , Jenny Connolly 1 , Kurt Jensen 1 , 

Josef Stehlik 2 , Abdallah Kfoury 1 ; 1 Heart Failure Prevention and 

Treatment Program, Intermountain Medical Center, Salt Lake 

City, UT; 2 Department of Cardiology, University of Utah, Salt 

Lake City, UT 

Evidence for an Association of Beta Blocker Dose with 

Outcome in Heart Failure: Insights from the Study of 

Anemia in a Heart Failure Population (STAMINA-HFP) 

Registry 

William G. Cotts 3 , Javed Butler 7 , Stephanie H. Dunlap 6 , Jalal K. 

Ghali 2 , Jun R. Chiong 5 , Ron M. Oren 8 , Matthew S. White 1 , Todd 

A. Schwartz 1 , J. Herbert Patterson 1 , Ileana L. Pina 4 , Kirkwood F. 

Adams, Jr. 1 ; 1 University of North Carolina at Chapel Hill, Chapel 

Hill, NC; 2 Wayne State University, Detroit, MI; 3 Northwestern 

University Feinberg School of Medicine, Chicago, IL; 4 Case 

Western Reserve University, Cleveland, OH; 5 Loma Linda 

University, Loma Linda, CA; 6 University of Cincinnati, 

Cincinnati, OH; 7 Emory University School of Medicine, Atlanta, 

GA; 8 Mercy Iowa City, Iowa City, IA 

Systolic Strain Abnormalities To Predict Hospital 

Readmission in Patients with Heart Failure and Normal 

Ejection Fraction 

Steven M. Borer 1 , David I. Silverman 1 , David 

O’Sullivan 1 ; 1 Cardiology, Hartford Hospital, Hartford, CT 

Prognostic Value of Blood Urea Nitrogen and Its 

Variations in Patients with Chronic Heart Failure 

Carlo Lombardi 1 , Marco Metra 1 , Alessandra Manerba 1 , Luca 

Bettari 1 , Silvia Bugatti 1 , Enrico Vizzardi 1 , Giovanni Cuminetti 1 , 

Elena Pezzotti 1 , Marianna Adamo 1 , Livio Dei Cas 1 ; 1 Department 

of Cardiology, University of Brescia, Brescia, Italy 

P289 

P290 

P291 

P292 

P293 

Clinical Profile and Significance of Improvement vs. 

Worsening in Renal Function during the Treatment of 

Acute Decompensated Heart Failure: Insights from the 

ESCAPE Trial Limited Dataset 

Jeffrey M. Testani 1 , Brian D. McCauley 1 , Jennifer Chen 1 , 

Stephen E. Kimmel 1 , Richard P. Shannon 1 ; 1 Medicine/Cardiology, 


Etiology and Severity of Pain in Outpatients with HF 

Steven Z. Pantilat 1 , David L. O’Riordan 1 , Teresa De Marco 1 , 

Kathleen A. Dracup 2 , Emily S. Philipps 1 ; 1 Department of 

Medicine, UCSF, San Francisco, CA; 2 School of Nursing, 

UCSF, San Francisco, CA 

Prognostic Significance of NTpro-BNP in Patients 

Having Heart Failure with Preserved Ejection Fraction, 

Compared with Those Having Reduced Ejection 

Fraction 

Gaurav Mathur 1 , Andrew Clark 2 , John G. Cleland 2 ; 1 Internal 

Medicine, Drexel University College of Medicine, Philadelphia, 

PA; 2 Academic Cardiology, University of Hull, Hull, United 

Kingdom 

Survival in Elderly Patients Supported with Continuous 

Flow LVAD as Destination Therapy 

Andrew N. Rosenbaum 1 , Ranjit John 2 , Monica M. Colvin- 

Adams 1 , Marc Pritzker 1 , Kenneth K. Liao 2 , Peter M. 

Eckman 1 ; 1 Department of Medicine, Cardiovascular Division, 

University of Minnesota, Minneapolis, MN; 2 Department of 

Surgery, Division of Cardiothoracic Surgery, University of 

Minnesota, Minneapolis, MN 

Left Ventricular Systolic Dysfunction and Myocardial 

Stunning in Out-of-Hospital Cardiopulmonary Arrest 

Patients 

Bradley A. Bart 1 , Maximilian Mulder 1 , Nathaniel L. Scott 1 , 

Thomas Dalton 1 , Stephen W. Smith 1 ; 1 Hennepin County Medical 

Center, Minneapolis, MN 

Monday 

P294 

Co-Morbid Determinants of Higher Inpatient Costs in 

147,013 Patients Admitted for Heart Failure 

Christopher S. Lee 1,2 , Grant H. Skrepnek 1 ; 1 Center for Health 

Outcomes and PharmacoEconomics, University of Arizona 

College of Pharmacy, Tucson, AZ; 2 Matrix 45 , Earlysville, VA 

74 

75

Sept. 13 

Monday 

Posters 

Posters 

Outcomes 

Posters 

Clinical Care/Management Strategies 

Sept. 13 

Monday 

Posters 

P295 

Sustained 5-Year Survival Benefit with Heart Failure 

Discharge Instructions 

Kismet D. Rasmusson 1 , Bobbi James 1 , Deborah Budge 1 , Rami 

Alharethi 1 , Benjamin D. Horne 1 , Donald L. Lappe 1 , Jenny J. 

Connolly 1 , Colleen Roberts 1 , Suzanne Simpson 1 , Abdallah G. 

Kfoury 1 ; 1 Heart Failure Prevention and Treatment Program, 

Intermountain Medical Center, Salt Lake City, UT 

P334 

Increased 90 Day Mortality in Patients with Elevated 

Copeptin and Low Sodium: Secondary Results from the 

Biomarkers in the Acute Heart Failure (BACH) Study 

Yang Xue 1 , Kevin Shah 1 , Paul Clopton 2 , Alan S. 

Maisel 1 ; 1 Cardiology, University of California San Diego, San 

Diego, CA; 2 Cardiology, San Diego Veteran Affairs Healthcare 

System, San Diego, CA 

Monday 

P296 

P297 

P331 

P332 

P333 

Prognostic Significance of Right Ventricular Systolic 

Function in Patients with Newly Diagnosed Heart 


Christina Chrysohoou 1 , Iason Kotroyiannis 1 , Athanasios 

Aggelis 1 , Stella Brili 1 , George Tsitsinakis 1 , Christos Antoniou 1 , 

George Metallinos 1 , Apostolos Tsantilas 1 , Christos Pitsavos 1 , 

Christodoulos Stefanadis 1 ; 1 Cardiology, University of Athens, 

Medical School, Athens, Greece 

Change in Renal Function and Diastolic Dysfunction 

Grade Predict Adverse Outcome in Chronic Heart 


Adrian I. Loffler 1 , Thomas P. Cappola 2 , Nancy K. 

Sweitzer 1 ; 1 Medicine, University of Wisconsin School of 

Medicine and Public Health, Madison, WI; 2 Medicine, Hospital 

of The University of Pennsylvania, Philadelphia, PA 


Pancreatitis-Associated Protein Levels Predict Severity 

of Disease In Ambulatory Heart Failure Patients 

Timothy P. Fitzgibbons 2 , Karen Berni-Giarusso 2 , Gina 

Zichitella 2 , Maggie Cabral 2 , Jean-Charles Dagorn 1 , Theo E. 

Meyer 2 ; 1 Dynabio SA, Marseille, France; 2 Heart Failure Program, 

UMass Memorial Medical Center, Worcester, MA 

Spironolactone and Beta Blockers in Patients with Left 

Ventricular Systolic Dysfunction 

Asaf Rabinovitz 1 , Jason N. Salamon 2 , Ronald Zolty 2 ; 1 Medicine, 

Jacobi Med Ctr, Bronx, NY; 2 Medicine, Division of Cardiology, 

Montefiore Med Ctr, Bronx, NY 

The Role of Electronic Medical Records (EMR) 

Innovations in Identifying Chronic Heart Failure (CHF) 

Self Care Knowledge Gaps: A Nursing Assessment Tool 

To Customize Patient Education at Point of Care 

Ganga Hematillake 1 , Prakash Deedwania 1 , Sean McFarland 2 , 

Alan Cohen 1 , Jian Huang 1 , Rebekah Carlson 2 , Julie Evans 2 , Paul 

Goebel 1 ; 1 VA Central California Health Care System and UCSF 

School of Medicine Fresno MEP, Fresno, CA; 2 VA Central 

California Health Care System, Fresno, CA 

P335 

P336 

P337 

P338 

P339 

P340 

Impact of Exercise Capacity among Elderly (≥75) with 


Jun R. Chiong 1 , Tricia Aguilar 2 ; 1 Medicine – Cardiology, Loma 

Linda University, Loma Linda, CA; 2 School of Public Health, 

Loma Linda University, Loma Linda, CA 

The Prevalence and Use of Advance Directives among 

Patients with Left Ventricular Assist Devices 

Keith M. Swetz1, Abigale L. Ottenberg1, Chadi Dib2, Monica 

R. Freeman1, Daniel P. Sulmasy3, Paul S. Mueller1;1Mayo 

Clinic, Rochester, MN; 2University of Oklahoma Health 

Sciences Center, Oklahoma City, OK; 3University of Chicago, 

Chicago, IL 

Beyond the Doppler: The Role of Non-Invasive Blood 

Pressure Measurement in Patients with Continuous Flow 

Left Ventricular Assist Devices 

Mustafa Toma 1 , Nicholas Kroll 1 , Heather Gschnell 1 , Sheryl 

Hostutler 1 , Susie Raspovic-Hopper 1 , Catherine Vacha 1 , Maria 

M. Mountis 1 ; 1 Heart and Vascular Institute, Cleveland Clinic 

Foundation, Cleveland, OH 

The Association of Do-Not-Resuscitate Preference with 

Quality of Life Preference and Mortality in Patients in 

the ESCAPE Trial 

Sandesh Dev 1 , Robert Clare 1 , Mona Fiuzat 1 , G. Michael Felker 1 , 

Christopher M. O’Connor 1 ; 1 Duke Clinical Research Institute, 

Duke University, Durham, NC 

A Study of the Unique Contribution of Spiritual Coping 

to Health-Related Quality of Life with Heart Failure 

Terry Larsen 1 ; 1 School of Nursing, California State University of 

San Marcos, San Marcos, CA 

Systemic Acidosis Predicts Malignant Ventricular 

Arrhythmias after Reperfusion Therapy for ST-Elevation 

Myocardial Infarction 

Toshiyuki Nagai 1 , Toshihisa Anzai 1 , Hidehiro Kaneko 1 , Atsushi 

Anzai 1 , Yoshinori Mano 1 , Yuji Nagatomo 1 , Shun Kohsaka 1 , 

Yuichiro Maekawa 1 , Tsutomu Yoshikawa 1 , Satoshi Ogawa 1 , 

Keiichi Fukuda 1 ; 1 Cardiology, Keio University School of 

Medicine, Tokyo, Japan 

Monday 

76 

77

Sept. 13 

Monday 

Posters 

Posters 


Posters 


Sept. 13 

Monday 

Posters 

Monday 

P341 

P342 

P343 

Patients’ Reporting Versus Electronic Health Record 

Documentation of Comorbidities among Heart Failure 

Patients 

Adnan Malik 1 , Lucy Fike 1 , Kunal Bhatt 1 , Catherine R. 

Norton 1 , Grigorios Giamouzis 1 , Charu Gupta 1 , Andreas P. 

Kalogeropoulos 1 , Vasiliki V. Georgiopoulou 1 , Sonjoy Laskar 1 , 

Andrew L. Smith 1 , Sandra Dunbar 2 , Javed Butler 1 ; 1 Division of 

Cardiology, Emory University, Atlanta, GA; 2 School of Nursing, 

Emory University, Atlanta, GA 

Potential Effects of Aggressive Decongestion during the 

Treatment of Decompensated Heart Failure on Renal 

Function and Survival: Insights from the ESCAPE Trial 

Limited Dataset 

Jeffrey M. Testani 1 , Jennifer Chen 1 , Brian D. McCauley 1 , 

Stephen E. Kimmel 1 , Richard P. Shannon 1 ; 1 Medicine/Cardiology, 


Simulated High Altitude Exposure for Heart Failure 

Patients 

Philip Formica 1 , Auris Browne 1 , Simon Maybaum 1 ; 1 Department 

of Cardiology, Montefiore Medial Center, Bronx, NY 

P347 

P348 

The Association between Treatment Performance and 

Cardiovascular Death for Patient with Acute Heart 

Failure Based on Large Prospective Hospital Cohort 

Registry 

Byung Su Yoo 1,2 , Young Jin Youn 1 , Jang Young Kim 1 , Seung 

Hwan Lee 1 , Junghan Yoon 1 , Kyung Hoon Choe 1 , Dong-Ju 

Choi 2,3 , Kyu Hyung Ryu 2 , Byung Hee Oh 2,4 , Myoung Mook 

Lee 2,5 ; 1 Cardiology, Wonju College of Medicine, Yonsei 

University, Wonju, Kangwon, Republic of Korea; 2 Investigator 

of Acute Heart Failure Registry, The Korean Society of 

Cardiology, Seoul, Republic of Korea; 3 Cardiology, Bundang 

Hospital, Seoul National University College of Medicine, 

SeoungNam, Republic of Korea; 4 Cardiology, Seoul National 

University College of Medicine, Seoul, Republic of Korea; 

5 

Cardiology, Dongguk University College of Medicine, Ilsan, 

Republic of Korea 

Clinical Characteristics and Prevelance of Hyponatremia 

in a Hospitalized Heart Failure Population 

Mona Fiuzat 1 , Linda Shaw 1 , Shailesh Shirolkar 1 , Michael Felker 1 , 

Christopher O’Connor 1 ; 1 Duke Clinical Research Institute, 

Durham, NC 

Monday 

P344 

P345 

P346 

Palliative Care: Missed Opportunities for Patients with 

End Stage Heart Failure 

Michele H. Caccavano 1 , Corrine Y. Jurgens 2 ; 1 Heart Failure 

& Cardiomyopathy Center, Stony Brook University Hospital 

Medical Center, Stony Brook, NY; 2 School of Nursing, Stony 

Brook University, Stony Brook, NY 

Characterization of Distinct Clinical Phenotypes in 

Patients with Cardiac Sarcoidosis 

Brian P. Betensky 1 , Lee R. Goldberg 1 ; 1 Internal Medicine, 

Division of Cardiovascular Medicine, Hospital of the University 

of Pennsylvania, Philadelphia, PA 

Applicability of Primary Prevention Therapy within the 

Veterans Administration 

Christopher J. Hudson 2 , Gregory W. Woo 2 , William M. 

Miles 1 , Thomas A. Burkart 1 , Jamie B. Conti 1 , Richard 

Schofield 2 ; 1 Department of Medicine, University of Florida, 

Gainesville, FL; 2 Department of Medicine, Malcolm Randall 

Veterans Administration Medical Center, Gainesville, FL 

P349 

P350 

P351 

Target Weight Guided Treatment of Acute Heart 

Failure Using Ultrafiltration or Usual Care: Results of a 

Randomized Pilot Study 

Cheryl Bartone 1 , Santosh G. Menon 1 , Dean J. Kereiakes 1 , 

Thomas M. O’Brien 1 , Wojciech Mazur 1 , Megan McClellan 1 , 

Eugene S. Chung 1 ; 1 Heart and Vascular Center, The Christ 

Hospital, Cincinnati, OH 

Physician Ethical and Legal Views Regarding 

Deactivation of Cardiac Implantable Electrical Devices 

Daniel B. Kramer 1 , Aaron S. Kesselheim 2 , Dan W. Brock 3 , 

William H. Maisel 1 ; 1 The Cardiovascular Institute, Beth 

Israel Deaconess Medical Center, Boston, MA; 2 Division of 

Pharmacoepidemiology and Pharmacoeconomics, Brigham and 

Women’s Hospital, Boston, MA; 3 Department of Global Health 

and Social Medicine, Harvard Medical School, Boston, MA 

Prognostic Implications of Family History in Pediatric 

Left Ventricular Non-Compaction 

Jeffrey J. Kim 1 , Joseph W. Rossano 1 , Jamie A. Decker 1 , Jack F. 

Price 1 , Ivan Wilmot 1 , Susan W. Denfield 1 , William J. Dreyer 1 , 

Jeffrey A. Towbin 2 , John L. Jefferies 1 ; 1 Pediatric Cardiology, 

Texas Children’s Hospital, Houston, TX; 2 Pediatric Cardiology, 

Cincinnati Children’s Hospital, Cincinnati, OH 

78 

79

Sept. 13 

Monday 

Posters 

Clinical Posters Care/Management Strategies 


Clinical Posters Care/Management Strategies 


Sept. 13 

Monday 

Posters 

Monday 

P352 

P353 

P354 

Evaluation for Cardiac Sarcoidosis – Uncertainty 

Despite Contemporary Multi-Modality Imaging 

Patricia Campbell, Garrick C. Stewart, Robert F. Padera, 

Richard N. Mitchell, Gayle L. Winters, William G. Stevenson, 

Raymond Y. Kwong, Marcelo F. Di Carli, Lynne W. 

Stevenson;Cardiology, Brigham and Women’s Hospital, Boston, 

MA 

Overdiagnosis of Left Ventricular Noncompaction 

Gagan D. Singh 1 , Ronald M. Witteles 1 ; 1 Stanford University 

Hospitals & Clinics, Stanford, CA 

Right Ventricular Performance Is Impaired in Metabolic 

Syndrome 

Dan Radulescu, Elena Buzdugan, Andreea Parv, Maria 

Radulescu, Sorin Pripon, Paula Mitrea, Gheorghe Sebesteyn, 

Constantin Cosma, Marian Mihaiu; Hospital Municipal, 

University of Medicine and Pharmacy, Cluj – Napoca, Cluj; 

Hospital Municipal, University of Medicine and Pharmacy, Cluj 

– Napoca, Cluj; Hospital Municipal, University of Medicine 

and Pharmacy, Cluj – Napoca, Cluj; Hospital Municipal, 

University of Medicine and Pharmacy, Cluj – Napoca, Cluj; 

Hospital Municipal, University of Medicine and Pharmacy, Cluj 

-Napoca, Cluj; Computer Sciences, Technical University, Cluj 

– Napoca, Cluj; Computer Sciences, Technical University, Cluj 

Napoca, Cluj; Babes – Bolyai University, Cluj – Napoca, Cluj; 

University of Veterinary Medicine, Cluj – Napoca, Cluj 

P358 

P359 

P360 

Use of 2-D Speckle Tracking Based Strain for 

Surveillance of Chemotherapeutic Induced 

Cardiotoxicity in a Pediatric Population 

Ricardo Pignatelli, Michael Taylor, Juan Plana, Lisa Sanchez, 

Kathy Kendall, Timothy Slesnick, Javier Ganame, John 

Jefferies;Pediatrics, Baylor College, Houston, TX; Pediatrics, 

Baylor College, Houston, TX; Cardiology, MDAnderson, 

Houston, TX; Cardiology, MDAnderson, Houston, TX; Pediatric 

Cardiology, Texas Children’s Hospital, Houston, TX; Pediatrics, 

Baylor College, Houston, TX; Medicine Dept, McMaster 

University, Hamilton,, ON; Pediatrics, Baylor College, Houston, 

TX 

Socio-Cultural Influences of Self-Care among African 

Americans with Heart Failure 

Victoria V. Dickson 1 , Margaret M. McCarthy 1 , Alexandra Howe 1 , 

Judith Schipper 1 , Stuart Katz 1 ; 1 NYU, New York, NY 

“No Sugar, No Fat, No Salt...What’s Left?” Perceptions 

of Self-Care among Individuals with Heart Failure Plus 

Comorbid Conditions 

Victoria V. Dickson 1 , Harleah Buck 2 , Barbara Riegel 2 ; 1 NYU, NY, 

NY; 2 Univ of Penn, Phila, PA 

Monday 

P355 

Is Thoracic Impedence Cardiography Ready to Replace 

Invasive Techniques in Measuring Cardiac Indices? A 

Meta Analysis 

Rajesh Ramineni 1 , Rahul Kodali 3 , Ramanna Merla 2 , 

Kenichi Fujise 2 , Venkata Kishore Mukku 2 , Alejandro 

Barbagelata 2 ; 1 Internal Medicine, University of Miami/Florida 

Atlantic University, Atlantis, FL; 2 Cardiology, University of 

Texas Medical Branch, Galveston, TX; 3 North Shore/Long 

Island Jewish Health System, New Hyde Park, NY 

P356 

Serial High Sensitive Troponin I Predicts Outcome in 

Patients with Acute Heart Failure 

Yang Xue 1 , Paul Clopton 2 , William F. Peacock 3 , Alan S. 

Maisel 1 ; 1 Cardiology, University of California San Diego, San 

Diego, CA; 2 Cardiology, San Diego Veteran Affairs Healthcare 

System, La Jolla, CA; 3 Emergency Medicine, Cleveland Clinic, 

Cleveland, OH 

P357 

Health Literacy, Self-Reported Education and Outcomes 

among Heart Failure Outpatients 

Vasiliki V. Georgiopoulou 1 , Andreas P. Kalogeropoulos 1 , Charu 

Gupta 1 , Grigorios Giamouzis 1 , Catherine R. Norton 1 , Kunal 

Bhatt 1 , Sonjoy Laskar 1 , Andrew L. Smith 1 , Sandra Dunbar 2 , 

Javed Butler 1 ; 1 Division of Cardiology, Emory University, 

Atlanta, GA; 2 School of Nursing, Emory University, Atlanta, GA 

80 

81

Sept. 14 

Tuesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Ballroom 6A 

SYMPOSIUM 


8:30-10:00 AM 

Ballroom 6B 

Sept. 14 

Tuesday 

AM 

A Reassessment of Dyspnea as a Critical 

Endpoint in Acute Heart Failure Trials 

Hypertension and Heart Failure: 

From Bench to Bedside 

Moderators: Mihai Gheorghiade, Chicago, IL 

Moderator: Burns C. Blaxall, Rochester, NY 

8:30 The Emergency Department Perspective 

Peter S. Pang, Chicago, IL 

8:30 Vasoactive Peptide Signaling and Vascular Control 

R. Clinton Webb, Augusta, GA 

Tuesday 

8:42 The Cardiologist’s Perspective 

Mihai Gheorghiade, Chicago, IL 

8:54 Regulatory Perspective on Dyspnea—FDA 

Norman L. Stockbridge, Silver Spring, MD 

9:08 Industry’s Perspective on Dyspnea 

Roger M. Mills, Whitehouse Station, NJ 

9:20 Dyspnea as an Endpoint in Acute Heart Failure Trials 



Learning Objective: Outline the pros and cons of using 

dyspnea as a critical endpoint in acute heart failure trials. 

8:50 Stretch and Cardiac Hypertrophy via β-Arrestin 

Signaling 

Howard A. Rockman, Durham, NC 

9:10 Cardiovascular Predictors of Hypertension Progression 

and Disease Outcomes 


9:30 Treating the Hypertensive Heart Failure Patient 

Jonathan G. Howlett, Calgary, AB, Canada 


Learning Objective: Describe selected microbiological 

determinant of hypertension, cardiovascular predictors of 

disease progression, and treatment options for the patient 

with heart failure and hypertension. 

Tuesday 





82 

83

Sept. 14 

Tuesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Room 6C 

SYMPOSIUM 


8:30-10:00 AM 

Room 6D 

Sept. 14 

Tuesday 

AM 

Prevention of Heart Failure Progression: 

New Insights for Stage B Management 

Surveillance of Patients with Heart Failure: 

How Do We Do It, When Do We Stop? 

Moderator: Bertram Pitt, Ann Arbor, MI 

8:30 Epidemiology and Pathophysiology of Stage B Heart 

Failure: Insights from SOLVD Prevention 30 Years Later 

Barry H. Greenberg, San Diego, CA 

Moderators: Kanu Chatterjee, Iowa City, IA 


8:30 Is the Physical Exam Useful in Following Patients? 

Eldrin F. Lewis, Boston, MA 

9:00 Post MI to Heart Failure 

Scott D. Solomon, Boston, MA 

8:45 Biomarkers: Do We Need Anything Else? 


9:15 Diabetes to Heart Failure 

Javed Butler, Atlanta, GA 

9:00 Imaging: When and How Often? 

Ayan R. Patel, Boston, MA 

Tuesday 

9:30 Obesity to Heart Failure 

Stefan D. Anker, Berlin, Germany 


Learning Objective: Implement strategies to prevent the 

progression of disease in patients with Stage B heart failure. 

9:15 Implantable Monitoring Devices: Can We Throw Away 

the Stethoscope? 

William T. Abraham, Columbus, OH 

9:30 When Do We Stop Monitoring and Therapy? 



Tuesday 

Learning Objective: Use the physical exam, biomarkers, 

and other strategies to monitor patients with heart failure, 

discontinuing therapy as warranted. 





84 

85

Sept. 14 

Tuesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Room 5AB 

POSTERS DISPLAYED 


9:30 AM-7:00 PM 


Sept. 14 

Tuesday 

AM 

Novel Concepts in Hypertrophic Gene 

Transcription 

PRESENTERS AT POSTERS 5:45 PM-6:45 PM 

Moderator: Federica del Monte, Boston, MA 

Categories Poster # 

8:30* MicroRNAs and Cardiac Hypertrophy 

Gianluigi Condorelli, La Jolla, CA 

Cardiovascular Physiology 048-070 

8:52* CaMKII in Cardiac Stress and Ischemic Responses 

Joan Heller Brown, San Diego, CA 

Cardiovascular Structure 077-081 

9:15* Cardiac Ncx-1 Gene Regulation by HDACs and Nkx2.5 

Donald R. Menick, Charleston, NC 

Neurohormones/Cytokines 093-103 

Tuesday 

9:38* Proteome Biology of Cardiac Mitochondria: One Protein 

Land Governed by Two Genomes 

Peipei Ping, Los Angeles, CA 


Molecular Biology and Genetics 117-128 

Surgery, Transplantation, Devices 154-178 

Tuesday 

Learning Objective: Describe current research related to 

hypertrophic gene transcription. 

Electrophysiology/Arrhythmias 191-202 

Clinical Trials 216-228 

Cardiovascular Pharmacology 236-243 

Epidemiology, Prevention 255-265 

Outcomes 298-330 

Clinical Care/Management Strategies 361-391 

Listing for Monday posters begins on page 50 

Listing for Tuesday posters begins on page 104 





86 

87

Sept. 14 

Tuesday 

AM 

CASE DISCUSSION 


10:30 AM-NOON 

Ballroom 6A 

CASE DISCUSSION 

Sept. 14 

Tuesday 

AM 

Tuesday 

Moderator: Lynne Warner Stevenson, Boston, MA 

Panelists: 

J. Malcolm O. Arnold, London, ON, Canada 

John Chin, Sacramento, CA 

Sharon A. Hunt, Stanford, CA 

Camelo A. Milano, Durham, NC 

Kismet D. Rasmusson, Murray, UT 

Patricia A. Uber, Baltimore, MD 

Bruce L. Wilkoff, Cleveland, OH 

10:30 Case 1: 38 Caucasian M software engineer presents to clinic 

with new diagnosis of cardiomyopathy for evaluation. He 

has been previously in good health, walks the dog without 

limitation. 2 weeks prior to visit, he presented with rightsided 

weakness for 4 hours which resolved, with negative 

MRI, CT, and hypercoagulability work-up. He has a history 

of migraines unlike recent symptoms. He is married with 

no children, drinks 2 beers daily with weekly heavy intake 

socially, had occasional cocaine use but none for 3 years. 

His father is living with an ICD after VT, father’s brother 

and nephew had sudden death before age 30. EKG shows 

inferior and lateral Q waves, normal QT. Echocardiogram 

shows LV size 5.4 cm, LVEF 45%, apical hypokinesis 

with no evidence of thrombus. Physical exam includes BP 

118/78, heart rate 60, and is consistent with normal resting 

filling pressures and perfusion, diffuse left ventricular lift 

nondisplaced, 1/6 systolic murmur. His current medications 

are ASA 81, clopidogrel 75 mg, and fish oil 1 gm bid. Does 

he need further therapy? 

10:52 Case 2: 22 yr old Caucasian F developed dyspnea and 

edema and was found to have an ejection fraction 19% 

in the middle of her 8th pregnancy. One year later she 

had bilateral pulmonary emboli and Factor V Leiden was 

identified. She was unable to comply with Coumadin and 

has been prescribed ACEI/carvedilol/furosemide in varying 

doses and inhalers for 2 years prior to admission with 3 

months of unrelenting orthopnea and immediate dyspnea on 

light exertion. Her tragic social history includes childhood 

abuse and unstable living situations, previous heavy alcohol 

use and continued smoking. At the time of transfer to 

transplant center, physical examination shows BP 90/76, HR 

118, RR 20, JVP 20 cm, 2+ edema and lukewarm calves, 

2/6 systolic murmurs over LSB and displaced LV apex, with 

palpable S3. The abdominal exam reveals flank bulging 

along otherwise cachectic silhouette with liver edge 8 cm 

below costal margin. She doesn’t want to stay long in the 

hospital. What can be done? 

11:14 Case 3: 64 African-American grandmother with 20 yr 

history of HTN, CAD, NIDDM, obesity, renal insufficiency 

with baseline creatinine 1.5, OSA on CPAP, recent PAF 

on amiodarone was admitted with increasing shortness of 

breath and chest discomfort. She had an acute inferior MI 

1992 with RCA stent in TIMI, no stenoses in coronary 

or renal arteries in 2006, and 2008 nuclear stress test had 

inferobasal defect with mild reversibility, EF 68%. She 

was admitted by PA to hospitalist service, where EKG and 

enzymes were negative for acute coronary syndrome, her 

home medications were given with addition of intravenous 

diuretics. During first 48 hours she initially had 2 liters of 

diuresis, then became anuric as serum creatinine increased 

from 1.4 to 4 mg/dl with increasingly severe dyspnea and 

some mental status changes. She was transferred to CCU 

where she received dialysis. What kind of cardio-renal 

syndrome is this? 

11:36 Case 4: 59 Caucasian F schoolteacher with history of 

HTN treated with 5 mg lisinopril, and shortness of breath 

progressing over about 3 months prior to admission. She has 

history of severe allergic reaction to 3 insect bites shortly 

before that time, and has been taking doxycycline for an 

abnormal chest x-ray for several weeks. She has noticed 

fullness in her chest and a decrease in appetite, feeling of 

abdominal bloating without edema. In the ED, initial BNP 

was 800, troponin 0.08, and CT scan showed no pulmonary 

emboli or adenopathy. The echocardiogram shows left 

ventricular dimension of 6.1 cm and left ventricular ejection 

fraction 20%. Initial physical examination shows heart rate 

100, blood pressure 100/76, and she is unable to lie flat due 

to respiratory distress. Lung exam shows 1 inch of rales 

bilaterally and a small right pleural effusion. The jugular 

venous pressure is 13 cm, there is no edema, the liver is 

tender but the edge is not palpable. An S3 and 1/6 systolic 

murmur are heard at the apex. What would you do next? 

Learning Objective: Using practice guidelines, research 

findings, and clinical experience, make decisions about the 

management of difficult cases in heart failure. 

Tuesday 


88 

89

Sept. 14 

Tuesday 

AM 

SYMPOSIUM 


10:30 AM-NOON 

Ballroom 6B 

SYMPOSIUM 


10:30 AM-NOON 

Room 6C 

Sept. 14 

Tuesday 

AM 

Patient Education: Strategies that Work 

Controversies in Mechanical Cardiac Support 

Tuesday 

Moderator: Mary N. Walsh, Indianapolis, IN 

10:30 Adherence and Literacy: How Can We Do Better? 

Nancy Houston-Miller, Stanford, CA 

10:45 Activity and Exercise: What Is the Right Activity 

Prescription? 

Ileana L. Piña, Cleveland, OH 

11:00 Stress Management with Biofeedback 

Christine S. Moravec, Cleveland, OH 

11:15 Managing Salt in the Diet 

Terry A. Lennie, Lexington, KY 

11:30 Managing Dietary Salt: A Public Health Dilemma 

Kirsten Bibbins-Domingo, San Francisco, CA 


Learning Objective: Use effective patient education 

strategies to improve medication adherence, exercise, and 

stress management. 

Moderators: David DeNofrio, Boston, MA 

Soon J. Park, Rochester, MN 

10:30 Biology of LV Recovery Following LVAD 

Michael A. Acker, Philadelphia, PA 

10:50 Risk Stratification for Patient Selection for 

LVAD Therapy 

Wayne C. Levy, Seattle, WA 

11:10 Pulsatile vs. Nonpulsatile Flow Devices: Lessons 

Learned from INTERMACS and Clinical Trials 

Joseph G. Rogers, Durham, NC 

11:30 Can We Afford to Use Mechanical Devices for 

Heart Failure? 

Daniel B. Mark, Durham, NC 


Learning Objective: Describe the biology of LV recovery 

following LVAD, effective strategies for risk stratification, 

the pros and cons of pulsatile vs. nonpulsatile devices, and 

the economics of LVAD use. 

Tuesday 

90 

91

Sept. 14 

Tuesday 

AM 

SYMPOSIUM 


10:30 AM-NOON 

Room 6D 

SYMPOSIUM 


10:30-NOON 

Room 5AB 

Sept. 14 

Tuesday 

AM 

Metabolic Pathways in the Failing Heart 

Innovations in Cardiomyocyte Signaling 

Moderator: Wolfgang H. Dillmann, La Jolla, CA 

Moderator: Anthony J. Muslin, St. Louis, MO 

Tuesday 

10:30 Nuclear Receptor Signaling and Heart Failure 

Daniel P. Kelly, Orlando, FL 

10:50 Adiponectin as a Cardioprotective Factor 

Kenneth Walsh, Boston, MA 

11:10 AMPK Activity in the Failing Heart 

Rong Tian, Seattle, WA 

11:30 Insulin Signaling in Cardiomyopathy 

Anthony Rosenzweig, Boston, MA 


Learning Objective: Discuss the role of metabolic pathways 

in the pathogenesis and potential treatment of heart failure. 

10:30* The APJ/Apelin Signaling Complex in Cardiac 

Hypertrophy and Failure 

Pilar Ruiz-Lozano, La Jolla, CA 

10:52* GSK3-β and Cardiac Hypertrophy and Failure 

Junichi Sadoshima, Newark, NJ 

11:14* Pathological PAR-1 Signaling in the Heart by Both 

Direct Activation and Transactivation 

Burns C. Blaxall, Rochester, NY 

11:37* Adenosine Receptors and Cardiac Hypertrophy and 


Arthur M. Feldman, Philadelphia, PA 


Tuesday 

Learning Objective: Discuss the role of cardiomyocyte 

signaling in cardiac hypertrophy and failure. 

92 

93

Sept. 14 

Tuesday 

PM 

Tuesday 

ORAL ABSTRACT SESSION 


12:30-1:30 PM 

Room 5AB 

Leading Clinical Research 

Moderators: Justin A. Ezekowitz, Edmonton, AB, Canada 

Peter P. Liu, Toronto, ON, Canada 

12:30* Pecutaneous Left Ventricular Partitioning 016 

for Ischemic Heart Failure: Results of the 

US-PARACHUTE Feasibility Study 

William T. Abraham, Ernest L. Mazzaferri, Ayesha K. Hasan, 

and US PARACHUTE Investigators, The 

Ohio State University, Columbus, OH 

12:45* Randomized Trial of Aldosterone 017 

AntagonisM in Diastolic Heart Failure 

(RAAM-DHF) 

Anita Deswal, Peter Richardson, Biykem Bozkurt, Douglas 

L. Mann, VA Medical Center & Baylor College of Medicine, 

Houston, TX 

1:00* Serum 24-Hydroxyvitamin D Concentration: 018 

Heart Failure Mortality, and Premature Death 

from All-Cause in US Adults: An Eight-Year 

Follow-Up Study 

Longjian Liu, Shelley R. Hankins, Robert A. Watson, 

Perry J. Weinstock, Howard J. Eisen, Drexel University, 


1:15* Admission, Discharge, or Change in BNP 019 

and Long-Term Mortality: Data from 

OPTIMIZE-HF Linked with Medicare Claims 

Robb Kociol, Linda K. Shaw, Gregg C. Fonarow, G. 

Michael Felker, Christopher M. O’Connor, Adrian F. 

Hernandez, Duke University, Durham, NC 


Learning Objective: Discuss findings from leading clinical 

research in heart failure. 

HOW TO SESSIONS 


12:30-1:30 PM 

Location 

7. How to Manage Dyslipidemia and Heart Failure Room 8 

Javed Butler, Atlanta, GA 

Nancy Houston-Miller, Stanford, CA 

Learning Objective: Managing the patient with heart 

failure and dyslipidemia 

8. How to Incorporate Existing and New Performance Room 7AB 

Measures Into Your Practice: What Do They Mean 

for Your Practice? 

Rebecca L. Angerstein, Norton, OH 

Paul J. Hauptman, St. Louis, MO 

Learning Objective: Incorporate current and new 

performance measures into your management of 


9. How to Choose and Optimize Device Therapy in Room 1AB 

Your Heart Failure Patient 

Paul J. Mather, Philadelphia, PA 

Leslie W. Miller, Washington, DC 

Learning Objective: Use guidelines, trial evidence, and 

clinical experience to select patients for device-based 

heart failure therapy. 

10. How to Use Genetics and Biomarkers in Your Room 4 

Outpatient Heart Failure Clinic 

Mona Fiuzat, Durham, NC 

Ray E. Hershberger, Miami, FL 

Margaret M. Redfield, Rochester, MN 

Learning Objective: Describe the effective use of genetics 

and biomarkers in the outpatient diagnosis and treatment 

of heart failure. 

Sept. 14 

Tuesday 

PM 

11. How to Treat Mitral Regurgitation in Systolic Room 3 


Tamara B. Horwich, Los Angeles, CA 

Ayan R. Patel, Boston, MA 

Tuesday 

Learning Objective: Use evidence-based treatment 

strategies to manage your patients with heart failure and 

mitral regurgitation. 

12. How to Assess Invasive and Noninvasive Hemodynamic Room 2 

Measurements 

J. Thomas Heywood, La Jolla, CA 

Michael A. Mathier, Pittsburgh, PA 

Learning Objective: Describe the effective assessment of invasive 

and noninvasive hemodynamic measurements in heart failure. 

94 

95

Sept. 14 

Tuesday 

PM 

HYDE PARK 


2:00-3:30 PM 


SYMPOSIUM 


2:00-3:30 PM 

Room 6C 

Sept. 14 

Tuesday 

PM 

Tuesday 

1:45 Announcement of Awards 

Jay N. Cohn New Investigator Awards 

Nursing Research Award 

2010 Nursing Clinical Excellence Award 

2010-11 HFSA Research Fellowship Awards 

Corrine Jurgens, Miller Place, NY 

Walter J. Koch, Philadelphia, PA 


Barbara J. Riegel, Philadelphia, PA 

Hani N. Sabbah, Detroit, MI 

Hyde Park Session 

Moderators: Douglas D. Schocken, Durham, NC 

Ronald M. Witteles, Stanford, CA 

2:00* Databases, Predictors, Statistical Modeling: 

Is the Current Approach to Clinical Research 

and Medicine Helping or Hurting Our Patients? 

Barry M. Massie, San Francisco, CA 

2:15* Do Not Call Furosemide a Devil 

Maya Guglin, Tampa, FL 

2:30* Severe Cancer Is Heart Failure – Being Cardiologists 

We Can Become Good Oncologists 

Stefan D. Anker, Berlin, Germany 

2:45* How to End the Stage D Heart Failure Ponzi Scheme 

and Rescue the American Auto Industry 

Michael B. Fowler, Stanford, CA 

3:00* My Mother Wanted Me to Be a Cardiologist, 

Not a VAD Mechanic!! 

Mathew S. Maurer, New York, NY 

3:15* What Is a Biomarker? 

Alan S. Maisel, San Diego, CA 


Learning Objective: Discuss new insights into the field of 

heart failure research, education, and clinical practice. 

Comorbidities in Heart Failure 

Moderator: Margaret M. Redfield, Rochester, MN 

2:00 Angina in Heart Failure: How Do We Manage? 


2:20 Sleep Disorders: Does Everyone with Heart 

Failure Snore? 

Stephen S. Gottlieb, Baltimore, MD 

2:40 Depression and Heart Failure: Is Diagnosing the 

Blues Helpful? 

Mark D. Sullivan, Seattle, WA 

3:00 Renal Disease and Heart Failure: Cause or Effect? 

Michael M. Givertz, Boston, MA 


Learning Objective: Effectively manage comorbidities, such 

as angina, sleep disorders, depression, and renal disease in 


Tuesday 





96 

97

Sept. 14 

Tuesday 

PM 

SYMPOSIUM 


2:00-3:30 PM 

Room 6D 

SYMPOSIUM 


2:00-3:30 PM 

Room 5AB 

Sept. 14 

Tuesday 

PM 

Guidelines, Performance Measures, and the 

Practice of Medicine: Mind the Gap 

Novel Participants in Cardiomyopathy and 


(Joint Session: HFSA and HFA of the ESC) 

Moderator: Ju Chen, La Jolla, CA 

Moderators: Douglas L. Mann, St. Louis, MO 

Piotr Ponikowski, Wroclaw, Poland 

2:00 Closing the Gap Between Guidelines and Practice 


2:25 Clinical Trials, Guidelines, and Performance Measures: 

Are They as Reliable as We Think They Are? 

Jalal K. Ghali, Detroit, MI 

2:00* TWEAK as a Novel Mediator of Cardiac Dysfunction in 


Ronglih Liao, Boston, MA 

2:22* Vinculin Abnormalities in the Failing Heart 

Robert S. Ross, San Diego, CA 

2:45* Novel Phosphatase Activity as a Target in Heart Failure 

Yibin Wang, Los Angeles, CA 

Tuesday 

2:50 The Value (and Shortcomings) of Clinical Judgment 

Piotr Ponikowski, Wroclaw, Poland 


Learning Objective: Describe the roles of clinical judgment, 

guidelines, and performance measures in the effective 

treatment of patients with heart failure. 

3:07* Protease-Dependent Profibrotic Signaling in 

Cardiac Hypertrophy 

Michael R. Zile, Charleston, SC 


Learning Objective: Describe novel participants in 

cardiomyopathy and heart failure, including TWEAK, 

vinculin, phosphatase, and proteome biology of cardiac 

mitochondria. 

Tuesday 





98 

99

Sept. 14 

Tuesday 

PM 

DEBATES 


4:00-5:30 PM 


SYMPOSIUM 


4:00-5:30 PM 

Room 6C 

Sept. 14 

Tuesday 

PM 

Moderators: Jay N. Cohn, Minneapolis, MN 

Marvin A. Konstam, Boston, MA 

Cognition and Heart Failure 

Moderator: Corrine Y. Jurgens, Stony Brook, NY 

DEBATE: LVADs in Class III HF: Should We Be Moving 

Treatment Upstream? 

4:00 Protagonist: Joseph G. Rogers, Durham, NC 

4:15 Antagonist: Stephen S. Gottlieb, Baltimore, MD 

4:30 Questions from moderators 

4:00 Neurobiological Basis of Cognitive Changes 

Mary A. Woo, Los Angeles, CA 

4:20 What Are the Best Measures of Cognition in Research 

and Clinical Practice? 

Stephen Moelter, Philadelphia, PA 

4:40 Cognition and Sleep: Are They Related? 

Barbara J. Riegel, Philadelphia, PA 

Tuesday 

DEBATE: Should 30-Day Heart Failure Readmission Be a 

Measure of Quality of Care? 

5:00 Cognition and Outcomes: Can We Improve 

Quality of Life? 

Susan J. Pressler, Ann Arbor, MI 


Tuesday 

4:45 Protagonist: Gregg C. Fonarow, Los Angeles, CA 

5:00 Antagonist: Lynne Warner Stevenson, Boston, MA 

5:15 Questions from moderators 

Learning Objective: Describe the neurobiological basis of 

cognitive changes due to heart failure, the measurement of 

cognitive changes, the relationship of cognition and sleep, 

and the role of cognition in improved outcomes. 

Learning Objective: Outline arguments for and against 

the use of LVADs in Class III heart failure and the 30-day 

readmission rate as a quality-of-care measure. 









100 

101

Sept. 14 

Tuesday 

PM 

SYMPOSIUM 


4:00-5:30 PM 

Room 6D 

SYMPOSIUM 


4:00-5:30 PM 

Room 5AB 

Sept. 14 

Tuesday 

PM 

Latest Developments in Stem Cell and Gene 

Therapy in Heart Failure 

The Cardiac Fibroblast as the Forgotten Cell in 

Cardiac Development and Disease 

Moderator: Ronglih Liao, Boston, MA 

Moderator: Francisco Villarreal, San Diego, CA 

4:00 The Clinical Experience with EPC’s 

Douglas W. Losordo, Chicago, IL 

4:00* Fibroblasts in Cardiac Development 

Simon J. Conway, Indianapolis, IN 

4:20 A Cellularized Patch for Cardiac Repair 

Steven Goldman, Tucson, AZ 

4:22* The Cardiac Fibroblast: The Renaissance Cell 

Troy A. Baudino, Temple, TX 

4:40 Cardiac Stem Cells and Myocardial Repair 

Annarosa Leri, Boston, MA 

4:44* New Roles in Fibroblasts in Cardiac Remodeling 

Paul A. Insel, La Jolla, CA 

Tuesday 

5:00 SERCA2a Gene Therapy for Heart Failure 

Roger J. Hajjar, New York, NY 


Learning Objective: Discuss current applications of stem 

cell and gene therapy in heart failure treatment. 

5:08* Novel Aspects of Cardiac Myocyte to Fibroblast 

Communication and Clinical Directions 

Gregory E. Morley, New York, NY 


Learning Objective: Discuss the role of cardiac fibroblasts 

in cardiac development, disease, and remodeling. 

Tuesday 









102 

103

Sept. 14 

Tuesday 

Posters 

Posters 


Posters 


Sept. 14 

Tuesday 

Posters 

P048 

Haemodynamic Guidance at the Time of CRT 

Implantation Improves Outcome in Patients with 

Narrow QRS and Dyssinchrony 

Dusan Z. Kocovic 1 , Nancy Britton 1 , Steven Rothman 1 , 

Mark Heiman 1 , Scott Cox 1 ; 1 Cardiology, Lankenau Hospital, 

Wynnewood, PA 

P055 

Left Ventricular Diastolic Dysfunction in Patients with 

Pulmonary Arterial Hypertension (PAH) 

Sina Dadfarmay 1 , Eyad Alhaj 1 , Rama Bindu Manchikalapudi 1 , 

Kumar Satya 1 , Robert Berkowitz 1 ; 1 Heart Failure and Pulmonary 

Hypertension, Hackensack University Medical Center, 

Hackensack, NJ 

tuesday 

P049 

P050 

P051 

P052 

P053 

P054 

LV-Only and LV-First Pacing Demonstrate Greater 

Improvements in Acute Hemodynamics than 

Synchronous BiV Pacing in Heart Failure with Preserved 


Y.C. Wang 1 , C.C. Yu 1 , Ruth N. Klepfer 2 , Katherine Hilpisch 2 , 

Vince Splett 2 , L.Y. Lin 1 , F.C. Chiu 1 , C.T. Tsai 1 , L.P. Lai 1 , J.J. 

Hwang 1 , Jiunn-Lee Lin 1 ; 1 CRDM, Medtronic, Inc., Minneapolis, 

MN; 2 National Taiwan University Hospital, Taipei, Taiwan 

Spot Measurement of Urine Sodium as an Index of 

Natriuretic and Diuretic Response to Intravenous 

Furosemide Infusion in Acute Decompensated Heart 


Dhssraj Singh 1 , Kevin Shrestha 1 , W.H. Wilson 

Tang 1 ; 1 Cardiovascular Medicine, Cleveland Clinic, Cleveland, 

OH 

Accuracy of the Assessment of Left Atrial Pressure Using 

Doppler Echocardiography 

Asim M. Rafique 1 , Anita Phan 1 , Tehrani Faramarz 1 , Nick 

Teleten 1 , Simon Biner, Robert J. Siegel 1 ; 1 Medicine/Cardiology, 

Cedars-Sinai Medical Center, Los Angeles, CA 

Pre-Ejection Time by Radial Artery Tonometry 

Correlates with Echo Doppler Hemodynamics during 

Biventricular Pacemaker Optimization 

Nima Taha 1 , Jing Zhang 1 , Rupesh Ranjan 1 , Tasneem Z. 

Naqvi 1 ; 1 University of Southern California, Los Angeles, CA 

Hypochromia Is Associated with Advanced Chronic 

Systolic Heart Failure Independent of Anemia 

W.H. Wilson Tang 1 , Kevin Shrestha 1 , Richard W. Troughton 2 , 

Allen G. Borowski 1 , Allan L. Klein 1 ; 1 Cardiovascular Medicine, 

Cleveland Clinic, Cleveland, OH; 2 Christchurch School of 

Medicine and Health Sciences, Christchurch, New Zealand 

Hemoglobin and Hematocrit Inversely Correlate with 

Systolic Function in Heart Failure 

Maya Guglin 1 , Sameer Gupta 1 ; 1 Internal Medicine, University of 

South Florida, Tampa, FL 

P056 

P057 

P058 

P059 

P060 

P061 

Echocardiographic Features of Acute Cardiorenal 

Syndrome in Patients with Advanced Heart Failure 

Sina Dadfarmay 1 , Eyad Alhaj 1 , Robert Berkowitz 1 ; 1 Heart Failure 

and Pulmonary Hypertension, Hackensack University Medical 

Center, Hackensack, NJ 

Left Atrial Function in Hypertrophic Cardiomyopathy: 

Importance and Relationship with Functional Class 

Afonso Y. Matsumoto, Edmundo Arteaga-Fernandez, Aloir 

Q. Araujo, Barbara M. Ianni, Vera M.C. Salemi, Charles 

Mady;Cardiomyopathy Unit, Heart Institute, Univ of Sao Paulo 

Medical School, Sao Paulo, Brazil 

Circulating Caspase-3 P17 Levels and 

Echocardiographic Parameters in Decompensated Heart 

Failure Patients with Preserved Ejection Fraction 

Sirtaz Adatya 1 , David Inyangetor 1 , Mariella Agosto 1 , Feinn 

Richard 1 , David Hager 1 , Erick Avelar 1 , Bruce Liang 1 ; 1 Cardiology, 

University of Connecticut, Farmington, CT 

Orientation and Magnitude of Left Ventricular Principal 

Strains as Indicator of Infarct Expansion 

Chun Xu 1 , Kevin Koomalsingh 1 , Gamaliel Issac 2 , Robert C. 

Gorman 1 , Joseph H. Gorman 1 , Lawrence Dougherty 2 , James 

J. Pilla 1 ; 1 Surgery Department, Hospital of University of 

Pennsylvania, Glenolden, PA; 2 Radiology Department, Hospital 

of University of Pennsylvania, Philadelphia, PA 

Impaired Stress-Induced Free Fatty Acid and Glucose 

Release in Congestive Heart Failure Patients with Insulin 

Resistance: A State of Metabolic Incompetence 

Nir Uriel 1 , Andrea Mignatti 1 , Paolo C. Colombo 1 , Gabriel Sayer 1 , 

Daniel Sims 1 , Samuel N. Jonas 1 , Serge Cremers 1 , Ulrich P. 

Jorde 1 ; 1 Medicine, Columbia University, New York, NY 

Impaired Right Ventricular Function Independently 

Predicts Advanced Renal Dysfunction in Patients with 


Frank Dini 1 , Paolo C. Colombo 2 , Maria Grazia Delle Donne 1 , 

Enrico Orsini 1 , Paolo Caravelli 1 , Mario Marzilli 1 ; 1 Cisanello 

University Hospital, Pisa, Italy; 2 Columbia University, New 

York 

tuesday 

104 

105

Sept. 14 

Tuesday 

Posters 

Posters 


Posters 


Sept. 14 

Tuesday 

Posters 

P062 

P063 

Novel Plasma Biomarker Candidates in Patients with 

Congestive Heart Failture 

William C. Maclellan 1 , James LeBlanc 1 , Mohamad Navab 1 , 

Gregg C. Fonarow 1 , Tamara B. Horwich 1 , William R. 

Maclellan 1 ; 1 UCLA, Westwood, CA 

Predictors of Right Ventricular Systolic Dysfunction in 

Compensated and Decompensated Heart Failure 

Maya Guglin 1 , Cho Win 1 ; 1 Internal Medicine, University of South 

Florida, Tampa, FL 

P070 

Biological Response to a Pedometer Based Walking 

Intervention in Heart Failure 

Carrie A. Geisberg (2009-10 HFSA Research Fellow) 1 , Holly M. 

Smith 1 , Michael T. Rock 2 , Douglas B. Sawyer 1 ; 1 Vanderbilt Heart 

and Vascular Institute, Vanderbilt Medical University, Nashville, 

TN; 2 Vanderbilt Division of Pediatric Infectious Diseases, 

Vanderbilt Medical University, Nashville, TN 

Cardiovascular Structure 

tuesday 

P064 

P065 

P066 

Segmental Myocardial Compromise of Left Ventricle and 

Left Atrial Function in Chagas’ Cardiomyopathy 

Afonso Y. Matsumoto, Barbara M. Ianni, Edmundo Arteaga- 

Fernandez, Aloir Q. Araujo, Vera M.C. Salemi, Charles 

Mady;Cardiomyopathy Unit, Heart Institute (InCor)- 

HC-FMUSP, Sao Paulo, Brazil 

CaM Kinase IIδ Is Required for Catecholamine-Induced 

Cardiac Fibrosis but Not Hypertrophy 

Michael Grimm 1 , Haiyun Ling 1 , Shikha Mishra 1 , Joan Heller 

Brown 1 ; 1 Department of Pharmacology, University of California, 

San Diego, La Jolla, CA 

Role of p38/Akt Signaling Pathway in the Regulation 

of Sodium/Calcium Exchanger Expression in Adult 

Cardiomyocytes 

Olga Chernysh 1 , Santhosh K. Mani 1 , Donald R. 

Menick 1 ; 1 Department of Medicine, Division of Cardiology, 

Medical University of South Carolina, Charleston, SC 

P077 

P078 

P079 

Abnormalities of Right Ventricular Strain in Cardiac 

Transplant Recipients 

Navin Rajagopalan 1 , Angel Lopez-Candales 2 ; 1 Cardiology, 

University of Kentucky, Lexington, KY; 2 Cardiovascular 

Institute, University of Pittsburgh, Pittsburgh, PA 

Left Ventricular Noncompaction Cardiomyopathy and 

Congenital Heart Disease: Two Strikes? 

Angela Lorts 1 , Haleh Heydarian 1 , Jeffrey Towbin 1 , Michelle 

Grenier 1 ; 1 The Heart Institute, Cincinnati Children’s Medical 

Center, Cincinnati, OH 

Characteristics of Left Atrial Function of Transplanted 

Hearts 

Sabha Bhatti 1 , Dorothy J. Tripodi 2 , Myron A. Waclawiw 2 , 

Douglas R. Rosing 2 , Yukitaka Shizukuda 1 ; 1 Division of 

Cardiovascular Diseases, University of Cincinnati, Cincinnati, 

OH; 2 National Heart, Lung, Blood Institute,, National Institutes 

of Health, Bethesda, MD 

tuesday 

P067 

P068 

P069 

Overnight Pulse Oximetry Is a Useful Tool to Screen 

for Sleep Apnea in Patients Admitted with Acute 

Decompensated Heart Failure 

Nada Shaban 1 , Diane Tran 1 , Richard Soucier 1 ; 1 St. Francis 

Hospital, Hartford, CT 

Can Etiology Predict Atrial Conduction Velocities in 

Congestive Heart Failure Patients? 

Nader Ghaly 1 , Tamara Brunker 1 , Tammer Ghaly 1 , David 

Muller 2 ; 1 Electrophysiology, AtlantiCare Regional Medical 

Center, Pomona, NJ; 2 CRM, St Jude Medical, Sylmar, CA 

Gender Differences in Ventilatory Control during 

Exercise in Heart Failure 

Fatima H. Kuniyoshi 1 , Bruce D. Johnson 1 , Jennifer M. Fitz- 

Gibbon 1 , Virend K. Somers 1 , Lyle J. Olson 1 ; 1 Mayo Clinic, 

Rochester, MN 

P080 

P081 

Improved Ventricular-Arterial Elastance Following 

Chronic Treatment Using the Rheos® System 

Implantable Device in Resistant Hypertension 

Dimitrios Georgakopoulos 1 , Abraham Kroon 2 , David S. Bach 3 , 

Christopher L. Kaufman 1 , William T. Abraham 4 , William C. 

Little, Michael R. Zile 5 ; 1 CVRx Inc., Minneapolis; 2 Maastricht 

University, Maastricht, Netherlands; 3 University of Michigan, 

Ann Arbor; 4 The Ohio State University, Columbus; 5 Medical 

University of South Carolina, Charlston; 6 Wake Forest 

University, Winston Salem 

Anatomical Variations of the Left Pericardiophrenic Vein 

and Related Vein Structures 

Randy Westlund 1 , Carolyn Bramante 2 , Anthony 

Weinhaus 2 ; 1 Cardiac Concepts, Minnetonka, MN; 2 Department of 

Integrative Physiology and Biology, University of Minnesota, 


106 

107

Sept. 14 

Tuesday 

Posters 

Posters 


Posters 


Sept. 14 

Tuesday 

Posters 

tuesday 

P093 

P094 

P095 

P096 

P097 

Serial Measurements of Mid-Region-pro-ANP and 

C-Terminal pro-Vasopressin (Copeptin) and Relation 

to Troponin T in Ambulatory Chronic Heart Failure 

Patients – Is Synergism Important? 

Wayne L. Miller 1 , Diane E. Grill 1 , Joachim Struck 2 , Andreas 

Bergmann 2 , Allan S. Jaffe 1 ; 1 Cardiovascular Division, Mayo 

Clinic, Rochester, MN; 2 BRAHMS (ThermoFisher Scientific), 

Hennigsdorf, Germany 

Low Vitamin D and High Parathyroid Hormone Levels 

Are Associated with Left Ventricular Dysfunction 

but Not with Increased Aortic Stiffness in Patients 

Undergoing Cardiac Catheterization for Coronary 

Artery Disease. 

Hidekatsu Fukuta 1 , Nobuyuki Ohte 1 , Kazuaki Wakami 1 , 

Toshihiko Goto 1 , Seiji Mukai 1 , Tomomitsu Tani 1 , Genjiro 

Kimura 1 ; 1 Department of Cardio-Renal Medicine and 

Hypertension, Nagoya City University Graduate School of 

Medical Sciences, Nagoya, Japan 

Increased Levels of Tissue Inhibitor of Metalloproteinase 

1 (TIMP-1) Are Independently Associated with Adverse 

Outcomes in Outpatients with Heart Failure 

Vasiliki V. Georgiopoulou 1 , Andreas P. Kalogeropoulos 1 , 

Grigorios Giamouzis 1 , Lucy Fike 1 , Kunal Bhatt 1 , Catherine R. 

Norton 1 , Mahdi R. Chowdhury 1 , Adnan Malik 1 , Sonjoy Laskar 1 , 

Andrew L. Smith 1 , Sandra Dunbar 2 , Javed Butler 1 ; 1 Division of 

Cardiology, Emory University, Atlanta, GA; 2 School of Nursing, 

Emory University, Atlanta, GA 

Inflammatory Biomarkers in Left Ventricular 

Remodeling under Stem Cell and Pharmacological 

Treatment in a Rat Model of Myocardial Infarction 

Sheryl L. Chow 1,2 , Arezoo Campbell 2 , Istvan Kovanecz 1,4 , Judy 

S.C. Wang 1,4 , Dolores Vernet 1,3 , George Kopchock 1 , Rodney A. 

White 1,4 , Nestor F. Gonzalez-Cadavid 1,3 , 4 ; 1 Surgery, LABioMed 

at Harbor-UCLA, Torrance, CA; 2 Pharmacy Practice and 

Pharmaceutical Sciences, Western University of Health 

Sciences, Pomona, CA; 3 Medicine, Charles Drew University, 

Los Angeles, CA; 4 School of Medicine, UCLA, Los Angeles, 

CA 

Increased Plasma Chromogranin A Is Related to 

Congestive Heart Failure 

Damien Gruson 1 , Sylvie A. Ahn 2 , Michel F. Rousseau 2 ; 1 Diabetes 

and Nutrition Unit, University of Louvain, Brussels, Belgium; 

2 

Division of Cardiology, University of Louvain, Brussels, 

Belgium 

P098 

P099 

P100 

P101 

P102 

P103 

Thioredoxin Is Elevated in Patients with Acute 

Fulminant Myocarditis 

Eun-Seok Jeon 1 , Jin-Oh Choi 1 , Soo-Hyun Yun 1 , Eun-Seon 

Ju 1 ; 1 Division of Cardiology, Samsung Medical Center, Seoul, 

Korea 

Serotonin as a Marker in Decompensated Systolic Heart 


Ahmed M. Selim 1 , Ramesh Chandra 1 , Nitasha Sarswat 1 , Pradnya 

Velankar 1 , Myrna Littlewort 1 , Norma Christian 1 , Catherine 

Galvin 1 , Ronald Zolty 1 ; 1 Cardiology, Albert Einstein College of 

Medicine/Weiler Division, Bronx, NY 

Plasma Galectin-3 Levels in Chronic Systolic Heart 

Failure: Association with All-Cause Mortality but 

Independent of Cardiac Structure and Function 

Zhili Shao 1 , Kevin Shrestha 1 , Richard W. Troughton 2 , Allen G. 

Borowski 1 , Allan L. Klein 1 , W.H. Wilson Tang 1 ; 1 Cardiovascular 

Medicine, Cleveland Clinic, Cleveland, OH; 2 Christchurch 

School of Medicine and Health Sciences, Christchurch, New 

Zealand 

Ethnicity Impacts proBNP1-108 and BNP Levels in 

Hypertensive Caucasians and Hispanics 

Lisa C. Costello-Boerrigter 1 , Guido Boerrigter 1 , Paul A. 

Kurlansky 2 , Denise M. Heublein 1 , Catherine Larue, John C. 

Burnett, Jr. 1 ; 1 Cardiorenal Research Laboratory, Mayo Clinic, 

Rochester, MN; 2 Cardiac Research, Florida Heart Research 

Institute, Miami, FL; 3 Cardiac Business Unit, Bio-Rad 

Laboratories, Marnes-la-Coquette, France 

Circulating Pronatriuretic Peptide Convertase Corin 

Is Present in Normal and Heart Failure Patients and 

Processes proBNP1-108 in Human Blood 

Tomoko Ichiki 1 , Brenda K. Huntley 1 , Denise M. Heublein 1 , 

Sharon M. Sandberg 1 , Paul M. McKie 1 , Michihisa Jougasaki 2 , 

John C. Burnett, Jr. 1 ; 1 Cardiorenal Research Laboratory, Mayo 

Clinic, Rochester, MN; 2 Institute for Clinical Research, 

Kagoshima Medical Center, Kagoshima, Japan 

Metabolic Syndrome and Its Associations with Plasma 

Adiponectin Levels in Patients with Chronic Heart 


Hoyoun Won 1 , Seok-Min Kang 1 , Jaewon Oh 1 , Jinho Kim 1 , Nam- 

Ki Hong 1 , Yangsoo Jang 1 , Namsik Chung 1 ; 1 Cardiology Division, 

Yonsei University College of Medicine, Seoul, Republic of 

Korea 

tuesday 

108 

109

Sept. 14 

Tuesday 

Posters 

Posters 


Posters 


Sept. 14 

Tuesday 

Posters 

P117 

Etsrp71 Regulates Vascular Development during 

Embryogenesis 

Junghun Kweon 1 , Tara L. Rasmussen 1 , Alicia M. Wallis 1 , Kathy 

M. Bowlin 1 , Michael Kyba 1 , Naoko Koyano-Nakagawa 1 , Daniel 

J. Garry 1 ; 1 Lillehei Heart Institute, Department of Medicine, 

University of Minnesota, Minneapolis, MN 

P123 

Reduction of Apoptosis Is Associated with Improvement 

of Post-Infarction Heart Failure Phenotype in P2X4 

Receptor Transgenic Mice 

Eliseu Chuang 1 , Jian-Bing Shen 1 , Bruce Liang 1 ; 1 Department 

of Cardiology, University of Connecticut School of Medicine, 

Farmington, CT 

tuesday 

P118 

Early Molecular Effects of B-Blocker Therapy in the 

Heart and Detection of Therapy Responsiveness by 

Transcriptomic Biomarkers 

Bettina Heidecker 1 , Edward K. Kasper 2 , Ilan S. Wittstein 2 , 

Hunter C. Champion 2 , Elayne Breton 2 , Stuart D. Russell 2 , Jessica 

E. Weinstein 1 , Michelle M. Kittleson 3 , Kenneth L. Baughman 4 , 

Joshua M. Hare 1 ; 1 Interdisciplinary Stem Cell Institute, 

University of Miami, Miller School of Medicine, Miami, FL; 

2 

Medicine, Johns Hopkins Hospital, Baltimore, MD; 3 Medicine, 

University of California, Los Angeles, Los Angeles, CA; 

4 

Medicine, Brigham and Women’s Hospital, Boston, MA 

P124 

P125 

Differences between Transthyretin (ATTR) Cardiac 

Amyloidosis Secondary to V122I Mutations and Wild 

Type TTR Presenting to a Tertiary Referral Center 

Bassel Noumi 1 , Farhana Latif 1 , Stephen Helmke 1 , Sergio Teruya 1 , 

Susan Deslisle 1 , Mathew S. Maurer 1 ; 1 Medicine, Columbia 

University, New York, NY 

Novel Alternatively Spliced Form of Natriuretic Peptide 

Convertase Corin 

Brenda K. Huntley 1 , Tomoko Ichiki 1 , John C. Burnett, 

Jr. 1 ; 1 Cardiorenal Research, Mayo Clinic, Rochester, MN 

tuesday 

P119 

P120 

P121 

P122 

Replication of Genome-Wide Association of the PTHLH- 

KLHDC5 Locus with Peripartum Cardiomyopathy 

Benjamin D. Horne 1,2 , Kismet D. Rasmusson 1 , Rami Alharethi 1 , 

Deborah Budge 1 , Kimberly D. Brunisholz 1 , John F. Carlquist 1,2 , 

Jennifer J. Connolly 1 , T. Flint Porter 1,2 , James J. Park 1 , Donald 

L. Lappe’ 1 , Joseph B. Muhlestein 1,2 , Heidi T. May 1 , Tami L. 

Bair 1 , Jeffrey L. Anderson 1,2 , Dale G. Renlund 1,2 , Abdallah G. 

Kfoury 1 ; 1 Intermountain Med Cntr, SLC, UT; 2 Univ Utah, SLC, 

UT 

Transcriptional Profiles of Reverse Remodeling 

Brian D. Lowes 1 , Ronald Zolty 3 , Edward M. Gilbert 2 , Alastair 

D. Robertson 1 , Michael R. Bristow 1 ; 1 University of Colorado, 

Denver, CO; 2 University of Utah, Salt Lake City, UT; 

3 

Montefirore Medical Center, Bronx, NY 

Discovery and Validation of Novel Genes in Cardiac 

Remodeling 

Brian D. Lowes 1 , Ronald Zolty 3 , Edward M. Gilbert 2 , Alastair 

D. Robertson 1 , Michael R. Bristow 1 ; 1 University of Colorado, 

Denver, CO; 2 University of Utah, Salt Lake City, UT; 

3 

Montefirore Medical Center, Bronx, NY 

Migration of Native Bone Marrow Cells to the Heart in 

Acute Non-Ischemic Cardiomyopathy 

Alejandro R. Trevino 1 , Keith A. Youker 1 , Luis J. Garcia 1 , Wilbert 

L. Jones 1 , Jerry Estep 1 , Carlos M. Orrego 1 , Guillermo Torre- 

Amione 1 ; 1 DeBakey Heart and Vascular Center, The Methodist 


P126 

P127 

P128 

P154 

Role of Nkx2.5 Acetylation by Histone Deacetylases in 

Regulating Sodium/Calcium Exchanger Expression in 

Adult Cardiomyocytes 

Mona S. Li 1 , Santhosh K. Mani 1 , Benjamin Addy 1 , Thirumagal 

Thiagarajan 1 , Christine B. Kern 1 , Donald R. Menick 1 ; 1 Medicine/ 

Cardiology, Medical University of South Carolina, Charleston, 

SC 

B-Type Natriuretic Peptide Pathway Genetic Sequence 

Variants and Correlation to Gene Expression 

Olesya Krivospitskaya 1 , James Yang 1 , Hanni N. Sabbah 1 , David 

E. Lanfear 1 ; 1 Henry Ford Hospital, Detroit, MI 

Role of Immunomodulation, iNOS and NO during an 

Inflammatory Response in Cardiomyocytes 

Musa T. Abidov 1 , Polisetty Ravishankar 2 , Irina G. Danilova 3 , 

Divya S. Katikaneni 4 ; 1 Immunopathology, MMA Sechenova, 

Moscow, RF, Russian Federation; 2 Department of Cardiac 

and Arterial Disorders, Bakulev Scientific Centre for 

Cardiovascular Surgery, Moscow, Russian Federation; 3 Biology 

and Life Sciences, Yekaterinburg Governement University, 

Yekaterinburg, Russian Federation; 4 Biotechnology, Jahnavi 

Degree College, Hyderabad, AP, India 


Time to Reconsider VAD Therapy? A Review of 

Mortality and Quality of Life in Advanced Heart Failure 


Linden A. Heflin 1 , Trevor A. Snyder 1 , Karl E. Nelson 1 , James 

W. Long 1 , Douglas A. Horstmanshof 1 ; 1 Advanced Cardiac Care, 

Integris Baptist Medical Center, Oklahoma City, OK 

110 

111

Sept. 14 

Tuesday 

Posters 

Posters 


Posters 


Sept. 14 

Tuesday 

Posters 

tuesday 

P155 

P156 

P157 

P158 

P159 

P160 

Which Left Ventricular Pacing Configuration Is Optimal 

during Cardiac Resynchronization Therapy Implant? 

Imran K. Niazi 1 , Vicki Fries 2 , Kyungmoo Ryu 2 ; 1 Arrhythmia 

Center for Southern Wisconsin, Milwaukee, WI; 2 St. Jude 

Medical, Sylmar, CA 

Health Insurance Is Usually Required for Heart 

Transplant Recipients but Not Donors; When Informed 

of this Discrepancy, Public Willingness to Donate May 

Decrease 

Jennifer T. Thibodeau 1 , Meena P. Rao 2 , Charu Gupta 3 , Colby 

R. Ayers 1 , Sachin Gupta 1 , Pradeep P.A. Mammen 1 , David W. 

Markham 1 , Joseph D. Mishkin 1 , Parag C. Patel 1 , Louise P. King 4 , 

Mark H. Drazner 1 ; 1 Division of Cardiology, UT Southwestern 

Medical Center, Dallas, TX; 2 Department of Internal Medicine, 

UT Southwestern Medical Center, Dallas, TX; 3 Department of 

Internal Medicine, Emory University, Atlanta, GA; 4 Department 

of Obstetrics and Gynecology, UT Southwestern Medical 

Center, Dallas, TX 

Elevation in Plasma-Free Hemoglobin in Patients with 

Advanced Heart Failure 

Sunil Pauwaa 1 , Antone Tatooles 1 , Pat Pappas 1 , Geetha 

Bhat 1 ; 1 Center for Heart Transplant and Assist Devices, Advocate 

Christ Medical Center, Oak Lawn, IL 

Differences in Pulsatile vs. Continuous-Flow Left 

Ventricular Assist Devices on Renal Function 

Antone Tatooles 1 , Laura A. Coyle 1 , Colleen T. Gallagher 1 , 

Geetha Bhat 1 , Pat Pappas 1 ; 1 Center for Heart Transplant and 

Assist Devices, Advocate Christ Medical Center, Oak Lawn, IL 

Factors Associated with HF Patients Being Offered 

Cardiac Resynchronization Therapy 

Antony G. Kaliyadan 1 , Mary P. Kaliyadan 3 , Kevin Rist 1 , 

Anthony A. Donato 1 ; 1 The Reading Hospital and Medical Center, 

West Reading, PA; 2 Drexel University College of Medicine, 


“Quilty” Biopsies Are Independently Associated with 

Improved Post Transplant Survival 

My-Le Nguyen 1 , Gautam V. Ramani 1 , Erika D. Feller 1 , 

Mandeep R. Mehra 1 , Allen P. Burke 1 , Bartley P. Griffith 1 , 

Sharon Augustine 1 , Carol Wade 1 , Willem J. Kop 1 ; 1 University of 

Maryland Medical Center, Baltimore 

P161 

P162 

P163 

P164 

P165 

P166 

Rapid Onset of Fulminant Myocarditis Portends a 

Favorable Prognosis and Ability To Bridge Mechanical 

Support to Recovery 

Pavan Atluri 1 , Brant W. Ullery 1 , Jessica L. Howard 1 , William 

Hiesinger 1 , J. Raymond Fitzpatrick 1 , Mariell Jessup 2 , Michael 

A. Acker 1 , Rohinton J. Morris 1 , Y. Joseph Woo 1 ; 1 Division 

of Cardiovascular Surgery, University of Pennsylvania, 

Philadelphia, PA; 2 Division of Cardiovascular Medicine, 


Can Intra-Cardiac Electrogram Amplitudes Be Used to 

Differentiate Ventricular Tachycardia from Ventricular 

Fibrillation in Implantable Devices? 

David Muller 1 , Raffaele Corbisiero 2 , Patricia Metoyer 2 , Rebecca 

Armbruster 2 ; 1 CRM, St Jude, Sylmar, CA; 2 Electrophysiology, 

Deborah Heart & Lung, Browns Mills, NJ 

The Left Ventricular Evoked Response Signal in Bipolar 

LV Pacing Leads of Large Electrode Surface Area 

Rahul N. Doshi 1 , Gautham Kalahasty 2 , John H. Lobban 3 , 

Michael C. Giudici 4 , Michael R. Gold 5 , Geng Zhang 6 , Kenneth 

Hayes 6 , Shibaji Shome 6 , Kenneth A. Ellenbogen 2 ; 1 St. Jude 

Medical Center, Fullerton, CA; 2 Virginia Commonwealth 

University, Richmond, VA; 3 Monongalia General Hospital, 

Morgantown, WV; 4 Genesis Heart Institute, Davenport, IA; 

5 

Medical University of South Carolina, Charleston, SC; 6 Boston 

Scientific CRM, St. Paul, MN 

Single Center Experience with Prophylaxis of 

Tuberculosis Infection in Heart Transplant Recipients 

Min-Seok Kim 1 , Cheol-Whan Lee 1 , Jae-Kwan Song 1 , Seong- 

Wook Park 1 , Seung-Jung Park 1 , Jae-Joong Kim 1 ; 1 Asan Medical 

Center Heart Institute, Seoul, Republic of Korea 

Diastolic Heart Failure: Long-Term Safety and 

Positioning Verification of an Intra-Left Ventricular 

Device 

Amir Elami 1 , Amir Sherman 2 , Yair Feld 3 , Gideon Meyer- 

Brodnitz 2 , Amit Tubishevitz 2 , Yael Benshabat 2 , Shay Dubi 4 , 

Lea Lak 2 , Lior Rosen 2 , Michal Lipperman 2 ; 1 Department 

of Cardiothoracic Surgery, Hadassah University Hospital, 

Jerusalem, Israel; 2 CorAssist Cardiovascular Ltd., Herzliya, 

Israel; 3 Genegrafts Ltd., Haifa, Israel; 4 Ofer Hi-Tech Ventures, 

Tel Aviv, Israel 

Modeling Border Zone Pacing as a Potential Method of 

Limiting Infarct Expansion 

James J. Pilla 1,2 , Kevin Koomalsingh 2 , Joseph H. Gorman, 

III 2 , Robert C. Gorman 2 ; 1 Department of Radiology, University 

of Pennsylvania, Philadelphia, PA; 2 Department of Surgery, 


tuesday 

112 

113

Sept. 14 

Tuesday 

Posters 

Posters 


Posters 


Sept. 14 

Tuesday 

Posters 

tuesday 

P167 

P168 

P169 

Impact of INTERMACS and Composite Preoperative 

Mortality Risk Score Stratification on Survival in 

Patients Receiving Heart Mate II LVAD as Bridge to 

Transplantation 

Nicholas Haglund 1 , Eugenia Raichlin 1 , Timothy Ryan 2 , John 

Um 2 , Ioana Dumitru 1 ; 1 Department of Cardiology, University 

of Nebraska Medical Center, Omaha, NE; 2 Department of 

Cardiothoracic Surgery, University of Nebraska Medical Center, 

Omaha, NE 

Destination Left Ventricular Device Therapy: What To 

Tell Patients and Families 

Sudarsana Chakeabarti 1 , Kathleen L. Grady 2 , JoAnn Lindenfeld 3 , 

Sarah J. Goodlin 4 ; 1 Northwestern University, Chicago, IL; 

2 

Northwestern University, Chicago, IL; 3 UCHSC, Aurora, CO; 

4 

PCER, Salt Lake City, UT 

Gene and Protein Expression Alterations in the 

Myocardium following Mechanical Circulatory Assist in 


Anna Meredith 1 , Amrit Samra 1 , Lise Matzke 1 , Crystal Leung 1 , 

Bruce McManus 1 ; 1 Providence Heart + Lung Institute at St. 

Paul’s Hospital, University of British Columbia, Vancouver, BC, 

Canada 

P173 

P174 

P175 

Usefulness of Electrical Conduction Intervals for 

Prediction of Optimal CRT Device Timing 

Robin Germany 1 , Christina Murray 1 , Brent Sakowski 2 , Alex 

Sambelashvili 2 , Michael Ujhelyi 2 ; 1 University of Oklahoma, 

Oklahoma City, OK; 2 Medtronic Inc., Mounds View, MN 

Echocardiographic Responders to CRT Exhibit Higher 

Right-Ventricular Contractility Compared to Non- 

Responders 

David Birnie 1 , Yaariv Khaykin 2 , Derek Exner 3 , John 

Sapp 4 , Sandeep Aggarwal 3 , Sandra Owen 3 , Aleksandre 

Sambelashvili 5 ; 1 University of Ottawa Heart Institute, Ottawa, 

ON, Canada; 2 Southlake Regional Health Centre, Newmarket, 

ON, Canada; 3 Libin Cardiovascular Institute of Alberta, Calgary, 

AB, Canada; 4 Queen Elizabeth II Health Sciences Center, 

Halifax, NS, Canada; 5 Medtronic Inc., Mounds View, MN 

Pneumonia in the First Year after Heart Transplant: 

Epidemiology, Risk Factors, and Effect on Survival 

Nir Uriel 1 , Sang-Whoo Pak 2 , Yacki Hayashi 2 , Natalie 

Gukasayan 2 , Simon J. Tsiouris 1 , Brian E. Scully 1 , Hiroo 

Takayama 2 , Yoshifumi Naka 2 , Paolo C. Colombo 1 , Donna 

Mancini 1 , Ulrich P. Jorde 1 ; 1 Medicine, Columbia University, New 

York, NY; 2 Surgery, Columbia University, New York, NY 

tuesday 

P170 

Alteration of Post Infarction Myocardial Strain with an 

Adjustable Pressure Device 

Kevin J. Koomalsingh 1 , Chun Xu 2 , Masahito Minakawa 1 , Tom 

Eperjesi 1 , Joseph H. Gorman 1 , Robert C. Gorman 1 , James 

Pilla 2 ; 1 Department of Surgery, University of Pennslyvania, 

Philadelphia, PA; 2 Department of Radiology, University of 

Pennslyvania, Philadelphia, PA 

P176 

Reverse Remodelling in Partial Mechanical Circulatory 

Support 

Jef H. Geens 1 , Steven Jacobs 1 , Michael Martin 2 , Wolfgang 

Kerkhoffs 2 , Filip R. Rega 1 , Daniel Burkhoff 2 , Walter Droogne 3 , 

Bart Meyns 1 ; 1 Cardiac Surgery, University Hospitals Leuven, 

Leuven, Belgium; 2 CircuLite, Inc, Hackensack; 3 Cardiology, 

University Hospitals Leuven, Leuven, Belgium 

P171 

Implantable Device To Modulate Diastolic Mechanics: 

Demonstration of Adjustable Support In Vivo and Recoil 

in Bench-Top Tests 

Saurabh Biswas 1 , Timothy Snowden 1 , Michael Moreno 1 , David 

A. Nelson 2 , Matthew W. Miller 2 , Theresa W. Fossum 2 , John C. 

Criscione 1,2 ; 1 Biomedical Engineering, Texas A&M University, 

College Station, TX; 2 Texas A&M Institute for Preclinical 

Studies, Texas A&M University, College Station, TX 

P177 

Utility of 3-Dimensional Transthoracic 

Echocardiography To Differentiate between Recipient 

and Donor Compartments’ Left Atrial Function in 

Transplanted Hearts 

Sabha Bhatti 1 , Yuhning L. Hu, Katie E. Butts, Karen A. 

Moore, Craig O. Breedlove, Yukitaka Shizukuda; 1 Division of 

Cardiovascular Diseases, University of Cincinnati, Cincinnati, 

OH 

P172 

Ventricular Arrhythmias in Left Ventricular Assist 

Device Patients with Implantable Cardioverter 

Defibrillators 

Erika Stahl 1 , Sunil Pauwaa 1 , Sejal Modi 1 , Pat Pappas 1 , Antone 

Tatooles 1 , Geetha Bhat 1 ; 1 The Center for Heart Transplant and 

Assist Devices, Advocate Christ Medical Center, Oak Lawn, IL 

P178 

Effect of Pocket Location on LVCan Evoked Response 

Signal for LV Capture Detection in CRT Devices 

Michael C. Giudici 1 , Gautham Kalahasty 2 , John H. Lobban 3 , 

Rahul N. Doshi 4 , Michael R. Gold 5 , Steven Eddy 6 , Phillip 

Schrumpf 6 , Yanting Dong 6 , Shibaji Shome 6 , Kenneth A. 

Ellenbogen 2 ; 1 Genesis Heart Institute, Davenport, IA; 2 Virginia 

Commonwealth University, Richmond, VA; 3 Monongalia 

General Hospital, Morgantown, WV; 4 St. Jude Medical 

Center, Fullerton, CA; 5 Medical University of South Carolina, 

Charleston, SC; 6 Boston Scientific CRM, St. Paul, MN 

114 

115

Sept. 14 

Tuesday 

Posters 

Posters 


Posters 


Sept. 14 

Tuesday 

Posters 

P191 

Cardiac Resynchronization Therapy Outcomes in 

Clinical Practice: Comparison with the COMPANION 

Study 

Alan J. Bank 1 , Kevin V. Burns 1 , Ryan M. Gage 1 , Daniel B. 

Vatterott 1 , Mariam Sajady 1 , Spencer H. Kubo 1 ; 1 St. Paul Heart 

Clinic, St. Paul, MN 

P198 

Standard Chest Xray Predicts LV Lead Location in CRT 

Patients Better Than Intraoperative Fluoroscopy 

Lu Chen 1 , Jay E. Tiongson 1 , Martin B. McDaniel 2 , Ulrika M. 

Birgersdotter-Green 1 ; 1 Cardiology, Cardiac Electrophysiology, 

University of California, San Diego, San Diego, CA; 2 Boston 

Scientific, Natick, MA 

tuesday 

P192 

P193 

P194 

P195 

P196 

Acute Contractility (dP/dt) Improvement Predicts 

Chronic Resynchronization Pacing Efficacy for 

Refractory Heart Failure in Congenital Heart 

Peter P. Karpawich 1 , Harinder Singh 1 , Kathleen Zelin 1 ; 1 Pediatric 

Cardiology, Children’s Hospital Michigan, Wayne State 

University, Detroit, MI 

Do Changes in Repolarization Predict Outcomes 

in Patients Undergoing Cardiac Resynchronization 

Therapy? 

Abhijit Ghatak 1 , Raja Pullatt 1 , Vamsi Pavuluri 1 , Steven Zweibel 1 , 

Christopher Clyne 1 , Jeffrey Kluger 1 ; 1 Cardiology, Hartford 

Hospital, Hartford, CT 

Symptomatic Heart Failure Is an Uncommon 

Presentation of Cardiac Sarcoidosis and Is Associated 

with a Higher Rate of Ventricular Arrhythmias 

Matthew D. Olson 1 , Matthew M. Zipse 1 , Joseph L. Schuller 1 , 

Diego F. Belardi 1 , Royce L. Bargas 1 , Christopher M. 

Lowery 1 , Aleong G. Ryan 1 , Paul D. Varosy 2 , William H. 

Sauer 1 ; 1 Electrophysiology, University of Colorado, Aurora, CO; 

2 

Electrophysiology, VA Medical Center, Denver, CO 

Obstructive Sleep Apnea Is Associated with Worsened 

Oxidative Stress and Treatment Resistance in Atrial 

Fibrillation 

R. Valadri, H. Bloom, R. Gadesam, D. Delurgio, D. Jones, S. 

Bhadriraju;Pulmonology, Emory University, Atlanta, GA 

Right Phrenic Nerve Stimulation for Apnea in Heart 

Failure Patients Using a Novel Intravenous Lead 

Ralph Augostini 1 , Dariusz Jagielski 2 , Xilong Zhang 3 , Shi-Jiang 

Zhang 3 , Dariusz Michalkiewicz 4 , Randy Westlund 5 ; 1 The Ohio 

State University Medical Center, Columbus, OH; 24 th Military 

Hospital, Wroclaw, Poland; 3 Jiangsu Province Hospital, Nanjing, 

China; 4 Central Military Hospital, Warsaw, Poland; 5 Cardiac 

Concepts, Minnetonka, MN 

P199 

P200 

P201 

P202 

Pro-Arrhythmic or Anti-Arrhythmic: The Role of Multi- 

Site Left Ventricular Pacing in Heart Failure 

Kathleen Zazzalli 1 , Raffaele Corbisiero 1 , David 

Muller 2 ; 1 Electrophysiology, Deborah Heart & Lung Center, 

Browns Mills, NJ; 2 CRMD, St Jude Medical, Sylmar, CA 

Spironolactone Suppresses the Frequency of Ventricular 

Arrhythmias among Patients with Left Ventricular 

Systolic Dysfunction and Implantable Cardioverter- 

Defibrillators 

Abdul Wase 1,2 , Zulfiqar Mirza 1,2 , Aparna Innaparthy 1,2 , Anwarul 

Kabir 1,2 , Muhammed B. Quraishi 1,2 , Ronald Markert 3 ; 1 Internal 

Medicine/Cardiology, Heart and Vascular Institute, Good 

Samaritan Hospital, Dayton, OH; 2 Internal Medicine, 

WrigWright State University Boonshoft School of Medicine, 

Dayton, OH; 3 Educational Research, Wright State University 

Boonshoft School of Medicine, Dayton, OH 

Microvolt T-Wave Alternans Is Related to Left 

Ventricular Remodeling after an Acute Coronary 

Syndrome Event 

Lauren T. Wasson 1 , William Whang 1 , Sujith Kuruvilla 1 , 

Manjunath Harlapur 1 , Karina Davidson 1 , Rochelle Goldsmith 1 , 

J. Thomas Bigger 1 , Daichi Shimbo 1 ; 1 Department of Medicine, 

Columbia University Medical Center, New York, NY 

Creatinine and Defibrillation Threshold among Patients 

with Congestive Heart Failure with a Biventricular ICD: 

Is There a Correlation? 

Abdul Wase 1 , Bilal Quraishi 1 , Anwarul Kabir 1 , Sue Sacksteter 1 , 

Hope Shaffer 1 , Jill Mahaffe 2 , Cynthia Hoersten 2 , Markert 

Ronald 3 ; 1 Cardiology, Good Samaritan Heart and Vascular 

Institute, Dayton, OH; 2 Cardiology, St. Rita’s Medical Center, 

Lima, OH; 3 Research, Wright State Unviversity Boonshoft 

School of Medicine, Dayton, OH 

tuesday 

P197 

Can Disease Etiology Predict Differences in Intra- 

Ventricular Conduction Delay in CRT Patients? 

Nader Ghaly 1 , Mary Tiernan 1 , David Muller 2 ; 1 Electrophysiology, 

AtlatiCare Regional Medical Center, Pomona, NJ; 2 CRM, St 

Jude, Sylmar, CA 

116 

117

Sept. 14 

Tuesday 

Posters 

Posters 


Posters 


Sept. 14 

Tuesday 

Posters 

tuesday 

P216 

P217 

P218 

P219 

P220 

P221 

The Effects of Short Term Beta-Blockade on Exercise 

Capacity and Left Ventricular Function in Elderly 

Patients with Heart Failure 

Milica Dekleva 1 , Hans Dirk Dungen 2 , Simone Incrot 2 , Tomas 

Rau 3 , Svetlana Apostolovic 4 , Fimm Waagstein; 1 Cardiology, 

University Clinical Centar Zvezdara, Belgrade, Serbia; 

2 

University Clinical Hospital Cherite, Berlin, Germany; 

3 

University Clinical Center, Hamburg, Germany; 4 University 

Clinical Center, Nis, Serbia 

A Simple Prediction Formula for Peak Oxygen 

Consumption in Subjects with Heart Failure 

Gregg Lanier 1 , Gabriel Wagman 1 , Tapan Godiwala 1 , Chi- 

Hong Tseng 2 , Timothy Timothy 1 ; 1 Zena and Michael A. Wiener 

Cardiovascular Institute, Mount Sinai School of Medicine, New 

York, NY; 2 Department of Medicine, University of California 

Los Angeles, Los Angeles, CA 

Symptom Status of Obese Patients with Heart Failure 

Seongkum Heo 1 , Debra K. Moser 2 , Susan J. Pressler 3 , Sandra 

B. Dunbar 4 , Terry A. Lennie 2 ; 1 Indiana University, Indianapolis; 

2 

University of Kentucky, Lexington; 3 University of Michigan, 

Ann Arbor; 4 Emory University, Atlanta 

Long-Term Changes in Intracardiac Impedance in 

Cardiac Resynchronization Therapy Patients 

Fredrik Gadler 1 , Nils Holmstrom 2 , Sven-Erik Hedberg 2 , Andreas 

Karlsson 2 , Cinzia Valzania 3 , Maria J. Eriksson 1 ; 1 Karolinska 

University Hospital, Stockholm, Sweden; 2 St. Jude Medical, 

Jarfalla, Sweden; 3 University of Bologna, Bologna, Italy 

Correlation between Atrial and Ventricular Pacing 

and Atrial Arrhythmia Burden in Double Chamber 

Pacemaker Patients 

Andrew J. Kaplan 1 , Jacques Mansourati 2 , N. Klein 3 , J. Beiras 

Torrado 4 , Isabell Roth 5 , Uwe Wiegand 6 ; 1 Tri City Cardiology 

Consultants, Mesa, AZ; 2 CHU Brest, Brest, France; 

3 

Universitatsklinikum Leipzig, Leipzig, Germany; 4 Hospital 

Xeral Vigo, Vigo, Spain; 5 Sorin Group GmbH, Munchen, 

Germany; 6 SANA-Klinikum Remscheid, Remscheid, Germany 

Role of Superoxide Dismutase in Exercise Tolerance 

in Patients with Hypertension Comparing to Ischemic 

Heart Disease 

Milica Dekleva 1 , Jelena Suzic 2 , Sanja Mazic 2 , Mirko Colic 3 , 

Milena Kleut 2 , Angelina Stevanovic 4 ; 1 University Clinical Centar 

Zvezdara, Belgrade, Serbia; 2 University Clinical Centar Dr 

Dragisa Misovic, Belgrade, Serbia; 3 Institute for Cardiovascular 

Disease Dedinje, Belgrade, Serbia; 4 Railway Health Care 

Institute, Belgrade, Serbia 

P222 

P223 

P224 

P225 

Implantable Cardioverter Defibrillator Electrogram 

Adjudication for Large National Device Registries: 

Methodology and Initial Observations from the 

ALTITUDE Study 

Brian D. Powell 1 , Yongmei Cha 1 , Samuel J. Asirvatham 1 , 

Michael K. Cao 2 , David A. Cesario 2 , Paul W. Jones 3 , Milan 

Seth 3 , David L. Hayes 1 , Leslie A. Saxon 2 , F. Roosevelt Gilliam, 

III 4 ; 1 Mayo Clinic, Rochester; 2 USC Keck School of Medicine, 

Los Angeles; 3 Boston Scientific, St. Paul; 4 Cardiology Associates 

of NE Arkansas, Jonesboro 

Device-Based Remote Monitoring as Contemporary 

Heart Failure Disease Management: Baseline 

Characteristics of Patients Enrolled in the OptiVol Care 

Pathway Study 

W.H. Wilson Tang 1 , Roy S. Small 2 , J. Thomas Heywood 3 , John 

Andriulli 4 ; 1 Department of Cardiovascular Medicine, Cleveland 

Clinic, Cleveland, OH; 2 The Heart Group, Lancaster, PA; 

3 

Scripps Clinic, La Jolla, CA; 4 Cooper University Hospital, 

University of Medciine and Dentistry of New Jersey, Voorhees, 

NJ 

Timecourse of Weight and Intrathoracic Impedance 

Changes during Volume Overload 

John Andriulli 1 , John McKenzie 2 , George H. Crossley 3 , Mary 

Anne Papp 4 , Jason Sims 5 , Sanjeev K. Gulati 6 ; 1 Southern New 

Jersey Cardiac, Vorhees, NJ; 2 Glendale Memorial Hospital & 

Medical Center, Glendale, CA; 3 Mid-State Cardiology of St. 

Thomas Heart, Nashville, TN; 4 Medical College of Wisconsin, 

Milwaukee, WI; 5 Medtronic, Mounds View, MN; 6 Sanger Heart 

& Vascular Institute, Charlotte, NC 

Influence of Race on Improvements in Use of Guideline 

Recommended Heart Failure Therapies: Findings from 

IMPROVE HF 

D.W. Reynolds 1 , N.M. Albert 2 , A.B. Curtis 3 , M. Gheorghiade 4 , 

J.T. Heywood 5 , P. Johnson Inge 6 , M.L. McBride 6 , M.R. Mehra 7 , 

C.M. O’Connor 8 , M.N. Walsh 9 , C.W. Yancy 10 , G.C. Fonarow 11 ; 1 U 

of OK, Oklahoma City, OK; 2 CCF, Cleveland, OH; 3 USF, 

Tampa, FL; 4 Northwestern U, Chicago, IL; 5 Scripps Clinic, 

La Jolla, CA; 6 Outcome Sciences, Cambridge, MA; 7 U of 

MD, Baltimore, MD; 8 DCRI, Durham, NC; 9 The Care Group, 

Indianapolis, IN; 10 Baylor, Dallas, TX; 11 UCLA, Los Angeles, 

CA 

tuesday 

118 

119

Sept. 14 

Tuesday 

Posters 

Posters 


Posters 


Sept. 14 

Tuesday 

Posters 

tuesday 

P226 

P227 

Documentation of QRS Duration and NYHA Class in HF 

Patients after a Performance Improvement Initiative: 

IMPROVE HF 

N.M. Albert 1 , A. Curtis 2 , M. Gheorghiade 3 , J. Heywood 4 , P. 

Johnson Inge 5 , M. McBride 5 , M. Mehra 6 , C. O’Connor 7 , D. 

Reynolds 8 , M. Walsh 9 , C. Yancy 10 , G. Fonarow 11 ; 1 CCF, Cleveland, 

OH; 2 USF, Tampa, FL; 3 Northwestern U, Chicago, IL; 4 Scripps 

Clinic, La Jolla, CA; 5 Outcome Sci, Cambridge, MA; 6 U MD, 

Baltimore; 7 DCRI, Durham, NC; 8 U OK, Oklahoma City; 9 The 

Care Group, Indianapolis, IN; 10 Baylor, Dallas, TX; 11 UCLA, Los 

Angeles 

External Wireless Monitoring of Bioimpedance in Heart 

Failure Patients: Results from the ACUTE Study 

Wilson W.H. Tang 1 , Vijay K. Chopra 2 , Niranjan Chakravarthy 3 , 

Imad Libbus 3 , Rodolphe P. Katra 3 ; 1 Cleveland Clinic, Cleveland, 

OH; 2 The Medicity, New Delhi, India; 3 Corventis, Inc, St. Paul, 

MN 

P238 

P239 

P240 

Efficacy of Dronederone Therapy on Atrial Fibrillation 

Burden Evaluated by Permanent Pacemaker Diagnostics 

Frank A. McGrew 1 , Eric E. Johnson 1 , Mark A. Coppess 1 , Regina 

Owen 1 ; 1 Stern Cardiovascular Clinic, Memphis, TN 

Effect of Nesiritide on Renal Function in Patients with 

Decompensated Diastolic Heart Failure 

Iosif Kelesidis, Pankaj Khullar, Zach Zhang, Timothy Vittorio, 

Ronald Zolty;Medicine- Cardiology, Montefiore Medical 

Center- Albert Einstein College of Medicine, Bronx, NY 

Negative Effect of Nesiritide on Renal Function in 

Patients with Decompensated Right Ventricular Heart 


Iosif Kelesidis, Jeremy A. Mazurek, Pradnya Velankar, Ronak 

Chaudhari, Ronald Zolty;Medicine- Cardiology, Montefiore 

Medical Center, Albert Einstein College of Medicine, Bronx, 

NY 

tuesday 

P228 

P236 

P237 

Withdrawn 


Predicting Adverse Effects during Angiotensin Receptor 

Blocker Treatment in Heart Failure: Results from the 

HEAAL Trial 

Michael S. Kiernan 1 , James D. Neaton 2 , Felipe A. Martinez 3 , 

Michel Komajda 4 , Kenneth Dickstein 5 , Gary Francis 2 , Faiez 

Zannad 6 , Marvin A. Konstam 1 ; 1 Tufts Medical Center, Boston, 

MA; 2 University of Minnesota, Minneapolis, MN; 3 Rusculleda 

Foundation for Clinical Research, Cordoba National University, 

Cordoba, Argentina; 4 Pitie-Salpetriere Hospital, Universite 

Pierre et Marie Curie-Paris 6 , Paris, France; 5 University of 

Bergen, Institute of Internal Medicine, Bergen, Norway; 6 CHU 

and University of Nancy, Nancy, France 

The Understanding of Fundamentals of Cardiac 

Regeneration and Role of Immunomodulation – A Novel 

Approach in Treating Heart Diseases and Preventing 


Musa T. Abidov 1 , Ravishankar Polisetty 2 , Irina G. Danilova 3 , 

Sai Shreya Katikaneni 4 , S.J. Medvedeva 3 , M.A. Rantsev 3 , I.F. 

Gette 3 ; 1 Immunopathology, MMA Sechenov, Moscow, Russian 

Federation; 2 Cardiovascular Surgery, Bakulev Scientific Centre 

for Cardiovascular Surgery, Moscow, Russian Federation; 

3 

Biology and Life Sciences, Yekaterinburg Government 

University, Yekaterinburg, Russian Federation; 4 Adult ICU, 

Narayana Hrudayalaya, Banglaore, KA, India 

P241 

P242 

P243 

P255 

Single Dose Sildenafil in Heart Failure Patients Does 

Not Alter Echocardiographic Parameters Reflecting Left 

Ventricular Filling Pressures 

Attila Nemeth 1 , Neal Dawson 1 , Diyana Gunawardena 1 , Charles 

Thomas 1 , Robert C. Bahler 1 ; 1 Medcine, Case Western Reserve 

School of Medicine, Cleveland, OH 

Statins and Response to Carvedilol Given to Patients 

with Chronic Heart Failure 

Bohdan J. Nessler 1 , Renata Golebiowska 1 , Andrzej Gackowski 1 , 

Jadwiga M. Nessler 1 ; 1 Dpt of Coronary Disease, Institute of 

Cardiology, Cracow, Poland 

Interaction of Gender and Change in B-Type Natriuretic 

Peptide Levels with Blood Pressure Lowering during 

Nesiritide Infusion 

David E. Lanfear 1 , Karen Leszczynski 1 , Hani N. Sabbah 1 ; 1 Heart 

and Vascular Institute, Henry Ford Hospital, Detroit, MI 


Dietary Habits in Relation to Biventricular Systolic 

Function, among Chronic Heart Failure Patients 

Christina Chrysohoou 1 , Demosthenes B. Panagiotakos 2 , Christos 

Pitsavos 1 , George Metallinos 1 , Iason Kotroyiannis 1 , Stella Brili 1 , 

Christos Antoniou 1 , George Tsitsinakis 1 , Apostolis Tsantilas 1 , 

Christodoulos Stefanadis 1 ; 1 First Department of Cardiology, 

Hippocrateion General Hospital, Athens, Attiki, Greece; 

2 

Biostatistics, Harokopion University, Athens, Attiki, Greece 

120 

121

Sept. 14 

Tuesday 

Posters 

Posters 


Posters 


Sept. 14 

Tuesday 

Posters 

P256 

Anemia in a Predominantly African American 

Population with Heart Failure 

Hammam D. Zmily 1 , Jareer O. Farah 1 , Mohammed 

Mohammed 1 , Azzat Ali 1 , S. William Tam 2 , Phillip Levy 1 , Jalal 

K. Ghali 2 ; 1 Internal Medicine, Wayne State University/Detroit 

Medical Center, Detroit, MI; 2 Cardiology, Detroit Medical 

Center, Detroit, MI 

P262 CHF Prevalence, Is It Declining? Analysis of 2007-2008 

NHANES Survey Data 

Pramil Cheriyath 1 , Obiora F. Anusionwu 1 , Kwangmi Ahn 2 , 

Daniel Fischman 1 ; 1 Department of Medicine, Harrisburg 

Hospital, Harrisburg, PA; 2 Department of Public Health 

Sciences, Penn State University, College of Medicine, Hershey, 

PA 

tuesday 

P257 

P258 

P259 

P260 

Characterization of Heart Failure Patients with 

Preserved Systolic Function: A Comparison between 

ADHERE-US Registry and ADHERE-International 

Registry 

Ryenn L. West 1 , Li Liang 1 , Gregg C. Fonarrow 2 , Robb 

Kociol 1 , Roger M. Mills 3 , Christopher O’Connor 1 , Adrian F. 

Hernandez 1 ; 1 Duke Clinical Research Institute, Durham, NC; 

2 

UCLA Cardiomyopathy Center, Los Angeles, CA; 3 Ortho- 

McNeil Janssen, Raritan, NJ 

Outpatient Disparities in Recommended Therapy for 

Congestive Heart Failure 

Dipanjan Banerjee 1 , Randall S. Stafford 2 ; 1 Division of 

Cardiovascular Medicine, Stanford University School of 

Medicine, Stanford, CA; 2 Stanford Prevention Research Center, 

Stanford University School of Medicine, Stanford, CA 

Echocardiographic Parameters in Women vs Men 

Admitted with Acutely Decompensated Heart Failure: 

Are We Treating the Same Disease? 

Puja B. Parikh 1 , Smadar Kort 1 , Abhijeet Singh 1 , Roopali Parikh 1 , 

Alexander Osei-Bonsu 1 , Hal A. Skopicki 1 ; 1 Medicine, Stony 

Brook University Medical Center, Stony Brook, NY 

Takotsubo Cardiomyopathy in Men: Different Face, 

Same Disease 

Ivan Mendoza 1 , Heshan Zaitoun 1 , Gian Novaro 1 ; 1 Cardiology, 

Cleveland Clinic Florida, Weston, FL 

P263 

P264 

P265 

Geriatrics, Emergency Medicine, Primary Care or 

Cardiology: Who Is the Heart Failure Specialist of the 

Future? 

Frank Smart 1 , Elizabeth Langlois 1 , Jackie Ferron-Clark 2 , Audrey 

Kleet 1 , Eileen Poletick 1 , Antonietta Henry 1 ; 1 Cardiovascular 

Medicine, Morristown Memorial Hospital, Morristown, NJ; 

2 

Cardiology/Medicine, Overlook Hospital, Summit, NJ 

Risk Prediction of Incident Heart Failure in a Preventive 

Cardiology Clinic: Validation of the Health ABC Heart 

Failure Risk Score with Natriuretic Peptide Testing 

W.H. Wilson Tang 1 , Yenal Harper 1 , Javed Butler 2 , Leslie Cho 1 , 

Stanley L. Hazen 1 ; 1 Cardiovascular Medicine, Cleveland Clinic, 

Cleveland, OH; 2 Cardiovascular Medicine, Emory University, 

Atlanta, GA 

Reduced Heart Rate Variability Correlates with Anaemia 

and Impaired Quality of Life in Patients with Chronic 

Compensated Heart Failure 

Christina Chrysohoou 1 , George Metallinos 1 , Stavroula 

Athanasopoulou 1 , Petros Arsenos 1 , George Tsitsinakis 1 , 

Polychronis Dilaveris 1 , Christos Antoniou 1 , Christos Pitsavos 1 , 

Costas Zisimos 1 , Christodoulos Stefanadis 1 ; 1 First Department 

of Cardiology, Hippocrateion General Hospital, Athens, Attiki, 

Greece 

Outcomes 

tuesday 

P261 

The Renal Effects of Low-Dose Dopamine Infusion in 

Elderly Patients Hospitalized for Acute Decompensated 


G. Giamouzis 1,2 , J. Butler 2 , R.C. Starling 3 , G. Karayannis 1 , D. 

Rovithis 1 , C. Parisis 1 , J. Nastas 4 , T. Tsaknakis 4 , J. Skoularigis 1 , 

F. Triposkiadis 1 ; 1 Larissa University Hospital, Larissa, Greece; 

2 

Emory University Hospital, Atlanta, GA; 3 Cleveland Clinic 

Foundation, Cleveland, OH; 4 Volos General Hospital, Volos, 

Greece 

P298 

Waist Circumference, Body Mass Index, and Survival in 

Systolic Heart Failure: The Obesity Paradox Revisited 

Adrienne L. Clark 1 , Gregg C. Fonarow 2 , Tamara B. 

Horwich 2 ; 1 David Geffen School of Medicine, University of 

California, Los Angeles, Los Angeles, CA; 2 Ahmanson-UCLA 

Cardiomyopathy Center, University of California, Los Angeles, 


122 

123

Sept. 14 

Tuesday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 14 

Tuesday 

Posters 

tuesday 

P299 

P300 

P301 

P302 

P303 

Home Telemonitoring Improves Health Status in the 

Post-Hospitalization Period for Patients with Heart 


Rebecca S. Boxer 1 , Christopher J. Burant 2 , Christina M. 

DiCarlo 3 , Cynthia Struk 4 , Elizabeth Madigan 2 , Ileana L. 

Pina 1 ; 1 Department of Medicine, Case Western Reserve 

University, Cleveland, OH; 2 Francis Payne Bolton School 

of Nursing, Case Western Reserve University, Cleveland, 

OH; 3 School of Medicine, Case Western Reserve University, 

Cleveland, OH; 4 Visiting Nurse Association of Ohio, Cleveland, 

OH 

Red Cell Distribution Width Predicts In-Hospital 

Mortality in Patients Admitted with Heart Failure 

Sandip K. Zalawadiya 1 , Hammam Zmily 1 , Jareer Farah 1 , 

Omaima Ali 1 , Suleiman Daifallah 2 , Jalal K. Ghali 1 ; 1 Detroit 

Medical Center/Wayne State University, Detroit, MI; 2 John 

D.Dingell VA Medical Center, Detroit, MI 

Best Practice for Australian Chronic Heart Failure 

Management Programs: Strategic Positioning for Health 

Service Quality and Expansion 

Patricia M. Davidson 1 , Andrea Driscoll 2 , Nancy Huang 3 , Zoe 

Aho 3 , Henry Krum 2 , Andrew Sindone 4 , John Atherton 5 , Simon 

Stewart 6 ; 1 Centre for Cardiovascular and Chronic Care, Curtin 

University & St Vincents Hospital, Sydney, NSW, Australia; 

2 

Department of Epidemiology & Preventive Medicine, Monash 

University, Melbourne, VIC, Australia; 3 National Heart 

Foundation, Melbourne, VIC, Australia; 4 Cardiology, Sydney 

University & Concord Hospital, Sydney, NSW, Australia; 

5 

Cardiology, University of Queensland & Royal Brisbane 

Hospital, Brisbane, QLD, Australia; 6 Preventative Cardiology, 

Baker IDI Heart & Diabetes Institute, Melbourne, VIC, 

Australia 

Change in Mortality in the Past 20 Years in Heart 

Failure Trials 

Robert J. Bryg 1 , David J. Bryg 1 , Andre B. Akhondi 1 , Tae Yang 1 , 

Paul A. Sobotka 2 ; 1 Division of Cardiology, Olive View-UCLA 

Medical Center, Sylmar, CA; 2 Hennepin County Medical Center, 


Serum Total Cholesterol Level Is Associated with 

Increased Short- and Long-Term Mortality in Patients 

Hospitalized With Non-Ischemic Acute Heart Failure: A 

Report from Korean Heart Failure (KorHF) Registry 

Dong-Ju Choi 1 , Sung-Ji Park 2 , Chang-Hwan Yoon 1 , Gu-Yung 

Cho 1 , Jin-Ho Choi 2 , Eu-Seok Jeon 2 ; 1 Cardiovascular Center, 

Seoul National University Hospital, Seongnam, Gyeonggi-Do, 

Korea; 2 Cardiovascular Image Center, Sunggunkwan University 

Samsung Hospital, Seoul, Korea 

P304 

P305 

P306 

P307 

P308 

P309 

P310 

Venous Thromboembolism Prophylaxis among Elderly 

Heart Failure Patients and 60-Day Outcomes: An 

Analysis from ADHERE Linked to Medicare Claims 

Robb D. Kociol 1 , Bradley G. Hammill 1 , Adrian F. Hernandez 1 , 

Winslow Klaskala 2 , Roger M. Mills 3 , Lesley H. Curtis 1 , Gregg 

C. Fonarow 4 ; 1 DCRI, Durham, NC; 2 J&J Pharmaceuticals, 

Titusville, NJ; 3 Ortho-McNeil Janssen, Raritan, NJ; 4 UCLA 

Cardiomyopathy Center, Los Angeles, CA 

Does Change in Serum Sodium Concentration Predict 

Outcomes in Patients Hospitalized with Heart Failure 

and Hyponatremia? 

Vinay D. Madan 1 , Michael W. Rich 1 ; 1 Cardiology, Washington 

University School of Medicine, Saint Louis, MO 

Loss after Initial Gain in LVEF with ß-Blocker Therapy 

in Heart Failure Patients 

Pavithra Pattabiraman 1 , Wenyaw Chan 1,2 , Anita Deswal 2 , 

Sameer Ather 2 , David Aguilar 2 , Kumudha Ramasubbu 2 , Allison 

Pritchett 2 , Biykem Bozkurt 2 ; 1 UT School of Public Health, 

Houston; 2 Winters Center for Heart Failure, MEDVAMC and 

Baylor College of Medicine, Houston 

Improved Predictive Models of Mortality in Chronic 

Heart Failure Using Time-Series Measurements of 

Inflammatory Biomarkers 

Devika Subramanian, Venkataraman Subramanian, Anita 

Deswal, Douglas L. Mann; Rice University, Houston, TX; 

Nottingham University Hospital, Nottingham, United Kingdom; 

VA Medical Center and Baylor College of Medicine, Houston, 

TX; Washington University School of Medicine, St. Louis, MO 

Peak Cardiac Power Measured Non-Invasively with 

a Bioreactance Technique Is a Predictor of Adverse 

Outcomes in Patients with Advanced Heart Failure 

Mathew R. Maurer, Hannah Rosenblum, Donna Mancini, Paula 

Williams, Daniel Burkhoff;Clinical Cardiovascular Research 

Laboratory for the Elderly, Columbia University Medical 

Center, New York, NY 

Diastolic Grading by Echocardiography: Another 

Paradox? 

Jun R. Chiong 1 , Tricia Aguilar 2 ; 1 Medicine – Cardiology, Loma 

Linda University, Loma Linda, CA; 2 School of Public Health, 

Loma Linda University, Loma Linda, CA 

Prevention of Deep-Vein Thrombosis across the 

Continuum Care in Patients with Congestive Heart 

Failure in the US 

Alpesh N. Amin 1 , Jay Lin 2 , Daniel Wiederkehr 3 ; 1 School of 

Medicine, University of California-Irvine, Irvine; 2 sanofiaventis, 

Bridgewater; 3 Quintiles Consulting, Hawthorne 

tuesday 

124 

125

Sept. 14 

Tuesday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 14 

Tuesday 

Posters 

P311 

Higher Mortality in African Americans Hospitalized with 


Omaima Ali 1 , Suleiman Daifallah 2 , Hammam Zmily 1 , 

Sandip Zalawadiya 1 , Jareer Farah 1 , Majd Ibrahim 1 , Jalal K. 

Ghali 1 ; 1 Wayne State University/Detroit Medical Center, Detroit, 

MI; 2 John D. Dingell VA Medical Center, Detroit, MI 

P317 

Significance of Left Axis Deviation on CRT Response: 

Analysis of MIRACLE & MIRACLE ICD 

Mark Borganelli 1 , Douglas Wolfe 1 , Sandra McCearley 1 , 

Michael Hall 1 , Sandra B. Charlton 2 , James J. Sims 2 , John 

Payne 1 ; 1 University of Mississippi Medical Center, Jackson, MS; 

2 

Medtronic, Inc., Moundsview, MN 

tuesday 

P312 

P313 

P314 

P315 

Multidisciplinary Outpatient Management of 

Chronic Heart Failure To Reduce 30 Day and 90 Day 

Readmission in High Risk Patients 

Ali Nathani 1 , Robin L. Braun 1 , Amin F. 

Rahmatullah 1 ; 1 Cardiology, Mercy Hospital, Coon Rapids, MN 

The Chronic Care Disconnect in Heart Failure Therapy 

Audrey Kleet 1 , Kathleen Borenstein 1 , Frank Manole 1 , Jackie 

Fearon-Clarke 2 , Elizabeth Langlois 1 , Antonietta Henry 1 , Nancy 

Bonnet 1 , Frank Smart 1 ; 1 Gagnon Cardiovascular Institute, 

Morristown Memorial Hospital, Morristown, NJ; 2 Gagnon 

Cardiovascular Institute, Overlook Hospital, Summit, NJ 

Impact of Blood Pressure on Myocardial Recovery and 

Outcomes in Recent Onset Cardiomyopathy: Results of 

IMAC2 

Paul Mather 1 , Jeffrey Alexis 2 , Richard Sheppard 3 , Vinay 

Thohan 4 , David Markham 5 , G. William Dec 6 , Peter Liu 7 , Dennis 

McNamara 8 ; 1 Jefferson Medical College, Philadelphia, PA; 

2 

University of Rochester, Rochester, NY; 3 McGill SMBD Jewish 

General, Montreal, QC, Canada; 4 Wake Forest University 

Baptist Medical Center, Winston-Salem, NC; 5 University of 

Texas Southwestern Medical Center, Dallas, TX; 6 Massachusetts 

General Hospital, Boston, MA; 7 University of Toronto, Toronto, 

ON, Canada; 8 University of Pittsburgh Medical Center, 


History of Heart Failure and Mortality among Veterans 

with Implantable Cardioverter-Defibrillators 

Paul D. Varosy 1,2 , Cara N. Pellegrini 3 , Yanfei Yang 3 , Edmund 

Keung 3 , Paul Heidenreich 4 , John S. Rumsfeld 1,2 , Barry M. 

Massie 3 ; 1 VA Eastern Colorado Health Care System, Denver, 

CO; 2 Medicine, University of Colorado Denver, Aurora, CO; 

3 

Medicine, San Francisco VAMC and UCSF, San Francisco, 

CA; 4 Medicine, Palo Alto VAMC and Stanford University, Palo 

Alto, CA 

P318 

P319 

P320 

P321 

Long-Term Outcomes in Patients with Peripartum 

Cardiomyopathy and No Recovery of Ventricular 

Function 

Kismet D. Rasmusson 1 , Deborah Budge 1 , Rami Alharethi 1 , 

Kimberly D. Brunisholz 1 , Jenny J. Connolly 1 , Kurt Jensen 1 , 

Benjamin D. Horne 1 , Michelle M. Endo 1 , Josef Stehlik 2 , 

Abdallah G. Kfoury 1 ; 1 Heart Failure Treatment & Prevention 

Program, Intermountain Medical Center, Salt Lake City, UT; 

2 

Department of Cardiology, University of Utah, Salt Lake City, 

UT 

Microalbuminuria Is an Independent Prognostic Marker 

in Patients with Established Heart Failure 

Humberto Villacorta 1 , Paula V. Ferradaes 1 , Evandro T. 

Mesquita 1 ; 1 Post-Graduate Program in Cardiovascular Sciences, 

Fluminense Federal University, Niterói, Rio de Janeiro, Brazil 

Vasodilator Efficacy in Racial Subgroups in the 

Treatment of Congestive Heart Failure 

Eric M. Bader 1 , Ronald Zolty 2 ; 1 Internal Medicine, Jacobi 

Medical Center – AECOM, Bronx, NY; 2 Internal Medicine, 

Division of Cardiology, Montefiore Medical Center – AECOM, 

Bronx, NY 

Beta Blockers, Myocardial Recovery and Outcomes in 

Recent Onset Cardiomyopathy: Results of IMAC2 

Randall Starling 1 , Leslie Cooper 2 , John Boehmer 3 , Guillermo 

Torre-Amione 4 , Daniel Pauly 5 , Ilan Wittstein 6 , Mark Zucker 7 , 

Jagat Narula 8 , Dennis McNamara 9 ; 1 Cleveland Clinic, Cleveland, 

OH; 2 Mayo Clinc, Rochester, MN; 3 Penn State Hershey Medical 

Center, Hershey, PA; 4 Methodist Hospital, Houston, TX; 

5 

University of Florida College of Medicine, Gainesville, FL; 

6 

Johns Hopkins Hospital, Baltimore, MD; 7 Newark Beth Israel 

Medical Center, Newark, NJ; 8 University of California at Irvine, 

Irvine, CA; 9 University of Pittsburgh Medical Center, Pittsburgh, 

PA 

tuesday 

P316 

Survival of Adult Heart Transplant Recipients Evaluated 

by the Kaiser Permanente Northern California (KPNC) 

Heart Transplant Program: An Alternate Model for Post 

Transplant Care? 

Parag P. Kale 1 , Dana Weisshaar 1 ; 1 Heart Transplant, Kaiser Santa 

Clara, Santa Clara, CA 

P322 

Heart Failure with Preserved Ejection Fraction 

in a Real World Patient Population: How Good 

Is Echocardiography at Identifying Elevated Left 

Ventricular Pressure? 

Alina M. Robert 1 , Mandeep S. Sidhu 1 , Jeremiah R. Brown 1 , 

Hannah Foote 2 , Timothy A. Beaver 1 , Salvatore P. Costa 1 , Daniel 

J. O’Rourke 1 , Robert T. Palac 1 , David J. Malenka 1 , Alan T. 

Kono 1 ; 1 Dartmouth-Hitchcock Medical Center, Lebanon, NH; 

2 

Rockefeller University, New York, NY 

126 

127

Sept. 14 

Tuesday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 14 

Tuesday 

Posters 

tuesday 

P323 

P324 

P325 

P326 

P327 

P328 

A Comparison of the Outcomes of Low Ejection Fraction 

Chronic Heart Failure Patients on Metoprolol Succinate 

with Those on Carvedilol 

Pradnya Velankar, Ahmed Selim, Ronald Zolty;Cardiology, 

Albert Einstein College of Medicine-Weiler Division, Bronx, 

NY 

Electronic Order Sets and Discharge Templates 

Improve Heart Failure Core Measure Performance: The 

Vanderbilt Experience 

John Starmer 1 , Thomas Di Salvo 1 ; 1 Vanderbilt Heart and Vascular 

Institute, Vanderbilt, Nashville, TN 

BMI and Survival in Patients Treated with a Continuous 

Flow Left Ventricular Assist Device as Bridge to 

Transplant: A Single Center Experience 

Mustafa Toma 1 , Gonzalo V. Gonzalez-Stawinski 2 , Carmel 

Halley 1 , Eiran Z. Gorodeski 1 , Nicholas G. Smedira 2 , Randall C. 

Starling 1 , Maria M. Mountis 1 ; 1 Cardiovascular Medicine, Heart 

and Vascular Institute, Cleveland Clinic Foundation, Cleveland, 

OH; 2 Thoracic and Cardiovascular Surgery, Heart and Vascular 

Institute, Cleveland Clinic Foundation, Cleveland, OH 

Glomerular Filtration Rate Estimated by a New 

Equation Is a Better Predictor for Cardiovascular 

Events in Early-Stage Chronic Kidney Disease Patients 

Hospitalized with Acute Heart Failure: Data from 

KorHF (Korean Acute Heart Failure) Registry 

Jaewon Oh 1 , Seok-Min Kang 1 , Hoyoun Won 1 , Jinho Kim 1 , 

Nam-Ki Hong 1 , Yangsoo Jang 1 , Namsik Chung 1 , Myoung- 

Mook Lee 2 ; 1 Cardiology Division, Yonsei University College of 

Medicine, Seoul, Republic of Korea; 2 Cardiovascular Division, 

Dongguk University Ilsan Hospital, Koyang, Republic of Korea 

Heart Failure Observed to Expected Mortality: Caveat 

Emptor 

Jeffrey Boord 1 , Thomas Di Salvo 1 ; 1 Vanderbilt Heart and Vascular 

Institute, Vanderbilt University Medical Center, Nashville, TN 

Anemia Is a Major Determinant of Long-Term Mortality 

and Hospitalization in Patients Hospitalized with Acute 

Decompensated Heart Failure: A Report from the 

Korean Heart Failure Registry (KorHFR) 

Sung-Ji Park 1 , Dong-Ju Choi 2 , Jin-Ho Choi 1 , Enu-Seok Cheon 1 , 

Gyu-Hyung Lee 3 , Myeon-Chan Cho 4 , Jae-Jung Kim 5 , Sung- 

Cheol Chae 5 ; 1 Cardiovascular Image Center, SunggyunKwan 

University Samsung Hospital, Seoul, Korea; 2 Cardiovascular 

Center, Seoul National University Bundang Hospital, Bundang, 

Gyeonggi-Do, Korea; 3 Cardiovascular Center, KonKuk 

University Hospital, Seoul, Korea; 4 Cardiovascular Center, 

Chungbuk University Hospital, Cheongju, Chungbuk, Korea; 

5 

Korean Heart Failure Registry, Seoul, Korea 

P329 

P330 

P361 

P362 

P363 

P364 

Selective Serotonin Reuptake Inhibitor Use May Reduce 

Mortality in Systolic Heart Failure Patients 

Ramesh Chandra 1 , Ahmed Selim 1 , Beenu Singh 1 , Ronald 

Zolty 1 ; 1 Medicine/Cardiology, Albert Einstein College of 

Medicine, Bronx, NY 

Predictors of Hospital Length of Stay in African 

Americans Admitted with Acute Decompensated Heart 


Jareer Farah 1 , Sandip Zalawadiya 1 , Hammam Zmily 1 , Suleiman 

Daifallah 2 , Omaima Ali 1 , Jalal K. Ghali 1 ; 1 Wayne State 

University/Detroit Medical Center, Detroit, MI; 2 John D. Dingell 

VA Medical Center, Detroit, MI 


Cocaine Users Hospitalized for Acute Decompensated 

Heart Failure: Falling between the Cracks – An 

Opportunity for Improved Care 

Imdad Ahmed 1 , Gavin Bart 2 , Bradley A. Bart 2 ; 1 Regions Hospital, 

St. Paul, MN; 2 Hennepin County Medical Center, Minneapolis, 

MN 

Stress Cardiomyopathy Induced by Common Surgical 

and Medical Interventions: When Patients Get More 

Than They Asked For 

Ivan Mendoza, Rodrigo Lago, Ricardo Cardona, Lynn 

Morris;Cardiology, Cleveland Clinic Florida, Weston, FL; 

Cardiology, Albert Einstein Medical Center, Philadelphia, PA 

Alcohol Septal Ablation to Treat Heart Failure Due to 

Dynamic Left Ventricular Outflow Tract Obstruction in 

a Patient with Glycogen Storage Disease Related to the 

PRKAG2 Gene Mutation 

Kathleen L. Tong 1 , Colleen Brown 2 , Thomas A. Ports 1 , Dana 

McGlothlin 1 , Teresa De Marco 1 ; 1 Cardiovascular Medicine, 

University of California, San Francisco, San Francisco, 

CA; 2 Genetics, University of California, San Francisco, San 

Francisco, CA 

Differential Responses to Hemodynamically Tailored 

Therapy on Intra-Abdominal Pressure and Cardio-Renal 

Impairment in Acute Decompensated Heart Failure 

Poh Shuan Daniel Yeo 1 , Carmel M. Halley 2 , Julio A. Barcena 3 , 

Wilfried Mullens 4 , W.H. Wilson Tang 2 ; 1 Cardiovascular Medicine, 

Tan Tock Seng Hospital, Singapore, Singapore; 2 Cardiovascular 

Medicine, Cleveland Clinic, Cleveland, OH; 3 Cardiovascular 

Medicine, Louis Stokes VA Medical Center, Cleveland, OH; 

4 

Cardiology, Ziekenhuis Oost Limburg Genk, University 

Hasselt, Genk, Belgium 

tuesday 

128 

129

Sept. 14 

Tuesday 

Posters 

Posters 


Posters 


Sept. 14 

Tuesday 

Posters 

tuesday 

P365 

P366 

P367 

P368 

P369 

Failure to Reach Anaerobic Threshold May Be a Risk 

Factor for Heart Failure 

John Moran 1 , Mark Landmeier 1 , Nithin Gottam 1 ; 1 Cardiology, 

Loyola University Medical Center, Maywood, IL 

Distribution, Treatment, and Health Record 

Documentation of Depression Symptoms in Heart 

Failure Outpatients 

Andreas P. Kalogeropoulos 1 , Vasiliki V. Georgiopoulou 1 , Lucy 

Fike 1 , Grigorios Giamouzis 1 , Kunal Bhatt 1 , Charu Gupta 1 , 

Catherine R. Norton 1 , Mahdi Chowdhury 1 , Adnan Malik 1 , 

Sonjoy Laskar 1 , Andrew L. Smith 1 , Sandra Dunbar 2 , Javed 

Butler 1 ; 1 Division of Cardiology, Emory University, Atlanta, GA; 

2 

School of Nursing, Emory University, Atlanta, GA 

Lack of Correlation Between I131 Labeled Albumin 

Measurements of Blood Volume and Serum B-Natiuretic 

Peptide Levels in Heart Failure Patients 

John E. Strobeck 1 , Robin Giordano 1 ; 1 Heart Failure Program, 

Department of Cardiology, The Valley Hospital, Ridgewood, NJ 

Utilization of Evidence Based Medications in Patients 

Prior to the Time of First Referral to Outpatient Heart 

Failure Clinics of the Canadian Heart Failure Network 

(CHFN) 

Malcolm Arnold 1 , Andrew Ignaszewski 2 , Johathan Howlett 3 , 

Peter Liu 4 , Marie Helene LeBlanc 5 , Anne Marie Kaan 2 , Gordon 

Marchiori 1 ; 1 University Hospital, London, Canada; 2 St Paul’s 

Hospital, Vancouver, Canada; 3 Foothills Hospital, Calgary, 

Canada; 4 University Health Network, Toronto, Canada; 5 Quebec 

Heart and Lung Institute, Quebec City, Canada 

The Thermodilution Catheterization Technique Does Not 

Reliably Identify Advanced Heart Failure Patients with 

Low Cardiac Indices 

Rachel Garcia-Criswell 1 , Joseph Fredi 1 , Thomas Di 

Salvo 1 ; 1 Vanderbilt Heart and Vascular Institute, Vanderbilt 

University Medical Center, Nashville, TN 

P371 

P372 

P373 

P374 

SERIOUS Medication Reconciliation Clinic: Improving 

Transitions of Care 

Sherry LaForest 1 , Julie Gee 2 , Adam Pugacz 1 , Julio Barcena 2 , 

Danielle Hoover 3 , Aubrey Guthrie 1 , Sharon Sabatka 1 , Catherine 

Ortiz 1 , William Salem 1 , Jose Ortiz 2 ; 1 Pharmacy Department, 

Cleveland VA Medical Center, Cleveland, OH; 2 Cardiology 

Division, Cleveland VA Medical Center, Cleveland, OH; 3 VA 

National Center for Patient Safety, Ann Arbor, MI 

Heart Failure Database Variables Most Frequently 

Recorded during Follow-Up at Specialist Heart Failure 

Outpatient Visits in the Canadian Heart Failure Network 

(CHN) 

Malcolm Arnold 1 , Andrew Ignaszewski 2 , Peter Liu 3 , Marie 

Helene LeBlanc 4 , Jonathan Howlett 5 , Anne Marie Kaan 2 , Gordon 

Marchiori 1 ; 1 University Hospital, London, Canada; 2 St Paul’s 

Hospital, Vancouver, Canada; 3 University Health Network, 

Toronto, Canada; 4 Quebec Heart and Lung Institute, Quebec 

City, Canada; 5 Foothills Hospital, Calgary, Canada 

Beta-Blocker Pretreatment Does Not Affect the 

Renoprotective Effects of Low-Dose Dopamine in 

Patients with Acute Decompensated Heart Failure 

G. Giamouzis 1,2 , J. Butler 2 , R.C. Starling 3 , G. Karayannis 1 , D. 

Rovithis 1 , C. Parisis 1 , J. Nastas 4 , T. Tsaknakis 4 , J. Skoularigis 1 , 

F. Triposkiadis 1 ; 1 Larissa University Hospital, Larissa, Greece; 

2 

Emory University Hospital, Atlanta, GA; 3 Cleveland Clinic 

Foundation, Cleveland, OH; 4 Volos General Hospital, Volos, 

Greece 

Revascularization Leads to Greater Reduction in 

Ischemia Than Medical Therapy in Patients with Left 

Ventricular Dysfunction and Stable Coronary Artery 

Disease 

Salvadore Borges-Neto 1 , Afshin Farzaneh-Far 1 , Linda K. Shaw 1 , 

Mona Fiuzat 1 , Harry Phillips 1 , Eric Velazquez 1 , Christopher M. 

O’Connor 1 ; 1 Duke University Medical Center and Duke Clinical 

Research Institute, Durham, NC 

tuesday 

P370 

Stroke in Children with Myocarditis: Does 

Anticoagulation Regimen Matter? 

Kimberly Lin 1 , Basavaraj Kerur 2 , Char Witmer 1 , Lauren Beslow 1 , 

Rebecca Ichord 1 , Beth Kaufman 1 ; 1 Pediatrics, Children’s Hospital 

of Philadelphia, Philadelphia; 2 Pediatrics, Albert Einstein M.C., 

Philadelphia 

130 

131

Sept. 14 

Tuesday 

Posters 

Posters 


Posters 


Sept. 14 

Tuesday 

Posters 

tuesday 

P375 

P376 

Do Angiotensin-Converting Enzyme (ACE) Inhibitors 

and Statins Prevent Anthracycline-Induced Alterations 

of the Left Ventricular Performance in Cancer Patients? 

Dan Radulescu, Andreea Parv, Maria Radulescu, Sorin Pripon, 

Paula Mitrea, Gheorghe Sebesteyn, Constantin Cosma, Marian 

Mihaiu;Hospital Municipal, University of Medicine and 

Pharmacy, Cluj- Napoca, Cluj; Hospital Municipal, University 

of Medicine and Pharmacy, Cluj – Napoca, Cluj; Hospital 

Municipal, University of Medicine and Pharmacy, Cluj – 

Napoca, Cluj; Hospital Municipal, University of Medicine and 

Pharmacy, Cluj -Napoca, Cluj; Computer Sciences, Technical 

University, Cluj – Napoca, Cluj; Computer Sciences, Technical 

University, Cluj Napoca, Cluj; , Babes – Bolyai University, 

Cluj – Napoca, Cluj; , University of Veterinary Medicine, Cluj 

– Napoca, Cluj 

Nurse Navigators – Forget the Tom-Tom 

Paula M. Candlish 1 , Kerry A. Staniford 1 ; 1 Heart Failure Service, 

Northern Sydney Central Coast Area Health Service, Gosford, 

NSW, Australia 

P381 

P382 

P383 

Attenuated Vasoconstriction of Chagas Disease in 

Decompensated Severe Heart Failure 

Marcelo E. Ochiai 1 , Euler C.O. Brancalhao 1 , Marcelo V. Lima 1 , 

Kelly R.N. Vieira 1 , Raphael S.N. Puig 1 , Juliano N. Cardoso 1 , 

Antonio C.P. Barretto 1 ; 1 Cotoxo Hospital, Heart Institute (InCor) 

University of Sao Paulo, Sao Paulo, SP, Brazil 

Estimation, Rather Than Direct Measurement, of 

Resting Oxygen Consumption Yields Inaccurate 

Hemodynamic Measurements during Right Heart 

Catheterization 

Philip Formica 1 , David Bartov 1 , Sandhya Murthy 1 , Per Sommer 1 , 

Denise D’Amore 1 , Simon Maybaum 1 ; 1 Department of Cardiology, 

Montefiore Medical Center, Bronx, NY 

Bi-Ventricular Pacing Improves Ejection Fraction and 

Ventricular Size in Systolic Heart Failure Patients 

Treated at a Community Referral Hospital 

Kalki Bommaraju 1 , Lee W. Jordan 1 ; 1 Riverside Methodist 

Hospital, Columbus, OH 

tuesday 

P377 

Non-Adherence Is Associated with Negative Perception 

and Poor Understanding of Medications, and Increased 

Left Ventricular End-Diastolic Diameter in a Population 

of Inner-City Patients with Systolic Heart Failure 

Mariana Markell 1 , Sima Terebello 1 , Meriam F. Caboral 2 , Judith 

E. Mitchell 2 ; 1 Renal Division, SUNY Downstate Medical Center, 

Brooklyn, NY; 2 Division of Cardiology, SUNY Downstate 

Medical Center, Brooklyn, NY 

P384 

Medication Adherence among Korean Patients with 

Heart Failure: A Pilot Study 

Jung Hwa Hwang 1 , Seok-Min Kang 2 , HyangKyu Lee 3 , Sang Hui 

Chu 4 ; 1 Yonsei University Health System, Severance Hospital 

Cardiovascular Center, Seoul, Korea; 2 Yonsei University College 

of Medicine, Seoul, Korea; 3 Yonsei University College of 

Nursing, Seoul, Korea; 4 Yonsei University College of Nursing, 

Seoul, Korea 

P378 

The Dutch Objective Burden Inventory – Validity and 

Reliability Testing in Canada 

Karen Harkness 1,2 , Makdessi Anthony 1 , Heather Arthur 1 , Robert 

McKelvie 1,2 ; 1 Faculty of Heath Sciences, McMaster University, 

Hamilton, ON, Canada; 2 Cardiac and Vascular Program, 

Hamilton Health Sciences, Hamilton, ON, Canada 

P385 

Epidemiological and Microbiological Features of 

Ventricular Assist Device Associated Infections 

Arun Raghav Mahankali Sridhar 1 , Isaac Mizrahi 2 , Samer S. 

Najjar 1 , Carolyn Hanny-Gilbert 1 , Shmuel Shoham 1 ; 1 Washington 

Hospital Center, Washington, DC; 2 Boston University School of 

Public Health, Boston, MA 

P379 

Meta-Analysis of the Accuracy of Doppler 

Echocardiography in the Assessment of Pulmonary 

Artery Systolic Pressure 

Mohammed Taleb, Sadik Kuder, Samer Khouri;Cardiovascular 

Disease, University of Toledo Medical Center, Toledo, OH 

P386 

Sleep Apnea Is Highly Prevalent in Patients Hospitalized 

for Heart Failure with Preserved Ejection Fraction 

Najmul I. Siddiqi 1 , Dennis Jurcevic 1 , Vidya Krishnan 1 , Mark E. 

Dunlap 1 ; 1 MetroHealth Medical Center, Case Western Reserve 


P380 

Clinical Outcomes of Very Elderly Patients with Acute 

Hospitalization for Heart Failure 

Richard S. Schofield 1,2 , Shawn D. Anderson 1 , Lynnette Boyer 1 , 

Carsten M. Schmalfuss 1,2 , Tamarah J. Jungklaus 1 , Amy R. 

Mullikin 1 , Samantha L. Malloy 1 , Jose R. Perez, Juan M. 

Aranda, Jr. 1,2 ; 1 Department of Veterans Affairs Medical Center, 

Gainesville, FL; 2 Division of Cardiovascular Medicine, 

University of Florida College of Medicine, Gainesville, FL 

P387 

Effect of Angiotensin-Converting Enzyme Inhibitors and 

Angiotensin Receptor Blockers on Outcomes in Patients 

with Alcoholic Cardioymopathy 

Ahmed M. Selim 1 , Israa Soghier 1 , Pradnya Velankar 1 , Ronald 

Zolty 1 ; 1 Cardiology, Albert Einstein College of Medicine/Weiler 

Division, Bronx, NY 

132 

133

Sept. 14 

Tuesday 

Posters 

tuesday 

P388 

P389 

P390 

P391 

Posters 


Use of Pulmonary Artery Systolic Pressure To Reveal 

Unsuspected Mismatch in Right-Left Sided Filling 

Pressure Elevation 

Patricia Campbell, Mahoto Kato, Garrick C. Stewart, Mark 

Liszkowski, Anju Nohria, Lynne W. Stevenson;Department of 

Cardiology, Brigham and Women’s Hospital, Boston, MA 

Chart-Based Collaborative Medication Review (CMR) 

To Improve Care of 351 Patients with Congestive Heart 

Failure (CHF) in a Veterans Affairs Medical Center 

(VAMC) 

Harleen Singh 1 , Jessina C. McGregor 1 , Justin Bednar 1 , Elva 

A. Van Devender 1 , Tammy Chan 1 , Sharon Shiraga 1 , Greg 

Larsen 2 ; 1 Pharmacy Practice, Oregon State University/Oregon 

Health & Science College of Pharmacy, Portland, OR; 

2 

Cardiology, Portland Veterans Affairs Medical Center(VAMC), 

Portland, OR 

Patient, Nurse, and Doctor Assessment of New York 

Heart Association Class, Health, and Quality of Life in 

Heart Failure: Comparison and Outcome Prediction 

Jerneja Farkas 1 , Darija Stevancec 2 , Aleksandra Balazic-Gjura 2 , 

Lea Majc-Hodoscek 2 , Mitja Lainscak 3 ; 1 Chair of Public Health, 

Faculty of Medicine, University of Ljubljana, Ljubljana, 

Slovenia; 2 Department of Internal Medicine, General Hospital 

Murska Sobota, Murska Sobota, Slovenia; 3 Division of 

Cardiology, University Clinic Golnik, Golnik, Slovenia 

Relaxation Biofeedback Intervention in Patients with 

Heart Failure: Results from a Randomized, Controlled, 

Single-Blind Trial 

Tsuey-Yuan Huang 1 , Shiow-Li Hwang 3 , Debra K. Moser 2 , Ming- 

Feng Tsai 1 , Fu-Tien Chiang 6 , Chun-Li Wang 4 , Feng-Chun Tsai 4 , 

Chun-Chi Chen 4 , Chih-Yuan Fang 4 , Kelvin Hsieh 4 , Kuan-Rau 

Chiou 5 ; 1 Nursing, Chang Gung Institute of Technology, Taoyuan, 

Taiwan; 2 Nursing, University of Kentucky, Lexington, KY; 

3 

Nursing, National Taipei College of Nursing, Taipei, Taiwan; 

4 

Chang Gung Memorial Hospital, Taoyuan, Taiwan; 5 Veterans 

General Hospital, Kaohsiung, Taiwan; 6 National Taiwan 

University Hospital, Taipei, Taiwan 



8:30-10:00 AM 

Ballroom 6B 

Late Breaking Clinical Trials: II 

Moderators: Kirkwood F. Adams, Jr., Chapel Hill, NC 

Gary S. Francis, Minneapolis, MN 

8:30 Novel Protein Therapeutics for Chronic Systolic Heart 

Failure: Chronic Subcutaneous BNP Administration 

(NICE BNP) 

Horng H. Chen, James Glockner, John A. Schirger, Alessandro 

Cataliotti, Robert D. Simari, Margaret M. Redfield, John C. 

Burnett, Mayo Clinic, Rochester, MN 




8:48 Reducing Decompensation Events Utilizing IntraCardiac 

Pressures in Patients with Chronic HF (REDUCEhf) 

Philip B. Adamson, Michael R. Gold, Robert C. Bourge, Lynne 

W. Stevenson, Robin Trupp, Kurt Stromberg, Bruce Wilkoff, 

Michael Zile, Oklahoma Heart Hospital, Oklahoma, OK 




9:06 Effects of n-3 Polyunsaturated Fatty Acides (PUFAs) on 

Left Ventricular Function and Functional Capacity in 

Patients with Dilated Cardiomyopathy 

Savida Nodari, Marco Triggiani, Alessandra Manerba, Giuseppe 

Milesi, Mihai Gheorghiade, Livio Dei Cas, University of 

Brescia, Brescia, Italy 


Steven R. Goldsmith, Minneapolis, MN 



Sept. 15 

Wednesday 

AM 

WEDNESDAY 

8:15 HFSA Annual Business Meeting 

Room 3 


Refreshments served in 2nd floor foyer area 

134 

135

Sept. 15 

Wednesday 

AM 



8:30-10:00 AM 

Ballroom 6B 

SYMPOSIUM 


8:30-10:00 AM 

Room 4 

Sept. 15 

Wednesday 

AM 

WEDNESDAY 

Late Breaking Clinical Trials: II (cont.) 

9:24 Congestive Heart Failure: A Multidisciplinary 

Non-Pharmacological Approach for Changing in 

E-Hospitalization and Prognosis in Patients with 

Concomitant Anxiety aNd Depression (CHANCE-AND) 

Viacheslav Mareev, M Danielyan, Yu Belenkov for CHANCE- 

AND Investigators, Russian Society of Heart Failure Specialists, 

Moscow, Russia 




9:42 CardioMEMS Heart Sensor Allows Monitoring of 

Pressures to Improved Outcomes in NYHA Class III 

Heart Failure Patients (CHAMPION) Trial: Impact of 

Hemodynamic Guided Care on Patients with Preserved 


Philip B. Adamson, William T. Abraham, Robert C. Bouge, 

Lynne W. Stevenson, Jay Yadav, Oklahoma Heart Hospital, 

Oklahoma, OK 


Gary S. Francis, Minneapolis, MN 

Just Say NO: Nitric Oxide Enhancement for 


Moderator: Wilson S. Colucci, Boston, MA 

8:30 Nitroso-Redox Imbalance in Heart Failure 

Joshua M. Hare, Miami, FL 

8:50 Nitric Oxide Enhancement Effects of Hydralazine 

and Isosorbide Dinitrate on Clinical Outcomes and 

Ventricular Remodeling 

Anne L. Taylor, New York, NY 

9:10 Molecular Signaling Significance of Nitrosylation/ 

Denitrosylation 

Kenneth P. Laurita, Cleveland, OH 

9:30 Nitroxyl (HNO) Donors in Normal and Failing Hearts 

Nazareno Paolocci, Baltimore, MD 


Learning Objective: Describe the role of nitric oxide in 

heart failure and the effects of nitric oxide enhancement on 

ventricular remodeling and clinical outcomes. 

WEDNESDAY 


Learning Objective: Describe the results of recent trials and 



Room 3 


Room 3 





136 

137

Sept. 15 

Wednesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Room 6D 

SYMPOSIUM 


8:30-10:00 AM 

Room 6C 

Sept. 15 

Wednesday 

AM 

WEDNESDAY 

Designing the Medical Home for Heart Failure 

Patients 

Moderator: Terry A. Lennie, Lexington, KY 

8:30 Utilizing Family to Improve Dietary Adherence 

Carolyn M. Reilly, Atlanta, GA 

8:50 How Do Interventions with Patients Affect Caregiver 

Outcomes? 

Misook L. Chung, Lexington, KY 

9:10 Interactions with Other Specialists: Coordinating the 

Medical Home from the Heart Failure Clinic 

Mary N. Walsh, Indianapolis, IN 

9:30 End-of-Life: Transitioning to Palliative Care 

Larry A. Allen, Denver, CO 


Learning Objective: Describe treatment strategies in the 

medical home model and how they impact the patient and 

caregivers. 

Common Dilemma of the Failing Right 

Ventricle in Pulmonary Hypertension: 

Are We Getting Better at Treating It? 

Moderator: Teresa De Marco, San Francisco, CA 

8:30 Update on Pulmonary Arterial Hypertension (PAH): 

From Drugs to Lifestyle Modifications 

Michael A. Mathier, Pittsburgh, PA 

8:50 PAH in Valvular Disease: Do Pulmonary 

Vasodilators Help? 

Myung H. Park, Baltimore, MD 

9:10 Pulmonary Hypertension in Systolic Heart Failure: 

Implications and Management 

Srinivas Murali, Pittsburgh, PA 

9:30 PAH and Diastolic Dysfunction: Can We Use 

Vasoactive Therapies? 

Marc J. Semigran, Boston, MA 


Learning Objective: Describe current treatment options for 

patients with pulmonary arterial hypertension. 

WEDNESDAY 


Room 3 


Room 3 





138 

139

Sept. 15 

Wednesday 

AM 

SYMPOSIUM 


10:30 AM-NOON 

Ballroom 6B 

SYMPOSIUM 


10:30 AM-NOON 

Room 4 

Sept. 15 

Wednesday 

AM 

M&M from Heart Failure Trials 

Update on Cardiac Transplantation 

Moderators: Milton Packer, Dallas, TX 

Norman L. Stockbridge, Silver Spring, MD 

10:30 I PRESERVE 

Peter E. Carson, Washington, DC 

10:50 SENIORS 

Andrew J.S. Coats, Sydney, Australia 

11:10 EVEREST: Vasopressin Antagonists 

Mihai Gheorghiade, Chicago, IL 

11:30 PROTECT: Adenosine Antagonists 


11:50 Overview 


Learning Objective: Outline findings of selected clinical 

trials and their implications for heart failure treatment. 

Moderator: Mariell L. Jessup, Philadelphia, PA 

10:30 Patient Selection and Risk Stratification 

Donna M. Mancini, New York, NY 

10:45 Understanding Common Immunosuppression Strategies 

Jon A. Kobashigawa, Los Angeles, CA 

11:00 Monitoring of Post-Transplant Patients: Invasive, 

Noninvasive and Molecular Strategies 

Stuart D. Russell, Baltimore, MD 

11:15 Cardiac Allograft Vasculopathy 

Randall C. Starling, Cleveland, OH 

11:30 Psychosocial Disorders and Distress After 

Cardiac Transplantation 

Katherine J. Hoercher, Cleveland, OH 


WEDNESDAY 

Learning Objective: Discuss patient selection and risk 

stratification for transplantation, immunosuppression, 

monitoring, and the role of cardiac allograft vasculopathy. 

WEDNESDAY 

140 

141

Sept. 15 

Wednesday 

AM 

SYMPOSIUM 


10:30 AM-NOON 

Room 6D 

SYMPOSIUM 


10:30 AM-NOON 

Room 6C 

Sept. 15 

Wednesday 

AM 

The Other Cardiomyopathies: 

Diagnosis and Management 

Heart Failure Readmissions: 

The 2010 Challenge 

Moderator: Hector O. Ventura, New Orleans, LA 

Moderator: Nancy M. Albert, Cleveland, OH 

10:30 Hypertrophic Cardiomyopathy 

Tamara B. Horwich, Los Angeles, CA 

10:30 The Spectrum of the Problem 

Barry M. Massie, San Francisco, CA 

10:50 Noncompaction Cardiomyopathy 

Euan A. Ashley, Stanford, CA 

10:50 Environmental and Social Reasons for Readmission 

Debra K. Moser, Lexington, KY 

WEDNESDAY 

11:10 Amyloid Cardiomyopathy 

Mathew S. Maurer, New York, NY 

11:30 The Athlete and Cardiomyopathy: 

Can They Play Ball? 

James P. Daubert, Durham, NC 


Learning Objective: Diagnose and manage hypertrophic, 

noncompaction, and amyloid cardiomyopathy and 

cardiomyopathy in the athlete. 

11:10 The CMS Report Card: Why Did Your Hospital 

Receive an “F”? 

Paul A. Heidenreich, Stanford, CA 

11:30 Disparities in Readmission: Are We Addressing 

the Real Problem? 



Learning Objective: Describe causes for heart failure 

readmissions and procedures for hospital evaluation. 

WEDNESDAY 

142 

143

Thank you for coming – 

see you next year! 

15th Annual 


September 18 – 21, 2011 

Hynes Convention Center 

Boston, MA 

Abstract Deadline: April 11, 2011 

www.hfsa.org 

145

CLINICAL TRIAL ROW 

EXHIBIT FLOOR PLAN 

OUTSIDE PROMENADE 

SAILS PAVILION 

POSTER S 

427 526 

525 

223 325 424 425 524 

323 422 

221 

421 520 

519 

219 318 321 420 518 

217 316 

417 516 

Laptop 

317 416 

Lounge 

513 

213 312 

413 512 

211 

411 510 

209 308 309 409 508 

507 

207 304 

405 504 

501 

201 300 301 401 500 

ENTRANCE 

BALLROOM 6 LOBBY 

CME Kiosk 

REGISTRATION 

Scientific 

Scientific 

Sessions 

Sessions 

146 

HFSA Exhibitor Booth # 

ABIOMED.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #424 

American Association of Heart Failure Nurses .. . . . . . . . . . . Booth #413 

American Heart Association........................... Booth #420 

Averion International Corporation....................... Booth #421 

BG Medicine, Inc.. ................................. Booth #318 

Biotronik.......................................... Booth #223 

Boston Scientific Corporation. ........................ Booth #507 

Cardiotronic, Inc.................................... Booth #323 

CHF Solutions. .................................... Booth #500 

Corceuticals. ...................................... Booth #524 

Cytokinetics, Inc. .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #513 

Daxor Corporation .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #405 

Elsevier, Inc........................................ Booth #504 

Evaheart Medical USA............................... Booth #520 

GeneDX .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #409 

Gilead Sciences, Inc. .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #416 

Gilead Sciences, Inc. .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #417 

HRA Research. .................................... Booth #518 

Heart Failure Society of America....................... Booth #501 

HFSA E-mail Retrieval Stations........................ Booth #525 

HeartWare, Inc...................................... Booth #317 

Insilicomed, Inc... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #425 

Lippincott Williams & Wilkins - Wolters Kluwer .. . . . . . . . . Booth #308 

Medtronic, Inc... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #301 

Millar Instruments, Inc.. ............................. Booth #304 

Miller Pharmacal Group, Inc........................... Booth #312 

NeuMeDx ........................................ Booth #411 

NitroMed. ........................................ Booth #316 

Otsuka America Pharmaceutical, Inc.. .................. Booth #309 

Oxford University Press.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #510 

St. Jude Medical.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #300 

Shape Medical Systems, Inc. .. . . . . . . . . . . . . . . . . . . . . . . . . Booth #325 

Sonometrics Corporation .. . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #526 

SonoSite .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #201 

SynCardia Systems, Inc. .. . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #422 

The Joint Commission .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #508 

Thoratec Corporation.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #401 

Wiley-Blackwell.................................... Booth #512 

WorldHeart Corporation.............................. Booth #516 

XDx Inc... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #321 

ZOLL .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth #519 

147

Clinical Trial Row 

EXHIBITORS 

Bayer HealthCare AG 

B1 

Boston Scientific 

B2 

COMPOSE 

The COMPOSE Study Program -Three Phase IIb, 

Placebo-Controlled, Randomized, Double-Blind, 

Fixed-Dose Studies of Cinaciguat (BAY 58-2667) in 

Patients With Acute Decompensated Heart Failure 

MultiSENSE 

Multisensor Chronic Evaluations in Ambulatory 


ABIOMED............................................424 

22 Cherry Hill Drive 

Danvers, MA 01923 

Website: www.abiomed.com 

Abiomed was founded in 1981 and is the only company in the world 

with exclusive labeling on ventricular assist devices for all potentially 

recoverable heart failure indications. Abiomed is dedicated to 

providing the most advanced medical technologies to heart patients, 

with the ultimate goal of heart recovery and improved quality of life. 

American Association of Heart Failure Nurses...............413 

CVRx 

B3 

Medtronic 

B4 

B5 

B6 

B7 

B8 

B9 

B10 

HOPE4HF 

Health Outcomes Prosepective Evaluation for Heart 

Failure with EF≥40% 

aCRT 

Adaptive CRT 

Attain Success 

Block HF 

Biventriuclar Versus Right Ventricular Pacing in 

Heart Failure Patients with Atrioventricular Block 

OptiVol Care Pathway Study 

PainFree SST 

Product Performance Studies 

RAFT 

Resynchronization/Defibrillation for Ambulatory 


15000 Commerce Parkway 

Suite C 

Mount Laurel, NJ 08054 

Website: www.aahfn.org 

The American Association of Heart Failure Nurses (AAHFN) is a 

specialty organization dedicated to advancing nursing education, 

clinical practice and research to improve heart failure patient 

outcomes. We serve as the interface for sharing ideas, translating 

research findings into practice and setting priorities for the future. 

American Heart Association..............................420 

7272 Greenville Avenue 

Dallas, TX 75231 

Website: www.americanheart.org 

The American Heart Association/American Stroke Association offers 

a complete portfolio of quality improvement programs dedicated to 

bettering patient care through guideline adherence. The programs 

address improving quality of patient care for patients of heart disease 

and stroke from primary prevention all the way through outpatient care. 

SynCardia Systems, Inc. 

B11 

Freedom IDE 

FoldRx Pharmaceuticals, Inc. 

B12 

THAOS 

Transthyretin Amyloidosis Outcomes Survey 

Averion International Corporation ........................421 

225 Turnpike Road 

Southborough, MA 01772 

Website: www.averion.com 

Averion is an international clinical research organization (CRO) 

that provides international phase I-IV clinical trial management 

and consulting services with a focus in Cardiovascular Diseases 

and Medical Devices. Our services span the product development 

lifecycle from first-in-man through to regulatory approval and postmarketing 

surveillance studies. 

148 

149

EXHIBITORS 

EXHIBITORS 

BG Medicine, Inc.......................................318 

610 North Lincoln Street 

Waltham, MA 02451 

Website: www.bg-medicine.com 

BG Medicine is focused on the discovery and commercialization of 

diagnostics based on biomarkers to improve patient outcomes. We are 

developing multiple product candidates for cardiac and other diseases, 

and have begun limited sales in Europe for our lead product, an assay 

to aid in identifying high-risk heart failure patients. 

Biotronik. ............................................223 

6024 Jean Road 

Lake Oswego, OR 97035 

Website: www.biotronik.com 

BIOTRONIK is a world leader in the design and development of 

cardiac rhythm management devices. Visit our booth to learn about 

our latest cardiac resynchronization defibrillator that automatically 

monitors and trends patients’ heart failure status through daily, wireless 

transmissions of clinically significant heart failure diagnostic data. 

Boston Scientific Corporation. ...........................507 

4100 Hamline Avenue North 


Website: www.bostonscientific.com 

Boston Scientific is a worldwide developer, manufacturer, and 

marketer of medical devices whose products are used in a broad 

range of interventional medical specialties. With approximately 

25,000 employees and annual revenue of more than $8 billion, Boston 

Scientific is the world’s largest medical device company dedicated to 

less-invasive therapies. 

Cardiotronic, Inc.......................................323 

7855 Ivanhoe Avenue, Suite 226 

La Jolla, CA 92037 

Website: www.cardiotronic.net 

CHF Solutions, Inc. ....................................500 

7601 Northland Drive 

Suite 170 

Brooklyn Park, MN 55428 

Website: www.chfsolutions.com 

CHF Solutions Inc. has pioneered aquapheresis therapy for patients 

with fluid overload. Inpatient or outpatient, perioheral or central, 

remove excess salt and water with aquapheresis and the Aquadex 

FlexFlow. It’s low blood flow, low extracorporeal blood volume, and 

precise removal rates allow you to expand the number of services that 

you offer and the types of patients that you see. 

Corceuticals...........................................524 

1 Prestige Place 

Suite 610 

Miamisburg, OH 45342 

Website: www.cardiamin.com 

Corceuticals® produces evidence based nutritional supplements for 

patients with congestive heart failure and cardiovascular diseases. 

The company recently launched Cardiamin®, the first evidence based 

daily multivitamin to address vitamin D deficiency with the inclusion 

of fish oil. The company has formed educational partnerships with 

the American Association of Heart Failure Nurses and the National 

Kidney Foundation. 

Cytokinetics, Inc........................................513 

280 East Grand Avenue 

South San Francisco, CA 94080 

Website: www.cytokinetics.com 

Cytokinetics, Inc. is a biopharmaceutical company focused on 

the discovery, development and commercialization of novel small 

molecule drugs that specifically target the cytoskeleton. Cytokinetics’ 

heart failure program is focused towards small molecule activators 

of cardiac myosin, the cytoskeletal motor protein in cardiac muscle 

responsible for cardiac contraction. 

Cardiotronic, based in California, specializes in 100% non-invasive 

cardiac output monitoring (EC) for all patient populations. Both the 

comprehensive AESCULON and compact ICON monitor provide 

continuous estimations of cardiac output, fluid status, and contractility. 

EC is a Medicare-covered test used to assist physicians in the 

selection and optimization of cardiovascular medications. 

150 

151

Daxor Corporation .....................................405 

350 Fifth Avenue 

Suite 7120 

New York, NY 10118 

Website: www.daxor.com 

Daxor Corporation’s BVA-100® Blood Volume Analyzer is a 

semi-automated instrument patented for direct measurement of 

blood volume, red cell and plasma volume. The system utilizes 

the Volumex® injection kit for a multi-sample blood volume. 

Measurement of blood volume is applicable for hypertension, CHF, 

transfusion, ICU/CCU, anemia, orthostatic hypotension and syncope. 

Elsevier, Inc. ..........................................504 

1600 JFK Boulevard, Suite 1800 

Philadelphia, PA 19103 

Website: www.elsevier.com 

Elsevier, proud publisher of the Journal of Cardiac Failure, the 

official journal of the Heart Failure Society of America. Come view 

the latest issue of the Journal and browse our other books, periodicals 

and online solutions in the field of cardiology. 

Evaheart Medical USA..................................520 

880 William Pratt Way 

Pittsburgh, PA 15238 

Website: www.evaheart-usa.com 

The EVAHEART Left Ventricular Assist System (LVAS) is an 

implantable centrifugal Blood Pump designed to generate flow and 

pressure in cardiac transplant candidates with advanced heart failure 

and compromised left ventricular function. The EVAHEART LVAS is 

embarking on a bridge-to-transplant clinical trial in the United States. 

GeneDx...............................................409 

207 Perry Parkway 

Gaithersburg, MD 20877 

Website: www.genedx.com 

EXHIBITORS 

GeneDx offers testing for more than 200 rare Mendelian disorders, 

using DNA sequencing and deletion/duplication analysis of the 

associated gene(s). GeneDx also offers genetic testing services for 

inherited cardiac disorders such as Hypertrophic cardiomyopathy, 

Dilated cardiomyopathy and Arrhythmias. Our services include 

mutation analysis, carrier testing, prenatal diagnosis, and mutation 

confirmations. 

Gilead Sciences, Inc.....................................416 

333 Lakeside Drive 

Foster City, CA 94404 

Website: www.gilead.com 

Gilead Sciences is a biopharmaceutical company that discovers, 

develops and commercializes innovative therapeutics in areas of 

unmet medical need. The company’s mission is to advance the 

care of patients suffering from life-threatening diseases worldwide. 

Headquartered in Foster City, California, Gilead has operations in 

North America, Europe and Australia. 

Gilead Sciences, Inc.....................................417 

333 Lakeside Drive 

Foster City, CA 94404 

Website: www.gilead.com 

Gilead Sciences is a biopharmaceutical company that discovers, 

develops and commercializes innovative therapeutics in areas of 

unmet medical need. The company’s mission is to advance the 

care of patients suffering from life-threatening diseases worldwide. 

Headquartered in Foster City, California, Gilead has operations in 

North America, Europe and Australia. 

HRA Research.........................................518 

400 Lanidex Plaza 

Parsippany, NJ 07054 

Website: www.hraresearch.com 

EXHIBITORS 

Our team of experienced interviewers will be distributing carefully 

developed questionnaires. We’ll be gathering the answers to vital 

marketing and clinical questions- answers that can affect the 

introduction of new products or the continuation of existing healthcare 

products and services. 

Heart Failure Society of America..........................501 

Court International, Suite 240 South 



Website: www.hfsa.org 

The Society welcomes you to our 14th Annual Scientific Meeting. We 

hope you enjoy your stay in San Diego and look forward to seeing you 

at the 15th Annual Scientific Meeting, September 18-21, 2011, Boston, 

MA. Please visit our booth for more information about the Society. 

152 

153

HFSA E-mail Retrieval Stations...........................525 

During exhibit hours, this booth will have computers available for 

attendees to retrieve their e-mail. 

HeartWare, Inc ........................................317 

205 Newbury Street 

Framingham, MA 01701 

Website: www.heartware.com 

HeartWare, Inc. is developing a family of implantable mechanical 

circulatory support systems for the treatment of advanced heart 

failure. HeartWare’s lead device, the HeartWare® Ventricular Assist 

System, incorporates state-of-the-art peripherals and features the 

only full-output pump designed to be implanted less invasively in the 

pericardial space. The HeartWare® System is commercially available 

in Europe and is the subject of a 150-patient US IDE trial. 

Insilicomed, Inc........................................425 

7825 Fay Avenue, Suite 200 

La Jolla, California 92037 

Website: www.insilicomed.com 

Insilicomed provides innovative medical simulation software and 

computational analysis services for cardiovascular device design, 

medical imaging and surgical planning. Current applications of our 

realistic patient-specific heart models aid new developments in heart 

failure diagnosis and treatment including cardiac rhythm management, 

mechanical cardiac restraint, ventricular assist devices and cardiac 

resynchronization therapy. 

Lippincott Williams & Wilkins – Wolters Kluwer Health......308 

Two Commerce Square 

2001 Market Street 

Philadelphia, PA 19103 

Website: www.wolterskluwer.com 

EXHIBITORS 

Lippincott Williams & Wilkins, a Wolters Kluwer Health company 

is a leading international publisher of medical books, journals, and 

electronic media. We proudly offer specialized publications and 

software for physicians, nurses, students and clinicians. Please visit 

our booth to browse our comprehensive product line. 

Medtronic, Inc.........................................301 

710 Medtronic Parkway 

Minneapolis, MN 55432 

Website: www.medtronic.com 

At Medtronic (www.medtronic.com), we’re committed to Innovating 

for life by pushing the boundaries of medical technology and actually 

changing the way the world treats chronic disease. Visit booth #301 to 

see how our newest products and therapies are solving unmet needs by 

diagnosing, monitoring, and treating patients. 

Millar Instruments, Inc..................................304 

6001-A Gulf Freeway 

Houston, TX 77023-5417 

Website: www.millarinstruments.com 

Millar Instruments manufactures a complete line of Mikro-Tip 

cardiac pressure and pressure-volume (PV) catheters for evaluation 

of cardiac function. Our catheters range from 8F down to 1F, with 

single to multiple sensors. Additionally, Millar offers the Mikro-Cath 

disposable pressure catheter. This single-use, sterile catheter delivers a 

high-fidelity signal for everyday cath lab use. 

Miller Pharmacal Group, Inc.............................312 

350 Randy Road, Suite 2 

Carol Stream, IL 60188 

Website: www.millerpharmacal.com 

Miller Pharmacal’s “MG PLUS PROTEIN” magnesium supplement 

treats and prevents the hypomagnesia caused by diuretics without 

causing the GI disturbances common with magnesium oxide. Each 

easy-to-swallow, glazed, non-enteric coated tablet contains 133 mgs of 

elemental magnesium, at a fraction of the cost of SLOW-MAG . 

NeuMeDx.............................................411 

2014 Ford Road, Unit G 

Bristol, PA 19007 

Website: www.neumedx.com 

EXHIBITORS 

NeuMeDx is the U.S. home of the new, patented family of 

PhysioFlow® Signal Morphology-based Impedance Cardiography 

(SM-ICG) products. Easy-to-use, safe products that provide 

accurate and repeatable measurements of patient hemodynamics in a 

wide variety of patient care setting and various clinical conditions. 

154 

155

NitroMed .............................................316 

6000 Fairview Road 

Suite 610 

Charlotte, NC 28210 

Website: www.nitromed.com 

EXHIBITORS 

Bidil’s a fixed dose combination of hydralazine and isosorbide 

dinitrate that’s approved for use in self proclaimed black patients with 

heart failure. It’s been shown to reduce mortality by 43% and risk of 

first hospitalization by 39% when added on to standard care including 

ACE inhibitors and beta blockers. 

EXHIBITORS 

Shape Medical Systems, Inc. .............................325 

5000 Township Parkway 


Website: www.shapemedsystems.com 

Shape Medical Systems provides predictive modeling to improve the 

detection and therapeutic outcome assessment of heart and lung disease. 

Technology assesses cardiopulmonary function, defines the probable 

source of heart or lung limitations, quantifies prognosis, predicts future 

risk, provides recommendations regarding future treatment and monitors 

the ongoing clinical response to therapy. 

Otsuka America Pharmaceutical, Inc. . . . . . . . . . . . . . . . . . . . . . 309 

2440 Research Boulevard 

Rockville, MD 20850 

Website: www.otsuka-us.com 

Otsuka is hard at work investigating potential new treatments, with 

numerous compounds in various stages of development to treat 

disorders of the cardiovascular, gastrointestinal, respiratory, renal, and 

central nervous systems, and to treat cancer and ophthalmic disorders. 

Our goal is to create new products for better health worldwide. For 

information, please visit www.otsuka-us.com. 

Oxford University Press .................................510 

2001 Evans Road 

Cary, NC 27513 

Website: www.oup.com 

Oxford University Press publishes some of the most respected medical 

and scientific books and journals in the world, including The ESC 

Textbook of Cardiovascular Medicine, and European Journal of Heart 

Failure, the official international journal of the European Society of 

Cardiology. Visit www.oup.com for more information. 

Sonometrics Corporation ................................526 

500 Nottinghill Road 

London, ON N6K 3P1 

Canada 

Website: www.sonometrics.com 

Sonometrics manufactures instrumentation, transducers and software 

for cardiovascular research. We can acquire hemodynamic data such 

as pressure, flow and ECG. Our advanced ultrasonic and fiber-optic 

instrumentation measures ventricular volumes, pressures, myocardial 

contractility, and wall motion. Our software provides complete data 

analysis, featuring standard hemodynamics and comprehensive PV Loop 

indices. 

SonoSite ..............................................201 

21919-30th Drive SE 

Bothell, WA 98021 

Website: www.sonosite.com 

SonoSite is the world leader and specialist in hand-carried and mountable 

ultrasound, as well as the industry leader in impedance cardiography 

equipment. 

St. Jude Medical. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 300 

807 Las Cimas Parkway 

Suite 400 

Austin, TX 78746 

Website: www.sjm.com 

St. Jude Medical develops medical technology designed to put more 

control into the hands of those who treat cardiac, neurological and 

chronic pain patients worldwide. The company is dedicated to advancing 

the practice of medicine by reducing risk wherever possible and 

contributing to successful patient outcomes. Learn more at sjm.com. 

SynCardia Systems, Inc. ................................422 

1992 East Silverlake Rd. 

Tucson, AZ 85713 

Website: www.syncardia.com 

The SynCardia temporary Total Artificial Heart (TAH-t) is the only 

FDA and CE approved device that provides circulatory restoration in 

morbidly ill patients with irreversible bi-ventricular failure, bridging 

them to transplantation. Visit our booth for updates on clinical studies 

for the Freedom driver, 50cc TAH-t, and pediatric VAD. 

156 

157

EXHIBITORS 

The Joint Commission...................................508 

One Renaissance Blvd 

Oakbrook Terrace, IL 60181 

Website: www.jointcommission.org 

The Joint Commission’s advanced certification for heart failure uses 

Get with the Guidelines heart failure measures as the clinical practice 

requirement. Advanced certification for heart failure provides a 

comprehensive evaluation of this patient population. Certification of your 

heart failure program demonstrates excellence in fostering better outcomes. 

Thoratec Corporation...................................401 

6035 Stoneridge Drive 

Pleasanton, CA 94588 

Website: www.thoratec.com 

With more than 15,000 implants and decades of experience, 

Thoratec® offers the broadest portfolio of mechanical circulatory 

support devices. Thoratec’s product line includes the CentriMag®, 

HeartMate®, PVAD, and IVAD. Now the HeartMate II® is FDA 

approved for both Bridge to Transplantation and Destination Therapy. 

EXHIBITORS 

XDx Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 321 

3260 Bayshore Blvd. 

Brisbane, CA 94005 

Website: www.xdx.com 

XDx is a molecular diagnostics company focused on the discovery, 

development and commercialization of gene expression testing in the 

areas of transplant medicine and autoimmunity. XDx has one marketed 

product, AlloMap® Molecular Expression Testing, a non-invasive 

gene expression test that aids in the management of heart transplant 

patients. 

ZOLL ................................................519 

121 Freeport Road 

Pittsburgh, PA 15238 

Website: www.zoll.com 

The ZOLL® LifeVest® wearable defibrillator protects patients at 

risk of sudden cardiac arrest, during a patient’s changing condition 

and when permanent SCA risk has not been established. The LifeVest 

provides patients constant monitoring, immediate protection, and 

peace of mind. 

Wiley Blackwell........................................512 

350 Main Street 

Malden, MA 02148 

Website: www.wiley.com 

Wiley-Blackwell meets the information needs of cardiology 

professionals in a wide variety of ways. Visit booth #512 for the latest 

issue of Congestive Heart Failure and to purchase books at a discount. 

Wiley-Blackwell is the scientific, technical, medical, and scholarly 

publishing business of John Wiley & Sons. 

WorldHeart Corporation ................................516 

4750 Wiley Post Way, Suite 120 

Salt Lake City, UT 84116 

Website: www.worldheart.com 

World Heart Corporation develops implantable mechanical circulatory 

support systems for long-term use. Its 4th-generation Levacor VAD 

is the only bearingless, fully magnetically levitated implantable 

centrifugal rotary pump to have seen clinical use. Currently 

conducting U.S. Clinical Trials. 

158 159

AUTHOR INDEX 

14th Annual Scientific Meeting 


“P” preceding number indicates a poster 

Aban, Immaculada 

P205 

Abdalrhim, Ahmed 

P027 

Abidov, Musa T. 

P128, P237 

Aboulhosn, Jamil 

P181 

Abraham, William T. 35, 85, 136, 016, P071, P080, 

P186 

Acker, Michael A. 

91, P161 

Ackerman, Michael J. 38 

Adamo, Marianna 

P287 

Adams, Jr., Kirkwood F. 

P285 

Adams, Patricia A. 40 

Adamson, Philip B. 28, 136 

Adatya, Sirtaz 

P058 

Addy, Benjamin 

P126 

Afshar-Kharghan, Vahid 

P082 

Aggarwal, Sandeep 

P174 

Aggelis, Athanasios 

P296 

Aggelopoulos, Panagiotis 

P251 

Agosto, Mariella 

P058 

Aguilar, David 

P272, P306 

Aguilar, Tricia 

P309, P335 

Ahmed, Ali 

P205 

Ahmed, Imdad 

P361 

Ahmed, Mustafa I. 

P205 

Ahn, Kwangmi 

P262 

Ahn, Sylvie A. 

P097 

Aho, Zoe 

P301 

Aime, Enzo 

P212 

Akhondi, Andre B. 

P302 

Ako, Junya 

P047 

Albert, N.M. 

P225, P226 

Albert, Nancy M. 28, 46, 143 

Aldea, Gabriel S. 

P129 

Aleong, Ryan 

P185 

Alexis, Jeffrey 

P314 

Alhaj, Eyad 

P055, P056 

Alharethi, Rami 

P119, P284, P295, P318 

Ali, Azzat 

P256 

Ali, Intiaz 

P092 

Ali, Omaima 

P252, P300, P311, P330 

Allen, Larry 

P207 

Allen, Larry A. 138 

Allison, Thomas G. 

P135 

Almeida, Nathan 36 

160 

AUTHOR INDEX 

Alo, Kenneth M. 

P214 

Al-Omari, Malik A. 

P135 

Alonso, Amanda 

P144 

Ambardekar, Amrut V. 37 

Ameenuddin, Syed 

P089 

Amin, Alpesh N. 

P310 

Anand, Inder 

P211 

Anand, Inder S. 35, 37 

Ancheta, Christine B. 

P267 

Ancheta, Irma B. 

P267 

Ancukiewicz, Damian 

P026 

Anderson, AS 34 

Anderson, Jeffrey L. 

P119 

Anderson, Mark E. 45 

Anderson, Shawn D. 

P380 

Andrews, Amy C. 

P184 

Andriulli, John 

P206, P223, P224 

Andriulli, John A. 

P213 

Andrus, Shauna 

P129 

Angerstein, Rebecca L. 95 

Anker, Stefan 

35, P228 

Anker, Stefan D. 

84, 96, P030, P083, P277 

Anselme, Frederic 

P212 

Anthony, Makdessi 

P378 

Antoniou, Christos 

P251, P254, P255, P265, P296 

Anusionwu, Obiora F. 

P262 

Anzai, Atsushi 

P112, P340 

Anzai, Toshihisa 

P112, P340 

Apostolovic, Svetlana 

P216 

Aranda, Jr., Juan M. 

P380 

Araujo, Aloir Q. 

P057, P064 

Arimura, Takuro 38 

Armbrecht, Eric S. 

P248 

Armbruster, Rebecca 

P162 

Arnce, Sarah A. 

P140 

Arnold, J. Malcolm O. 88 

Arnold, Malcolm 

P368, P372 

Aronow, Wilbert S. 

P205 

Arsenos, Petros 

P254, P265 

Arteaga-Fernandez, Edmundo P057, P064 

Arthur, Heather 

P378 

Ashley, Euan A. 142 

Asirvatham, Samuel J. 

P131, P187, P222 

Athanasopoulou, Stavroula 

P265 

Ather, Sameer 

P306 

Atherton, John 

P301 

Atluri, Pavan 

P161 

Augostini, Ralph 

P188, P196 

Augustin, Sibylle 38 

161

AUTHOR INDEX 

Augustine, Sharon 

P160 

Avelar, Erick 

P058 

Ayers, Colby R. 

P156 

Aziz, Emad F. 

P190 

Bach, David S. 

P071, P080 

Bader, Eric M. 

P320 

Bahl, Joseph J. 

P140 

Bahler, Robert C. 

P241 

Bailey, Kent R. 

010, P246 

Bair, Tami L. 

P119 

Balazic-Gjura, Aleksandra 

P390 

Banerjee, Dipanjan 

P258 

Bank, Alan J. 

35, P191 

Baran, DA 34 

Barbagelata, Alejandro 

P355 

Barcena, Julio 

P371 

Barcena, Julio A. 

P364 

Bargas, Royce L. 

P194 

Barger, Philip M. 38 

Baron, H 34 

Barretto, Antonio C.P. 

P381 

Bart, Bradley A. 

P293, P361 

Bart, Gavin 

P361 

Bartone, Cheryl 

P349 

Bartov, David 

P382 

Basu, Ratnadeep 

P043, P107 

Bateman, Michael G. 

P074 

Battie, Cynthia 

P267 

Baudino, Troy A. 103 

Bauer, Lisa C. 36 

Baughman, Kenneth L. 

P118 

Bayes-Genis, Antonio 

P210 

Baykaner, Tuna 

P234 

Beaver, Timothy A. 

P322 

Beck, Tasha 

P149 

Becker, Richard C. 41 

Bednar, Justin 

P389 

Beiras Torrado, J. 

P220 

Bekkouche, Nadine S. 

P271 

Belardi, Diego F. 

P194 

Belenkov, Yu 136 

Bellavia, Diego 

P028, P230 

Belziti, Cesar A. 

P045 

Benike, Sherry L. 

P036 

Benshabat, Yael 

P165 

Berger, Ronald 

P188 

Bergmann, Andreas 

P093 

Berkowitz, Robert 

P055, P056 

Berni-Giarusso, Karen 

P331 

162 

AUTHOR INDEX 

Bernstein, Daniel 39 

Bers, Donald M. 45 

Beslow, Lauren 

P370 

Betensky, Brian P. 

P345 

Bettari, Luca 

P210, P287 

Bettencourt, Paulo 

P210 

Bhadriraju, S. 

P195 

Bhat, Geetha 

P136, P157, P158, P172 

Bhatt, Deepak L. 

P253 

Bhatt, Kunal 

P095, P341, P357, P366 

Bhatti, Sabha 

P079, P177 

Bianco, Nicole R. 

P180 

Bibbins-Domingo, Kirsten 90 

Bigger, J. Thomas 

P201 

Bindu Manchikalapudi, Rama P055 

Biner, Simon 

P051 

Birgersdotter-Green, Ulrika 

P179 

Birgersdotter-Green, Ulrika M. P198 

Birnie, David 

P174 

Biscotti, Mauer 

P151 

Bishu, Kalkidan 

39, P027 

Bishu, Kalkidan G. 

P091 

Biswas, Saurabh 

P171 

Blaxall, Burns C. 83, 93 

Blekhman, Yana 

P116 

Bloch, Kenneth D. 37 

Block, Norman L. 38 

Bloom, H. 

P195 

Bodmer, Rolf 49 

Boehmer, John 

P204, P321 

Boehmer, John P. 

47, P279 

Boerrigter, Guido 37, P039, P101, P233, P244, 

P246 

Bogaev, RC 34 

Bommaraju, Kalki 

P383 

Bonnet, Nancy 

P313 

Boord, Jeffrey 

P327 

Borenstein, Kathleen 

P313 

Borer, Steven M. 

P286 

Borganelli, Mark 

P317 

Borges-Neto, Salvadore 

P374 

Borowski, Allen G. 

P031, P053, P087, P100 

Bourge, Robert C. 135, 136 

Bowles, Kathryn H. 40 

Bowles, Neil E. 38 

Bowlin, Kathy M. 

P117 

Boxer, Rebecca 

P208 

Boxer, Rebecca S. 

P299 

Boyer, Lynnette 

P380 

163

AUTHOR INDEX 

Bozkurt, Biykem 

94, P272, P283, P306 

Bradfield, Jason 

P282 

Bramante, Carolyn 

P081 

Brancalhao, Euler C.O. 

P381 

Brasher, Heather L. 

P115 

Braun, Robin L. 

P312 

Braunwald, Eugene 37 

Breedlove, Craig O. 

P177 

Breton, Elayne 

P118 

Brewer, Robert J. 

P139 

Brian, Lahr 

P244 

Bridges, C.R. 38 

Brili, Stella 

P254, P255, P296 

Bristow, Michael 

P207 

Bristow, Michael R. 

34, 42, P120, P121 

Britton, Nancy 

P033, P048 

Broberg, Craig S. 

P181 

Brock, Dan W. 

P350 

Brooke, Kelly L. 

P137, P138, P148 

Brown, Colleen 

P363 

Brown, Jeremiah R. 

P322 

Brown, Joan Heller 86 

Browne, Auris 

P343 

Bruckner, Brian 

P133 

Bruckner, Brian A. 

P146 

Brunisholz, Kim 

P284 

Brunisholz, Kimberly D. 

P119, P318 

Brunker, Tamara 

P068 

Bryg, David J. 

P302 

Bryg, Robert 94 

Bryg, Robert J. 

P302 

Bubb, Tammy 

P149 

Buck, Harleah 

P360 

Budge, Deborah 

P119, P284, P295, P318 

Bugatti, Silvia 

P287 

Bullock-Palmer, Renee P. 

P075 

Burant, Christopher J. 

P299 

Burkart, Thomas A. 

P346 

Burke, Allen P. 

P160 

Burkhoff, Daniel 

P152, P176, P308 

Burnett, John C. 31, 135, P027, P036, P039, 

P085, P086, P233, P246 

Burnett, Jr., John C. 39, 42, P028, P034, P091, 

P101, P102, P125, P230, P244 

Burns, Kevin V. 

P191 

Burt, Janis 

P140 

Bushinsky, David 

35, P228 

Butler, J. 

P261, P373 

164 

AUTHOR INDEX 

Butler, Javed 84, 95, P095, P264, P285, 

P341, P357, P366 

Buttrick, Peter M. 37 

Butts, Katie E. 

P177 

Buxton, Alfred E. 47 

Buzdugan, Elena 

P354 

Caboral, Meriam F. 

P075, P377 

Cabral, Maggie 

P331 

Cabrera, Antonio G. 

P283 

Caccavano, Michele H. 

P344 

Camp, Amanda 38 

Campbell, Arezoo 

P096 

Campbell, Jennifer 36 

Campbell, Patricia 

P352, P388 

Candlish, Paula M. 

P376 

Cannone, Valentina 

37, P246 

Cantin, Bernard 

P092 

Cao, Michael 

P131 

Cao, Michael K. 

P187, P222 

Cappleman, Sarah 

P141 

Cappola, Thomas P. 

34, 42, P297 

Caravelli, Paolo 

P061 

Cardona, Ricardo 

P362 

Cardoso, Juliano N. 

P381 

Carlquist, John F. 

P119 

Carlson, Rebekah 

P333 

Carson, Peter E. 140 

Cataliotti, Alessandro 37, 135, P039, P230, P244, 

P246 

Cavallari, Larisa H. 

P116 

Cecere, Renzo 

P092 

Cercek, Bojan 

P247 

Cesario, David A. 

P131, P187, P222 

Cha, Yongmei 

P187, P222 

Cha, Yong-Mei 

P131, P137, P138, P148 

Chae, Sung-Cheol 

P328 

Chakeabarti, Sudarsana 

P168 

Chakravarthy, Niranjan 

P227 

Champion, Hunter C. 

P118 

Chan, Tammy 

P389 

Chan, Wenyaw 

P272, P306 

Chandra, Ramesh 

P099, P329 

Chang, Sungwon 

P288 

Charlton, Sandra B. 

P317 

Chatterjee, Kanu 85 

Chaudhari, Ronak 

P240 

Chaudhry, Hina W. 

P026 

Cheema, Faisal 

37, P134 

Cheema, Faisal H. 

P141 

165

AUTHOR INDEX 

Chen, Chun-Chi 

36, P391 

Chen, Horng H. 37, 39, 135, P028, P036, P039, 

P085, P089, P091, P245, P269 

Chen, Jennifer 

P289, P342 

Chen, Ju 99 

Chen, Lu 

P198 

Chen, Michael M. 

P231 

Cheng, Lihong 

P104, P111 

Cheng, Mei L. 

P211 

Cheon, Enu-Seok 

P328 

Cheriyath, Pramil 

P262 

Chernysh, Olga 

P066 

Chew, Michael 37 

Chiang, Fu-Tien 

36, P391 

Chin, John 88 

Chiong, Jun R. P072, P266, P267, P285, P309, 

P335 

Chiou, Kuan-Rau 

36, P391 

Chiribau, Calin 

P104 

Chiu, F.C. 

P049 

Cho, Gu-Yung 

P303 

Cho, Leslie 

P264 

Cho, Myeon-Chan 

P328 

Choe, Kyung Hoon 

P347 

Choi, Dong-Ju 

P303, P328, P347 

Choi, Jin-Ho 

P303, P328 

Choi, Jin-Oh 

P098 

Chokshi, Aalap 

37, P110, P134 

Chopra, Vijay K. 

P227 

Chow, Fung L. 

P025, P107 

Chow, Sheryl L. 

P096 

Chowdhury, Mahdi 

P366 

Chowdhury, Mahdi R. 

P095 

Christian, Norma 

P099 

Christman, Karen L. 

43, P040 

Christoforatou, Evagelia 

P251, P254 

Chrysohoou, Christina 

P251, P254, P255, P265, P296 

Chu, Sang Hui 

P384 

Chuang, Eliseu 

P123 

Chuang, Joyce S. 

P040 

Chung, Eugene S. 

P349 

Chung, Misook 

P273 

Chung, Misook L. 138 

Chung, Namsik 

P103, P326 

Chuprun, J. Kurt 

P106 

Clare, Robert 

P338 

Clark, Adrienne L. 

P298 

Clark, Andrew 

P291 

Claus, Piet 

P152 

166 

AUTHOR INDEX 

Clavell, Alfredo L. 

P135 

Cleland, John G. 

P291 

Cleveland, Jr., Joseph C. 37 

Clopton, Paul 

P083, P276, P334, P356 

Clyne, Christopher 

P193 

Coats, Andrew S.J. 140 

Coe, James Y. 

P032 

Cohen, Alan 

P333 

Cohn, Jay N. 100 

Colic, Mirko 

P221 

Collins, Sean 

P084 

Collins, Sean P. 

46, P037 

Colombo, Paolo C. 

P060, P061, P142, P151, P175 

Colucci, Wilson S. 38, 137 

Colvin-Adams, Monica M. 

P292 

Condorelli, Gianluigi 86 

Conger, Steve 

P035 

Connolly, Jennifer J. 

P119 

Connolly, Jenny 

P284 

Connolly, Jenny J. 

P295, P318 

Conte, John V. 

P149 

Conti, Jamie B. 

P346 

Conway, Simon J. 103 

Cook, Stephen 

P181 

Cooper, Leslie 

P321 

Coppess, Mark A. 

P238 

Corbisiero, Raffaele 

P162, P199 

Cordopatis, Paul 

P088 

Cordova, Juan Pablo 

P190 

Cosma, Constantin 

P354, P375 

Costa, Kevin 43 

Costa, Kevin D. 

P026 

Costa, Salvatore P. 

P322 

Costanzo, Maria Rosa 35 

Costello-Boerrigter, Lisa 

P244 

Costello-Boerrigter, Lisa C. 

37, P036, P101, P246 

Cotts, William G. 

34, P285 

Courtney, D. Mark 

P037 

Cowling, Randy T. 

P109 

Cox, Scott 

P033, P048 

Coyle, Laura A. 

P136, P158 

Crawford, Brian H. 

P108 

Cremers, Serge 

P060 

Criscione, John C. 

P171 

Crossley, George 

P188 

Crossley, George H. 

P206, P224 

Cuminetti, Giovanni 

P287 

Curtis, A. 

P226 

Curtis, A.B. 

P225 

167

AUTHOR INDEX 

Curtis, Lesley H. 

P304 

Czarnecka, Danuta 

P186 

Dadfarmay, Sina 

P055, P056 

Dagorn, Jean-Charles 

P331 

Daifallah, Suleiman 

P252, P300, P311, P330 

Dalton, Thomas 

P293 

Daly, Daly C. 

P135 

D’Amore, Denise 

P382 

Daniels, Lori B. 

P083 

Danielyan, M. 136 

Danilova, Irina G. 

P128, P237 

Das, Jayanta R. 

P247 

Daubert, James P. 47, 142 

Davidson, Karina 

P201 

Davidson, Patricia M. 

P288, P301 

Davis, Gordon 

P207 

Davis, RB 34 

Dawson, Neal 

P241 

Day, John D. 

P179, P279 

De Marco, Teresa 

28, 139, P290, P363 

De Nazareth, Andrew 36 

Dec, G. William 

P314 

Decker, Jamie A. 

P283, P351 

Deedwania, Prakash 

P205, P333 

Deedwania, Prakash C. 41 

Dei Cas, Livio 

135, P287 

Dekleva, Milica 

P209, P216, P221 

del Monte, Frederica 86 

del Rio, Carlos 

P232 

Delle Donne, Maria Grazia 

P061 

Delurgio, D. 

P195 

Denfield, Susan W. 

P283, P351 

Deng, MC 34 

DeNofrio, David 91 

Desai, Ravi V. 

P205 

Desai, Sarika K. 

P247 

Deslisle, Susan 

P124 

Deswal, Anita 

94, P272, P306, P307 

Dev, Sandesh 

P338 

DeWire, Scott M. 

P229 

Di Carli, Marcelo F. 

P352 

Di Salvo, Thomas 

P324, P327, P369 

Di Somma, Salvatore 

P276 

Dib, Chadi 

P336 

DiCarlo, Christina M. 

P299 

Dickfeld, Timm 

P182, P183 

Dickson, Victoria V. 

P359, P360 

Dickstein, Kenneth 

P236 

Dilaveris, Polychronis 

P254, P265 

168 

AUTHOR INDEX 

Dillmann, Wolfgang H. 

92, P029 

Dimkovic, Sinisa 

P209 

Dini, Frank 

P061 

Divakaran, Vijay G. 

P082 

Diwan, Abhinav 

P105 

Doehner, Wolfram 

P277 

Dohad, Suhail 

P247 

Donato, Anthony A. 

P159 

Dong, Yanting 

P178 

Dordunoo, Dzifa 

P149 

Dorn, II, Gerald W. 

P105 

Doshi, Rahul N. 

48, P163, P178 

Dougherty, Lawrence 

P059 

Doval, Hernan C. 

P045 

Dracup, Kathleen 36 

Dracup, Kathleen A. 

P290 

Drazner, Mark H. 

P156 

Dreyer, William J. 

P283, P351 

Driscoll, Andrea 

P301 

Droogne, Walter 

P176 

Dubi, Shay 

P165 

Dulce, Raul 38 

Dumitru, Ioana 

P167 

Dunbar, Sandra 

P095, P341, P357, P366 

Dunbar, Sandra B. 

P218 

Dungen, Hans Dirk 

P216 

Dunlap, Mark E. 

P386 

Dunlap, Stephanie H. 

P285 

Dupree, Carla S. 40 

Earing, Michael 

P181 

Eckman, Peter M. 

P292 

Eddy, Steven 

P178 

Edwards, Brooks S. 

P135 

Eggebeen, Joel D. 

P215 

Eggen, Michael D. 

P074 

Eisen, Howard J. 94 

Elkayam, Uri 40 

Ek Vitorin, Jose 

P140 

Elami, Amir 

P165 

Elashoff, B 34 

Elias, Barbara 

P146 

Ellenbogen, Kenneth A. 

P163, P178 

Elzawam, Yacen M. 

P282 

Endo, Michelle M. 

P318 

Eperjesi, Tom 

P170 

Eriksson, Maria J. 

P219 

Estep, Jerry 

P122 

Estep, Jerry D. 

P133, P146 

Esterbrooks, Dennis 36 

169

AUTHOR INDEX 

Etzion, Yoram 

P024 

Eurlings, Luc W. 

P210 

Evans, Julie 

P333 

Evans, Ronald 30 

Ewald, Gregory A. 

34, P143 

Exner, Derek 

P174 

Ezekowitz, Justin A. 46, 94 

Fabbri, Sharon 

P072 

Fajadet, Jean 

P203 

Fajardo, Giovanni 39 

Falconi, Mariano 

P045 

Fang, Chih-Yuan 

36, P391 

Fang, James C. 

40, P208 

Farah, Jareer 

P252, P300, P311, P330 

Farah, Jareer O. 

P256 

Faramarz, Tehrani 

P051 

Fargnoli, A. 38 

Farkas, Jerneja 

P390 

Farr, Maryjane 

P134, P141 

Farzaneh-Far, Afshin 

P374 

Fearon-Clarke, Jackie 

P313 

Feld, Yair 

P165 

Feldman, Arthur M. 93 

Felker, G. Michael 

31, 39, 42, 85, P207, P338 

Felker, Michael 

P348 

Feller, Erika D. 

P160 

Fermann, Gregory 

P084 

Ferradaes, Paula V. 

P319 

Ferron-Clark, Jackie 

P263 

Fike, Lucy 

P095, P341, P366 

Finegan, Tracy 36 

Fischman, Daniel 

P262 

Fishbein, Daniel P. 

P129 

Fisher, Mary 

P235 

Fitzgerald, David M. 

P215 

Fitz-Gibbon, Jennifer M. 

P069 

Fitzgibbons, Timothy P. 

P331 

Fitzpatrick, J. Raymond 

P161 

Fiuzat, Mona 

95, P207, P338, P348, P374 

Fleg, Jerome L. 44 

Fonarow, G. 

P226 

Fonarow, G.C. 

P225 

Fonarow, Gregg 

P205 

Fonarow, Gregg C. 28, 41, 94, 98, 100, P062, 

P253, P298, P304 

Fonarrow, Gregg C. 

P257 

Foote, Hannah 

P322 

Force, Thomas 30, 48 

Forfia, Paul R. 

29, P038 

170 

AUTHOR INDEX 

Forman, DE 34 

Forman, Sandra 

P270 

Formica, Philip 

P343, P382 

Fossum, Theresa W. 

P171 

Fowler, Michael B. 96 

Foyil, Sarah A. 

P105 

Francis, Gary 

P236 

Francis, Gary S. 136 

Frantz, Robert P. 

P135 

Fredi, Joseph 

P369 

Freeman, Monica R. 

P153, P336 

Fries, Vicki 

P155 

From, Aaron M. 

P245 

Fujise, Kenichi 

P355 

Fukuda, Keiichi 

P112, P340 

Fukuta, Hidekatsu 

P094 

Gackowski, Andrzej 

P242 

Gadesam, R. 

P195 

Gadler, Fredrik 

P219 

Gage, Ryan M. 

P191 

Gagliano, Giulia 

P276 

Galindo, Jennifer 36 

Gallagher, Colleen T. 

P136, P158 

Galle, Elizabeth 

P204 

Galvin, Catherine 

P099 

Ganame, Javier 

P358 

Gao, Feng 38 

Garcia, Luis J. 

P122, P146 

Garcia Gonzales, Diane 

P266 

Garcia-Criswell, Rachel 

P369 

Garry, Daniel J. 

P117 

Gaviria, Moises F. 

P136 

Gayheart-Walsten, Pamela 

P235 

Gee, Julie 

P371 

Geens, Jef H. 

P152, P176 

Geisberg, Carrie A. 

P070 

Georgakopoulos, Dimitrios 

P071, P080 

George, Gebe 

P141 

Georgiopoulou, Vasiliki V. 

P095, P341, P357, P366 

Germany, Robin 

P150, P173 

Gersony, Deborah 

P181 

Gette, I.F. 

P237 

Ghali, Jalal K. 98, P252, P256, P285, P300, 

P311, P330 

Ghaly, Nader 

P068, P197 

Ghaly, Tammer 

P068 

Gharacholou, Shahyar M. 

P253 

Ghatak, Abhijit 

P193 

Gheorghiade, M. 

P225, P226 

171

AUTHOR INDEX 

Gheorghiade, Mihai 

82, 135, 140, P037 

Ghosh, Zhumur 39 

Giamouzis, G. 

P261, P373 

Giamouzis, Grigorios 

P095, P341, P357, P366 

Gilbert, Edward M. 

P120, P121 

Gilbertson, David T. 

P042 

Gilliam, F.R. 

P279 

Gilliam, III, F. Roosevelt 

P131, P187, P222 

Gilson, Marta M. 

P149 

Giordano, Robin 

P367 

Giudici, Michael C. 

P163, P178 

Givertz, Michael M. 97 

Glockner, James 135 

Godiwala, Tapan 

P217 

Godoy, Sarah M. 

P271 

Goebel, Paul 

P333 

Goff, Jr., David C. 

P215 

Gold, Jessica I. 

P106 

Gold, Michael R. 

135, P163, P178 

Goldberg, Ira 

37, P110 

Goldberg, Lee R. 

P345 

Goldman, Jonathan H. 

P231 

Goldman, Steven 

102, P140 

Goldsmith, Rochelle 

P201 

Goldsmith, Steven R. 

135, P042 

Golebiowska, Renata 

P242 

Gonzalez-Cadavid, Nestor F. 

P096 

Gonzalez-Stawinski, Gonzalo V. P325 

Goodlin, Sarah J. 

P168 

Gorman, Joseph H. 

P059, P170 

Gorman, Robert C. 

P059, P166, P170 

Gorman, III, Joseph H. 

P166 

Gorodeski, Eiran Z. 

P325 

Goto, Toshihiko 

P094 

Gottam, Nithin 

P365 

Gottlieb, Roberta A. 45 

Gottlieb, Stephen S. 

97, P271 

Gowen, Maxine 

P229 

Grady, Kathleen L. 

P168 

Gramaccini, Serena 

P276 

Graves, Daniel E. 

P283 

Greenberg, Barry H. 

32, 34, 84, P109 

Grenier, Michelle 

P078 

Griffith, Bartley P. 

P160 

Grill, Diane E. 

P093 

Grimm, Michael 

P065 

Groo, Vicki L. 

P116 

Gruson, Damien 

P097 

Grzesiak, Aleksandra 

P030 

172 

AUTHOR INDEX 

Gschnell, Heather 

P337 

Gu, Charles 38 

Gu, Yusu 

P040 

Guglin, Maya 

96, P046, P054, P063, P250 

Gukasayan, Natalie 

P175 

Gulati, Sanjeev K. 

P206, P224 

Gunawardena, Diyana 

P241 

Guo, Danny 

39, P043, P107 

Gupta, Charu 

P156, P341, P357, P366 

Gupta, Ramesh C. 

P132 

Gupta, Sachin 

P156 

Gupta, Sameer 

P054 

Gurvitz, Michelle 

P181 

Guthrie, Aubrey 

P371 

Habibzadeh, M. Reza 

P231 

Haddad, Haissam 

P092 

Hadri, Lahouaria 

P026 

Hager, David 

P058 

Haglund, Nicholas 

P167 

Hajjar, Roger J. 

34, 43, 102, P026 

Hall, Jennifer L. 

P113 

Hall, Michael 

P317 

Halley, Carmel 

P325 

Halley, Carmel M. 

P364 

Hamilton, Dale J. 

P115 

Hamlin, Robert 

P232 

Hammill, Bradley G. 

P304 

Han, Wenlong 

P029 

Hankins, Shelley R. 94 

Hanny-Gilbert, Carolyn 

P385 

Harders, Gerald E. 

37, P028, P085 

Hare, Joshua M. 

38, 137, P118 

Harkness, Karen 

P378 

Harlapur, Manjunath 

P201 

Harper, Yenal 

P264 

Harris, Kristie M. 

P271 

Harstad, Lynn K. 

P036 

Hasan, Ayesha 

P186 

Hasan, Ayesha K. 94 

Hassan, Saamir 

P082 

Haude, Michael 

P203 

Hauptman, Paul J. 

95, P248 

Hayashi, Yacki 

P175 

Hayes, David L. P131, P137, P138, P148, P222, 

P279 

Hayes, Kenneth 

P163 

Hazen, Stanley L. 

P264 

Hedberg, Sven-Erik 

P219 

Heflin, Linden A. 

P154 

173

AUTHOR INDEX 

Heidecker, Bettina 

P118 

Heidenreich, Paul 

P185, P315 

Heidenreich, Paul A. 

34, 40, 143, P279 

Heiman, Mark 

P048 

Helgerson, Sam 

P132 

Heller Brown, Joan 

P065 

Hellkamp, Anne S. 

P253 

Helmke, Stephen 

P073, P124 

Hematillake, Ganga 

P333 

Henrikson, Charles 

P188 

Henry, Antonietta 

P263, P313 

Henry, Scott E. 

P139 

Heo, Seongkum 

P218 

Hernandez, Adrian F. 

94, P253, P257, P304 

Hernandez, Salvador 

P282 

Hershberger, Ray E. 48, 95 

Herzog, Eyal 

P190 

Hettrick, Doug 

P130 

Heublein, Denise 

P244 

Heublein, Denise M. 

37, P086, P101, P102, P246 

Heydarian, Haleh 

P078 

Heywood, J. 

P226 

Heywood, J. Thomas 

28, 95, P213, P223 

Heywood, J.T. 

P225 

Hiesinger, William 

P161 

Hill, Joseph A. 

P105 

Hillman, Katja 

P189 

Hilpisch, Katherine 

P049 

Hirabayashi, Kagami 

P090 

Hochman, Judith 

P270 

Hodge, David O. 

P137, P138, P148, P269 

Hoercher, Katherine J. 141 

Hoersten, Cynthia 

P202 

Hollander, Judd 

P037 

Holmes, Sari D. 

P271 

Holmstrom, Nils 

P219 

Hong, Nam-Ki 

P103, P326 

Hoover, Danielle 

P371 

Hoppe, Uta C. 

P203 

Horne, Benjamin 

P284 

Horne, Benjamin D. 

P119, P295, P318 

Horstmanshof, Douglas A. 

P154 

Horwich, Tamara B. 

95, 142, P062, P298 

Hostutler, Sheryl 

P337 

Houser, Steven R. 30 

Houston-Miller, Nancy 90, 95 

Howard, Jessica L. 

P161 

Howard, Stephen A. 

P074 

Howe, Alexandra 

P359 

174 

AUTHOR INDEX 

Howlett, Johathan 

P368 

Howlett, Jonathan 

P372 

Howlett, Jonathan G. 83 

Hranitzky, Patrick M. 

P179 

Hsieh, Kelvin 

36, P391 

Hu, Diane 

P040 

Hu, Qinghua 38 

Hu, Yuhning L. 

P177 

Huang, I-Zu 

35, P228 

Huang, Jian 

P333 

Huang, Nancy 

P301 

Huang, Tsuey-Yuan 

36, P391 

Hudson, Christopher J. 

P346 

Hunt, Sharon A. 88 

Hunter, Claire 36 

Huntley, Brenda K. 39, P085, P086, P089, P102, 

P125 

Hwang, Boyoung 36 

Hwang, J.J. 

P049 

Hwang, Jung Hwa 

P384 

Hwang, Shiow-Li 

36, P391 

Iaizzo, Paul A. 

P074 

Ianni, Barbara M. 

P057, P064 

Iasuhiro, Ikeda 

P230 

Ibrahim, Majd 

P311 

Ichiki, Tomoko 39, P028, P039, P085, P086, 

P102, P125 

Ichord, Rebecca 

P370 

Ignaszewski, Andrew 

P368, P372 

Ikeda, Nahoko 

P047 

Ilsar, Itamar 

P132 

Inada, Keiichi 

P189 

Incrot, Simone 

P216 

Innaparthy, Aparna 

P200 

Insel, Paul A. 103 

Inyangetor, David 

P058 

Isaac, Debra 

P092 

Ishida, Kouki 

P047 

Ishimori, Naoki 

P090 

Issac, Gamaliel 

P059 

Ivanhoe, Russell 35 

Iwabuchi, Kazuya 

P090 

Jacobs, Steven 

P152, P176 

Jaffe, Allan S. 

P093 

Jagielski, Dariusz 

P188, P196 

Jain, Anil 

P268, P281 

James, Bobbi 

P295 

Jang, Yangsoo 

P103, P326 

Januzzi, Jr., James L. 31, 42 

175

AUTHOR INDEX 

Jastrzebski, Marek 

P188 

Jean-Louis, Girardin 

P075 

Jeffereis, John L. 

P283 

Jefferies, John 

P358 

Jefferies, John L. 

P351 

Jeger, Raban 

P270 

Jensen, Kurt 

P284, P318 

Jeon, Eun-Seok 

P098 

Jeon, Eu-Seok 

P303 

Jessup, Mariell 

P161 

Jessup, Mariell L. 34, 141 

Jesus, Siller 

P214 

Jhaveri, Rahul 

P270 

Jiao, Zhe 

P108, P111 

Jin, Xiaohua 

P024 

John, Ranjit 

P292 

Johnson, Bruce D. 

P069 

Johnson, Eric E. 

P238 

Johnson, Julene K. 36 

Johnson, Nancy 

P188 

Johnson, Nicholle M. 

P140 

Johnson Inge, P. 

P225, P226 

Jokerst, Nan Marie 32 

Jonas, Samuel N. 

P060 

Jones, D. 

P195 

Jones, Paul 

P131 

Jones, Paul W. 

P187, P222, P279 

Jones, Wilbert L. 

P122, P146 

Jordan, Lee W. 

P383 

Jorde, Ulrich 

P142, P144 

Jorde, Ulrich P. 

P060, P151, P175 

Jougasaki, Michihisa 

39, P102 

Ju, Eun-Seon 

P098 

Jugdutt, Bodh I. 44 

Juneman, Elizabeth 

P140 

Jungklaus, Tamarah J. 

P380 

Jurcevic, Dennis 

P386 

Jurgens, Corrine Y. 

96, 101, P344 

Kaan, Anne Marie 

P368, P372 

Kabir, Anwarul 

P200, P202 

Kachniarz, Bartlomiej 

P151 

Kaelin, Jr., William G. 38 

Kalahasty, Gautham 

P163, P178 

Kale, Parag P. 

P316 

Kaliyadan, Antony G. 

P159 

Kaliyadan, Mary P. 

P159 

Kalogeropoulos, Andreas P. 

P095, P341, P357, P366 

Kanashiro-Takeuchi, Rosemeire M. 38 

Kaneko, Hidehiro 

P112, P340 

176 

AUTHOR INDEX 

Kang, Seok-Min 

P103, P326, P384 

Kao, A 34 

Kaplan, Andrew J. 

P212, P220 

Karayannis, G. 

P261, P373 

Karlsson, Andreas 

P219 

Karpawich, Peter P. 

P192 

Kaschina, Elena 

P030 

Kasper, Edward K. 

P118 

Kassiri, Zamaneh 

39, P025, P043, P107 

Kastorini, Christina M. 

P251 

Katikaneni, Divya S. 

P128 

Katikaneni, Sai Shreya 

P237 

Kato, Mahoto 

P189, P388 

Katra, Rodolphe P. 

P227 

Katz, M. 38 

Katz, Stuart 

P270, P359 

Katz, Stuart D. 

P249 

Kaufman, Beth 

P370 

Kaufman, Christopher L. 

P071, P080 

Kay, Joseph 

P181 

Kearney, Debra L. 38 

Kehagia, Ioanna 

P251 

Kelesidis, Iosif 

P239, P240 

Kellar, Robert S. 

P140 

Kelly, Daniel P. 92 

Kelly, Jessica L. 

P280 

Kendall, Kathy 

P358 

Kent, David M. 

P280 

Kenyon, Kenneth W. 

P129 

Kereiakes, Dean J. 

P349 

Kerkhoffs, Wolfgang 

P176 

Kern, Christine B. 

P126 

Kerur, Basavaraj 

P370 

Kesselheim, Aaron S. 

P350 

Ketchum, Eric S. 

P129 

Keung, Edmund 

P185, P315 

Kfoury, Abdallah 

P284 

Kfoury, Abdallah G. 

34, P119, P295, P318 

Khairy, Paul 

P181 

Khalil, Nashwa 

P133 

Khamag, Haneen 

P282 

Khan, Raffay 

37, P110 

Khawaja, Tuba 

37, P134 

Khaykin, Yaariv 

P174 

Khouri, Samer 

P379 

Khullar, Pankaj 

P239 

Kiernan, Michael S. 

P236 

Kijtawornrat, Anusak 

P232 

Kim, Jae-Joong 

P164 

177

AUTHOR INDEX 

Kim, Jae-Jung 

P328 

Kim, Jang Young 

P347 

Kim, Jeffrey J. 

P283, P351 

Kim, Jinho 

P103, P326 

Kim, Min-Seok 

P164 

Kimmel, Stephen E. 

P289, P342 

Kimura, Akinori 38 

Kimura, Genjiro 

P094 

King, Louise P. 

P156 

Kinugawa, Shintaro 

P090 

Kirkpatrick, James N. 

P038 

Kittleson, Michelle M. 

P118 

Kitzman, Dalane 

35, 44, P228 

Kitzman, Dalane W. 

P215 

Klaskala, Winslow 

P304 

Kleet, Audrey 

P263, P313 

Klein, Allan L. 

P031, P053, P087, P100 

Klein, N. 

P220 

Klepfer, Ruth N. 

P049 

Kleut, Milena 

P221 

Kluger, Jeffrey 

P193 

Knowlton, Kirk U. 49 

Kobashigawa, Jon 

P092 

Kobashigawa, Jon A. 141 

Koch, W.J. 38 

Koch, Walter J. 

30, 32, 96, P088, P106 

Kociol, Robb 

94, P257 

Kociol, Robb D. 

P304 

Kocovic, Dusan Z. 

P033, P048 

Kodali, Rahul 

P355 

Koehler, Jodi 

P130 

Koehler, Keith 

P235 

Kohsaka, Shun 

P340 

Kok, Wouter E.M. 

P210 

Komajda, Michel 

P236 

Kondareddy, Sreekanth R. 

P143 

Kono, Alan T. 

P322 

Konstam, Marvin A. 

100, P236, P280 

Koomalsingh, Kevin 

P059, P166 

Koomalsingh, Kevin J. 

P170 

Kop, Willem J. 

P160, P271 

Kopchock, George 

P096 

Korinek, Josef 37 

Kort, Smadar 

P259, P278 

Kossar, Alex 

P142 

Kotroyiannis, Iason 

P255, P296 

Kovanecz, Istvan 

P096 

Kowsar, A. 

P212 

Koyano-Nakagawa, Naoko 

P117 

178 

AUTHOR INDEX 

Kramer, Daniel B. 

P350 

Kramer, Daniel G. 

P280 

Kranias, Evangelia G. 30 

Krantz, David S. 

P271 

Krishnan, Vidya 

P386 

Krivospitskaya, Olesya 

P127 

Kroll, Nicholas 

P337 

Kroon, Abraham 

P071, P080 

Krum, Henry 

P301 

Kubo, Norifumi 

P047 

Kubo, Spencer H. 

P191 

Kuder, Sadik 

P379 

Kuniyoshi, Fatima H. 

P069 

Kurlansky, Paul A. 

P101 

Kuruvilla, Sujith 

P201 

Kushwaha, Sudhir 39 

Kushwaha, Sudhir S. 

P135 

Kweon, Junghun 

P117 

Kwong, Raymond Y. 

P352 

Kyba, Michael 

P117 

LaCroix, Bonnie 

P113 

LaForest, Sherry 

P371 

Lago, Rodrigo 

P362 

Lahr, Brian 

37, P246 

Lai, L.P. 

P049 

Lainscak, Mitja 

P277, P390 

Lak, Lea 

P165 

Lamas, Gervasio 

P270 

Lancaster, Jordan J. 

P140 

Landmeier, Mark 

P365 

Lanfear, David E. 

39, P127, P139, P243 

Langlois, Elizabeth 

P263, P313 

Lanier, Gregg 

P217 

Lappe, Donald L. 

P119, P295 

Lark, Michael 

P233 

Lark, Michael W. 

P229 

Larsen, Greg 

P389 

Larsen, Terry 

P339 

Larue, Catherine 

P086, P101 

Laskar, Sonjoy 

P095, P341, P357, P366 

Latif, Farhana 

P124 

Laurita, Kenneth P. 137 

Lazaros, George 

P251 

LeBlanc, James 

P062 

LeBlanc, Marie Helene 

P368, P372 

Lee, Cheol-Whan 

P164 

Lee, Christopher S. 

P294 

Lee, Gyu-Hyung 

P328 

Lee, HyangKyu 

P384 

179

AUTHOR INDEX 

Lee, Myoung Mook 

P347 

Lee, Myoung-Mook 

P326 

Lee, Randall J. 

P132 

Lee, Seung Hwan 

P347 

Leier, Carl V. 34 

Lennie, Terry A. 

36, 90, 138, P218, P273 

Leri, Annarosa 102 

Lerman, Amir 

P086 

Leszczynski, Karen 

P243 

Leunens, Veerle 

P152 

Leung, Crystal 

P169 

Levy, Phillip 

P256 

Levy, Wayne C. 

91, P129, P211 

Lewis, Eldrin F. 85 

Lewis, Gregory D. 37 

Li, Mona S. 

P126 

Liang, Bruce 

P058, P123 

Liang, Li 

P257 

Liao, Kenneth K. 

P292 

Liao, Ronglih 38, 97, 102 

Libbus, Imad 

P227 

Liggett, Stephen B. 42 

Lima, Marcelo V. 

P381 

Lin, Jay 

P310 

Lin, Jiunn-Lee 

P049 

Lin, Kimberly 

P370 

Lin, L.Y. 

P049 

Lindenfeld, JoAnn 

46, P168 

Lindsell, Christopher 

P084 

Ling, Haiyun 

P065 

Linke, Wolfgang 

P027 

Lipeicki, Janusz 

P203 

Lipperman, Michal 

P165 

Lipsitz, Stuart R. 

P249 

Liszkowski, Mark 

P388 

Little, William C. 

P071, P080 

Littlewort, Myrna 

P099 

Liu, Longjian 94 

Liu, Peter 

P314, P368, P372 

Liu, Peter P. 94 

Lobban, John H. 

P163, P178 

Loebe, Matthias 

P115, P133, P146 

Loffler, Adrian I. 

P297 

Lombardi, Carlo 

P287 

Long, James W. 

P154 

Lopez-Candales, Angel 

P077 

Lorts, Angela 

P078 

Losordo, Douglas W. 102 

Love, Charles 

P188 

180 

AUTHOR INDEX 

Lovelock, Joshua D. 

P108, P111 

Lowery, Christopher M. 

P194 

Lowes, Brian D. 

37, P120, P121 

Lui, George 

P181 

Lymperopoulos, Anastasios 

P088 

Ma, Xiucui 

P105 

Mabo, Philippe 

P212 

MacDonald, Peter S. 

P288 

Macheret, Fima 

P086, P244 

Mackedanz, Shari A. 

P042 

Maclellan, William C. 

P062 

Maclellan, William R. 

P062 

Madan, Vinay D. 

P305 

Madigan, Elizabeth 

P299 

Mady, Charles 

P057, P064 

Maekawa, Yuichiro 

P112, P340 

Magafa, Vassiliki 

P088 

Maggioni, Aldo P. 

P211 

Mahaffe, Jill 

P202 

Mahankali Sridhar, Arun Raghav P385 

Mahoney, Douglas 

P245 

Maid, Gustavo 

P045 

Maisel, Alan 

96, P083, P276 

Maisel, Alan S. 

P334, P356 

Maisel, William H. 

P350 

Majc-Hodoscek, Lea 

P277, P390 

Malenka, David J. 

P322 

Malhotra, Rajeev 37 

Malik, Adnan 

P095, P341, P366 

Malik, Fady I. 

P231 

Malloy, Samantha L. 

P380 

Mammen, Pradeep P.A. 

P156 

Mancini, Donna P134, P141, P142, P151, P175, 

P308 

Mancini, Donna M. 141 

Manerba, Alessandra 

135, P287 

Mani, Santhosh K. 

P066, P126 

Mann, Douglas L. 

32, 98, P082, P143, P307 

Mano, Yoshinori 

P112, P340 

Manole, Frank 

P313 

Mansourati, Jacques 

P220 

Marchiori, Gordon 

P368, P372 

Mareev, Viacheslav 136 

Margulies, Kenneth B. 44 

Mark, Daniel B. 91 

Mark, Heiman 

P033 

Markell, Mariana 

P377 

Markert, Ronald 

P200 

Markham, David 

P314 

181

AUTHOR INDEX 

Markham, David W. 

P156 

Maron, David 

P084 

Marshall, Joanne P. 

P271 

Martin, Fernando L. 

37, P028, P085, P086 

Martin, Michael 

P152, P176 

Martinez, Felipe A. 

P236 

Martini, Jeffrey S. 

P106 

Marx, Steven 

P110 

Marzec, Lucas 

P038 

Marzilli, Mario 

P061 

Massie, Barry M. 

96, 143, P185, P315 

Mather, Paul 

P314 

Mather, Paul J. 95 

Mathier, Michael A. 95, 139 

Mathur, Gaurav 

P291 

Matsuda, Torahiro 

P108, P111 

Matsumoto, Afonso Y. 

P057, P064 

Matzke, Lise 

P169 

Maurer, Mathew R. 

P308 

Maurer, Mathew S. 

96, 142, P073, P124 

May, Heidi T. 

P119 

Maybaum, Simon 

35, P343, P382 

Mazhari, Reza 

P232 

Mazic, Sanja 

P221 

Mazur, Wojciech 

P349 

Mazurek, Jeremy A. 

P234, P240 

Mazzaferri, Jr, Ernest L. 94 

McBride, M. 

P226 

McBride, M.L. 

P225 

McCarthy, EP 34 

McCarthy, Margaret M. 

P359 

McCauley, Brian D. 

P289, P342 

McCearley, Sandra 

P317 

McClellan, Megan 

P349 

McDaniel, Martin B. 

P198 

McFarland, Sean 

P333 

McGlothlin, Dana 

P363 

McGregor, Jessina C. 

P389 

McGrew, Frank A. 

P238 

McKay, Charles 36 

McKelvie, Robert 

P378 

McKenna, William 38 

McKenzie, John 

P206, P224 

McKie, Paul 

P244 

McKie, Paul M. 37, P028, P036, P039, P085, 

P102 

McLaughlin, Vallerie V. 29 

McManus, Bruce 

P169 

McNally, Elizabeth M. 48 

182 

AUTHOR INDEX 

McNamara, Dennis 

P314, P321 

McNamara, Dennis M. 40 

McPherson, John 

P084 

Mebazaa, Alexandre 

P037 

Medvedeva, S.J. 

P237 

Mehra, M. 

P226 

Mehra, M.R. 

P225 

Mehra, Mandeep R. 

P160 

Mehta, Nawzer 

P203 

Mehta, Sachin 

P082 

Mendoza, Ivan 

P260, P362 

Menick, Donald R. 

86, P066, P126 

Menon, Santosh G. 

P349 

Meredith, Anna 

P169 

Merkel Kraus, Stacia 

P179 

Merla, Ramanna 

P355 

Mesquita, Evandro T. 

P319 

Metallinos, George 

P254, P255, P265, P296 

Metoyer, Patricia 

P162 

Metra, Marco 

P287 

Meyer, Pamela 

P149 

Meyer, Theo E. 

P331 

Meyer-Brodnitz, Gideon 

P165 

Meymandi, Sheba K. 

P282 

Meyns, Bart 

P152, P176 

Michalkiewicz, Dariusz 

P186, P188, P196 

Mignatti, Andrea 

P060 

Mihaiu, Marian 

P354, P375 

Milano, Carmelo A. 40, 88 

Miles, William M. 

P346 

Milesi, Giuseppe 135 

Miller, Alan B. 40 

Miller, Karen 

P084 

Miller, Leslie W. 95 

Miller, Matthew W. 

P171 

Miller, Wayne L. 

P093 

Miller, Jr., Fletcher A. 

P230 

Mills, Roger M. 

82, P211, P257, P304 

Minakawa, Masahito 

P170 

Minamishima, Yoji Andy 38 

Mirza, Zulfiqar 

P200 

Mishkin, Joseph D. 

P156 

Mishra, Prasun 

P208 

Mishra, Shikha 

P065 

Mitchell, Judith E. 

P075, P377 

Mitchell, Richard N. 

P352 

Mitrea, Paula 

P354, P375 

Mizrahi, Isaac 

P385 

Moazami, Nader 

P143 

183

AUTHOR INDEX 

Modi, Sejal 

P172 

Moelter, Stephen 101 

Mohammed, Mohammed 

P256 

Mohammed, Selma 

39, P027 

Mohammed, Selma F. 

P034, P091 

Mokadam, Nahush A. 

P129 

Momomura, Shin-ichi 

P047 

Mongeon, Francois-Pierre 

P181 

Moore, Karen A. 

P177 

Morales, David L.S. 

P283 

Moran, John 

P365 

Moravec, Christine 

90, P041 

Moravec, Christine S. 

P145 

Moreno, Michael 

P171 

Morgado, Micaela 38 

Morgan, Jeffrey A. 

P139 

Morgan, Kevin 

P035 

Morgan, Timothy M. 

P215 

Morley, Gregory E. 103 

Morris, Lynn 

P362 

Morris, Rohinton J. 

P161 

Morrissy, Stephen J. 

P041 

Morrow, John 

P110 

Moser, Debra K. 

36, 143, P218, P273, P391 

Moslehi, Javid 38 

Most, Patrick 45 

Mountis, Maria M. 

P325, P337 

Movahed, Mohammad R. 

P044 

Mudd, James O. 

P149 

Mueller, Paul S. 

P153, P336 

Muhlestein, Joseph B. 

P119 

Mujib, Marjan 

P205 

Mukai, Seiji 

P094 

Mukku, Venkata Kishore 

P355 

Mulder, Maximilian 

P293 

Mullens, Wilfried 

P364 

Muller, David 

P068, P162, P197, P199 

Mullikin, Amy R. 

P380 

Munger, Mark A. 40 

Munoz, Gisele 36 

Murad, Khalil 

P215 

Murali, Srinivas 139 

Murphy, Ryan M. 37 

Murray, Christina 

P150, P173 

Murthy, Sandhya 

P382 

Musat, Dan 

P190 

Muslin, Anthony J. 

93, P024 

Mussivand, Tofy 

P076 

Naftilan, Allen 

P084 

184 

AUTHOR INDEX 

Nagai, Toshiyuki 

P112, P340 

Nagatomo, Yuji 

P340 

Najjar, Samer S. 

P385 

Naka, Yoshifumi 37, P134, P141, P142, P144, 

P151, P175 

Naqvi, Tasneem Z. 

P052 

Narula, Jagat 

P321 

Nastas, J. 

P261, P373 

Natarajan, Sundar 

P249 

Nathani, Ali 

P312 

Navab, Mohamad 

P062 

Neaton, James D. 

P236 

Nelson, David A. 

P171 

Nelson, Karl E. 

P154 

Nemeh, Hassan W. 

P139 

Nemeth, Attila 

P241 

Nessler, Bohdan J. 

P242 

Nessler, Jadwiga M. 

P242 

Neuman, Stacey L. 

P275 

Newman, David 

P190 

Newton, Phillip J. 

P288 

Nguyen, My-Le 

P160 

Niazi, Imran K. 

P155 

Nodari, Savida 135 

Nohria, Anju 

P388 

Noon, George P. 

P146 

Norton, Catherine R. 

P095, P341, P357, P366 

Noumi, Bassel 

P073, P124 

Novaro, Gian 

P260 

Nowak, Richard 

P083 

Nowak, Richard M. 

P037 

Nunoda, Shinichi 38 

Nylund, Britta L. 

P271 

Oberti, Pablo 

P045 

O’Brien, Thomas M. 

P349 

Ochiai, Marcelo E. 

P381 

O’Connell, Aurelia 36 

O’Connor, C. 

P226 

O’Connor, C.M. 

P225 

O’Connor, Christopher 

P257, P348 

O’Connor, Christopher M. 

32, 96, 136, 140, P338, P374 

Oehler, Elise 

P230 

Oehler, Elise A. 

37, P028, P036 

Ogawa, Satoshi 

P340 

Ogut, Ozgur 

39, P027 

Oh, Byung Hee 

P347 

Oh, Jaewon 

P103, P326 

Ohtani, Tomohito 

39, P027, P091 

Ohte, Nobuyuki 

P094 

185

AUTHOR INDEX 

Olson, Lyle J. 

P069 

Olson, Matthew D. 

P194 

Olson, Timothy M. 

37, P246 

Omens, Jeffrey H. 

P040 

Ono, Taisuke 

P090 

Onufer, John R. 

P275 

Opotowsky, Alexander 

P181 

Oren, Ron M. 

P285 

O’Riordan, David L. 

P290 

O’Rourke, Daniel J. 

P322 

Orrego, Carlos 

P133 

Orrego, Carlos M. 

P122, P146 

Orsini, Enrico 

P061 

Ortiz, Catherine 

P371 

Ortiz, Jose 

P371 

Osei-Bonsu, Alexander 

P259, P278 

O’Sullivan, David 

P286 

Ottenberg, Abigale L. 

P153, P336 

Oudit, Gavin Y. 

39, P025, P043, P107 

Owen, Regina 

P238 

Owen, Sandra 

P174 

Oyeleye, Mary O. 

P029 

Oza, Ashish L. 

P275 

Packer, Milton 29, 140 

Padera, Robert 38 

Padera, Robert F. 

P352 

Padilla Garcia, Eva 

P282 

Pak, Sang-Whoo 

P175 

Pak, Sang-Woo 

37, P141, P142, P144, P151 

Palac, Robert T. 

P322 

Panagiotakos, Demosthenes B. P255 

Pang, Peter 

P037 

Pang, Peter S. 82 

Pantilat, Steven Z. 

P290 

Panyasing, Yaowalak 

P232 

Paolocci, Nazareno 137 

Paone, Gaetano 

P139 

Papp, Mary Anne 

P206, P224 

Pappagianopoulos, Paul P. 37 

Pappas, Pat 

P136, P157, P158, P172 

Parikh, Ankit D. 

P249 

Parikh, Puja B. 

P259, P278 

Parikh, Roopali 

P259, P278 

Parisis, C. 

P261, P373 

Park, James J. 

P119 

Park, Myung H. 139 

Park, Seong-Wook 

P164 

Park, Seung-Jung 

P164 

Park, Soon J. 

91, P153 

186 

AUTHOR INDEX 

Park, Sung-Ji 

P303, P328 

Parker, Kevin Kit 43 

Parv, Andreea 

P354, P375 

Patangay, Abhilash 

P147 

Patel, Ayan R. 85, 95 

Patel, Parag C. 

P156 

Patel, Shitalben R. 

P116 

Pattabiraman, Pavithra 

P306 

Patterson, J. Herbert 

40, 46, P285 

Pauly, Daniel 

P321 

Pauwaa, Sunil 

P157, P172 

Pavuluri, Vamsi 

P193 

Payne, John 

P317 

Paz, Yehuda Edo 

P144 

Peacock, Frank 

P083 

Peacock, William F. 

P356 

PEARL-HF Investigators 

P228 

Pellegrini, Cara N. 

P185, P315 

Pellikka, Patricia A. 

P230 

Penninger, Josef M. 

39, P043 

Pereira, Naveen L. 

P135 

Perez, Celso 

P267 

Perez, Jose R. 

P380 

Perez Etchepare, Raul 

P045 

Perpar, Jennifer 

P145 

Petersen, Denise 

P072 

Peterson, Eric D. 

P253 

Peterson, Kirk L. 

P040 

Pezzotti, Elena 

P287 

Pfeffer, Marc A. 32, 34 

Pflugfelder, Peter 

P092 

Phan, Anita 

P051 

Philipps, Emily S. 

P290 

Phillips, Harry 

P374 

Phillips, RS 34 

Piano, Mariann R. 36 

Pignatelli, Ricardo 

P358 

Pilla, James 

P170 

Pilla, James J. 

P059, P166 

Pimenta, Joana M. 

P210 

Piña, Ileana L. 

34, 90, P285, P299 

Ping, Peipei 86 

Pitrolo, Francesco 

P230 

Pitsavos, Christos 

P251, P254, P255, P265, P296 

Pitt, Bertram 

35, 84, P228 

Pizarro, Rodolfo 

P045 

Plana, Juan 

P358 

Poletick, Eileen 

P263 

Polisetty, Ravishankar 

P237 

187

AUTHOR INDEX 

Ponikowski, Piotr 

98, P186 

Porter, T. Flint 

P119 

Ports, Thomas A. 

P363 

Poss, Kenneth D. 49 

Powell, Brian D. 

P131, P187, P222 

Pozehl, Bunny J. 36 

Pratap, Balaji 

P190 

Pressler, Susan J. 

101, P218 

Price, Jack F. 

P283, P351 

Pripon, Sorin 

P354, P375 

Pritchett, Allison 

P306 

Pritzker, Marc 

P292 

Prokunina-Olsson, Mila 

P113 

Prosser, Connie 

P032 

Pugacz, Adam 

P371 

Puig, Raphael S.N. 

P381 

Pullatt, Raja 

P193 

Punovic, Nevena 

P209 

Purevjav, Enkhsaikhan 38 

Qin, Qianhong 

P104, P108, P111 

Quraishi, Bilal 

P202 

Quraishi, Muhammed B. 

P200 

Rabinovitz, Asaf 

P332 

Rabinowitz, J. 38 

Radulescu, Dan 

P354, P375 

Radulescu, Maria 

P354, P375 

Rafique, Asim M. 

P051 

Rahmatullah, Amin F. 

P312 

Raichlin, Eugenia 

P135, P167 

Rajagopalan, Navin 

P077 

Rajagopalan, Viswanathan 39 

Ramani, Gautam V. 

P160 

Ramaraj, Radhakrishnan 

P044 

Ramasubbu, Kumudha 

P272, P306 

Ramineni, Rajesh 

P355 

Rane, Aboli A. 

P040 

Ranjan, Rupesh 

P052 

Rantsev, M.A. 

P237 

Rao, Meena P. 

P156 

Raskin, Anna 

P035 

Rasmussen, Tara L. 

P117 

Rasmusson, Kismet 

P284 

Rasmusson, Kismet D. 

88, P119, P295, P318 

Raspovic-Hopper, Susie 

P337 

Rastogi, Sharad 

P132 

Rathman, Lisa D. 

P213 

Rau, Tomas 

P216 

Ravishankar, Polisetty 

P128 

Rayburn, Barry 35 

188 

AUTHOR INDEX 

Reardon, John 

P232 

Reddy, Madhu 36 

Reddy, Sushma 39 

Redfield, Margaret 39 

Redfield, Margaret M. 95, 97, 135, P027, P034, P036, 

P091, P230 

Reed, Alana L. 

P108 

Rega, Filip R. 

P152, P176 

Reilly, Carolyn Miller 138 

Rengo, Giuseppe 

P088 

Renlund, Dale G. 

P119 

Reuter, David G. 

P203 

Revers, Cathy 

P032 

Reynolds, D. 

P226 

Reynolds, D.W. 

P225 

Reynolds, Harmony 

P270 

Rich, Michael W. 

44, P305 

Richard, Feinn 

P058 

Richardson, Peter 94 

Riegel, Barbara 

P360 

Riegel, Barbara J. 96, 101 

Rist, Kevin 

P159 

Robbins, Jeffrey 38, 48 

Robert, Alina M. 

P322 

Roberts, Colleen 

P295 

Robertson, Alastair D. 

P120, P121 

Rock, Michael T. 

P070 

Rockman, Howard A. 83 

Rodeheffer, Richard 

P244, P245 

Rodeheffer, Richard J. 

37, P135, P246 

Rogers, Joseph G. 91 

Rolfes, Christopher D. 

P074 

Roll, Sue 

P084 

Rominger, David 

P229 

Ronald, Markert 

P202 

Rosen, Lior 

P165 

Rosenbaum, Andrew N. 

P292 

Rosenblum, Hannah 

P308 

Rosenzweig, Anthony 92 

Rosing, Douglas R. 

P079 

Ross, Heather 

P092 

Ross, Robert S. 99 

Rossano, Joseph W. 

P283, P351 

Roth, Isabell 

P220 

Rothman, Steven 

P033, P048 

Rousseau, Michel F. 

P097 

Rovithis, D. 

P261, P373 

Rumsfeld, John S. 

P185, P315 

Ruiz-Lozano, Pilar 93 

189

AUTHOR INDEX 

Russell, Stuart D. 

141, P118, P149 

Ryan, Aleong G. 

P194 

Ryan, Timothy 

P167 

Ryder, Oliver A. 32 

Ryu, Kyu Hyung 

P347 

Ryu, Kyungmoo 

P155 

Saba, Magdi 

P182, P183 

Sabatka, Sharon 

P371 

Sabbah, Hani N. 

38, 96, P132, P243 

Sabbah, Hanni N. 

P127 

Sabbah, Michael S. 

P132 

Sacksteter, Sue 

P202 

Sadoshima, Junichi 93 

Sadowski, Jerzy 

P203 

Saikali, Khalil G. 

P231 

Sajady, Mariam 

P191 

Sakakura, Kenichi 

P047 

Sakowski, Brent 

P150, P173 

Salah, Khibar 

P210 

Salamon, Jason N. 

P234, P332 

Salamonson, Yenna 

P288 

Salem, William 

P371 

Salemi, Vera M.C. 

P057, P064 

Saliaris, Anastasios 

P182, P183 

Sambelashvili, Aleksandre 

P174 

Sambelashvili, Alex 

P150, P173 

Samra, Amrit 

P169 

Sanchez, Lisa 

P358 

Sandberg, Sharon M. 

P102 

Sangaralingham, S. Jeson 

P028, P039, P085 

Sangarlingham, S. Jeson 37 

Sapp, John 

P174 

Sarkar, Shantanu 

P130 

Sarswat, Nitasha 

P099 

Satya, Kumar 

P055 

Sauer, William H. 

P185, P194 

Sauser, Kori 

P037 

Sawyer, Douglas B. 

P070 

Saxon, Leslie A. 41, 47, P131, P187, P204, 

P222, P279 

Sayer, Gabriel 

P060 

Schaefle, Ken 

P134 

Schaefle, Kenneth J. 

P141 

Schally, Andrew V. 38 

Schiller, Nelson B. 

P231 

Schipper, Judith 

P359 

Schirger, John A. 

135, P036, P135 

Schloss, Edward 

P188 

Schmalfuss, Carsten M. 

P380 

190 

AUTHOR INDEX 

Schmitt, Gary 

P235 

Schocken, Douglas D. 96 

Schofield, Richard 

P346 

Schofield, Richard S. 

P380 

Schomisch, Steven J. 

P145 

Schonberg, Andrene 36 

Schrumpf, Phillip 

P178 

Schuller, Joseph L. 

P194 

Schulze, Christian P. 

P141 

Schulze, P. Christian 

37, P110, P134 

Schwartz, Todd A. 

P285 

Scott, Nathaniel L. 

P293 

Scully, Brian E. 

P175 

Sebesteyn, Gheorghe 

P354, P375 

Seiler, Jens 

P189 

Sekularac, Nikola 

P209 

Selim, Ahmed 

P323, P329 

Selim, Ahmed M. 

P099, P274, P387 

Selzman, Kimberly A. 

P184 

Semigran, Marc J. 37, 139 

Serrao, Gregory W. 

P026 

Seth, Milan 

P131, P222, P279 

Sethna, Dorab 

P035 

Shaban, Nada 

P067 

Shaffer, Hope 

P202 

Shah, Ashish 

P149 

Shah, Kevin 

P334 

Shah, Ravi 37 

Shannon, Richard P. 

P289, P342 

Shao, Zhili 

P100 

Sharon, Sandberg 

P244 

Shaw, Linda 

P348 

Shaw, Linda K. 

94, P374 

Sheikh, Asad 

P235 

Shen, Jian-Bing 

P123 

Sheppard, Richard 

P314 

Sherman, Amir 

P165 

Sheu, Shey-Shing 45 

Shimbo, Daichi 

P201 

Shinbane, Jerold 

P247 

Shiraga, Sharon 

P389 

Shirolkar, Shailesh 

P348 

Shizukuda, Yukitaka 

P079, P177 

Shoham, Shmuel 

P385 

Shome, Shibaji 

P163, P178 

Shorofsky, Stephen 

P182, P183 

Shrestha, Kevin 

P031, P050, P053, P087, P100 

Siddiqi, Faisal 

P182, P183 

Siddiqi, Najmul I. 

P386 

191

AUTHOR INDEX 

Sidhu, Mandeep S. 

P322 

Siegel, Robert J. 

P051 

Silverman, David I. 

P286 

Simari, Robert A. 

P036 

Simari, Robert D. 

135, P034 

Siminiak, Tomasz 

P203 

Simpson, Suzanne 

P295 

Sims, Daniel 

P060, P151 

Sims, James J. 

P317 

Sims, Jason 

P206, P224 

Sindone, Andrew 

P301 

Singh, Abhijeet 

P259, P278 

Singh, Beenu 

P329 

Singh, Dhssraj 

P050 

Singh, Gagan D. 

P353 

Singh, Harinder 

P192 

Singh, Harleen 

P389 

Singh, Manpreet 

P190 

Singh, Parvati 37 

Siot, Pierre H. 

P212 

Sipahi, Ilke 

P208 

Skopicki, Hal A. 

P259, P278 

Skoularigis, J. 

P261, P373 

Skrepnek, Grant H. 

P294 

Slesnick, Timothy 

P358 

Slusser, Joshua 

P245 

Slusser, Joshua P. 

P269 

Small, Roy S. 

P213, P223 

Smart, Frank 

P263, P313 

Smedira, Nicholas G. 

P325 

Smer, Aiman M. 

P282 

Smith, Andrew L. 

P095, P341, P357, P366 

Smith, Holly M. 

P070 

Smith, Stephen W. 

P293 

Snowden, Timothy 

P171 

Snyder, Trevor A. 

P154 

Snyderman, Ralph 32 

Sobirin, Mochamad Ali 

P090 

Sobotka, Paul A. 

P302 

Soergel, David G. 

P229 

Soghier, Israa 

P274, P387 

Soliman, Elsayed Z. 

P215 

Solomon, Scott D. 84 

Somers, Virend K. 

P069 

Sommer, Per 

P382 

Song, Jae-Kwan 

P164 

Song, Robert 

P142 

Spoko, George 40 

Sorescu, Dan 

P104, P108, P111 

192 

AUTHOR INDEX 

Soucier, Richard 

P067 

Southard, Jeff 

P235 

Southard, Lee 

P235 

Speece, Ty 

P235 

Sperling, Matthew 

P084 

Splett, Vince 

P049 

Springer, Jochen 

P030 

Srinivasan, Divya 

P147 

Srivastava, Mukta 

P182 

Stafford, Randall S. 

P258 

Stahl, Erika 

P172 

Stainier, Didier Y.R. 49 

Stamos, Thomas D. 

P116 

Staniford, Kerry A. 

P376 

Starling, R.C. 

34, P261, P373 

Starling, Randall 

P321 

Starling, Randall C. 

46, 141, P145, P325 

Starmer, John 

P324 

Stefanadis, Christodoulos 

P251, P254, P255, P265, P296 

Stehlik, Josef 

P284, P318 

Steinberg, Jonathan S. 

P204 

Steidley, D. Eric 40 

Stevancec, Darija 

P390 

Stevanovic, Angelina 

P209, P221 

Stevenson, Lynne W. 

135, 136, P189, P352, P388 

Stevenson, Lynne Warner 34, 100 

Stevenson, William G. 

P189, P352 

Stewart, Garrick C. 

P352, P388 

Stewart, Simon 

P301 

Stockbridge, Norman L. 82, 140 

Stolen, Kira Q. 

P179 

Storrow, Alan 

P037, P084 

Stout, Rebecca 

P136 

Strobeck, John E. 

P367 

Stromberg, Kurt 135 

Struck, Joachim 

P093 

Struk, Cynthia 

P299 

Suarez, Jorge 

P029 

Subramanian, Devika 

P307 

Subramanian, Venkataraman 

P307 

Suga, Tadashi 

P090 

Sugawara, Yoshitaka 

P047 

Sullivan, Mark D. 97 

Sulmasy, Daniel P. 

P336 

Sumaroka, M. 38 

Sussman, Mark A. 30 

Sutliff, Roy L. 

P108 

Suzic, Jelena 

P221 

Swain, J. 38 

193

AUTHOR INDEX 

Swan, Suzanne K. 

P042 

Swanson, Lynne 

P147 

Sweet, Wendy 

P041 

Sweet, Wendy E. 

P145 

Sweitzer, Nancy K. 

P297 

Swetz, Keith M. 

P153, P336 

Swingen, Cory M. 

P074 

Systrom, David M. 37 

Szymkiewicz, Steven J. 

P180 

Taha, Nima 

P052 

Takayama, Hiroo 37, P134, P141, P142, P144, 

P151, P175 

Takeuchi, Lauro M. 38 

Taleb, Mohammed 

P379 

Tam, S. William 

P256 

Tanaka, Atsuko 

P104, P108, P111 

Tang, W.H. Wilson 46, 85, P031, P041, P050, 

P053, P087, P100, P213, P223, 

P264, P268, P281, P364 

Tang, Wilson W.H. 

P227 

Tani, Tomomitsu 

P094 

Tao, Joyce 

P035 

Tarazona, Norman 

P132 

Tatooles, Antone 

P157, P158, P172 

Tatooles, Antone J. 

P136 

Taub, Pam 

P083 

Tavares, Miguel 

P037 

Taylor, Anne L. 137 

Taylor, Doris A. 43 

Taylor, Michael 

P358 

Taylor, Sally 

P208 

Tedrow, Usha 

P189 

Teerlink, John R. 

31, 82, 135, P231 

Teleten, Nick 

P051 

Terebello, Sima 

P377 

Teruya, Sergio 

P073, P124 

Testani, Jeffrey M. 

P289, P342 

Teuteberg, JJ 34 

Thai, Hoang 

P140 

Thakur, Pramodsingh H. 

P147 

Thanavaro, Kristin 

P183 

Thiagarajan, Thirumagal 

P126 

Thibodeau, Jennifer T. 

P156 

Thohan, Vinay 

P314 

Thomas, Charles 

P241 

Thomas, Melissa K. 

P113 

Tian, Rong 92 

Tiernan, Mary 

P197 

Tijssen, Jan G.P. 

P210 

194 

AUTHOR INDEX 

Timothy, Timothy 

P217 

Ting, Jennifer 

P181 

Tiongson, Jay E. 

P198 

Tita, Cristina 

P139 

Toma, Mustafa 

P325, P337 

Tomasulo, C. 38 

Toncev, Anton 

P209 

Toncev, Dragana 

P209 

Tong, Kathleen L. 

P363 

Tong, Matthew 

P268 

Tong, Wilson 

P281 

Tonne, Jason M. 

P230 

Topkara, Veli K. 

38, P114, P143 

Torre-Amione, Guillermo P115, P122, P133, P146, P214, 

P321 

Touyz, Rhian 

P092 

Towbin, Jeffrey 

P078 

Towbin, Jeffrey A. 

38, P351 

Toy, Stephanie 

P035 

Traina, Mahmoud 

P282 

Tran, Diane 

P067 

Trent, Chad 

P110 

Treuer, Adriana V. 38 

Trevino, Alejandro R. 

P122, P146 

Triggiani, Marco 135 

Trikalinos, Thomas A. 

P280 

Tripodi, Dorothy J. 

P079 

Triposkiadis, F. 

P261, P373 

Troughton, Richard W. 

P031, P053, P087, P100 

Trupp, Robin 135 

Tsai, C.T. 

P049 

Tsai, Feng-Chun 

36, P391 

Tsai, Ming-Feng 

36, P391 

Tsaknakis, T. 

P261, P373 

Tsantilas, Apostolis 

P255 

Tsantilas, Apostolos 

P296 

Tschirner, Anika 

P030 

Tseng, Chi-Hong 

P217 

Tsiachris, Athanasios 

P251 

Tsiouris, Simon J. 

P175 

Tsitsinakis, George 

P254, P255, P265, P296 

Tsutsui, Hiroyuki 

P090 

Tubishevitz, Amit 

P165 

Turnbull, Irene C. 

P026 

Tzeng, Huei-Ping 38 

Uber, Patrica A. 88 

Udelson, James E. 

31, P280 

Ujeyl, Amaar 

P189 

Ujhelyi, Michael 

P150, P173 

195

AUTHOR INDEX 

Ullery, Brant W. 

P161 

Ullrich, Susan 

P149 

Um, John 

P167 

Uriel, Nir 

P060, P142, P144, P151, P175 

US PARACHUTE Investigators 94 

Vacek, James 

P235 

Vacha, Catherine 

P337 

Valadri, R. 

P195 

Valantine, HA 34 

Valente, Anne 

P181 

Valzania, Cinzia 

P219 

Van Devender, Elva A. 

P389 

Van Patten, Danielle 

P144 

Van Tichelen, Ingrid 

P152 

Varela, Jaquelin 38 

Varosy, Paul D. 

P185, P194, P315 

Vatterott, Daniel B. 

P191 

Vela, Luz E. 

P115 

Velankar, Pradnya 

P099, P240, P274, P323, P387 

Velazquez, Eric 

P374 

Velazquez, Eric J. 35, 83, 197 

Verdiani, Valerio 

P210 

Verma, Sameer 

P046 

Vernet, Dolores 

P096 

Ventura, Hector O. 142 

Verrier, Edward D. 

P129 

Victorica, Javier 

P045 

Vieira, Kelly R.N. 

P381 

Villacorta, Humberto 

P319 

Villarreal, Francisco J. 103 

Violin, Jonathan D. 

P229 

Vitense, Holly 

P130 

Vittorio, Timothy 

P239 

Vizzardi, Enrico 

P287 

Vogel, Mark W. 

P269 

von Haehling, Stephan 

P030, P277 

Vulcano, Norberto 

P045 

Waagstein, Fimm 

P216 

Waagstein, Finn 

P205 

Waclawiw, Myron A. 

P079 

Wada, Hiroshi 

P047 

Wade, Carol 

P160 

Wagman, Gabriel 

P217 

Wagner, Mary B. 

P108 

Wakami, Kazuaki 

P094 

Walker, John S. 37 

Walker, Lori A. 37 

Wallis, Alicia M. 

P117 

Walsh, Kenneth 92 

196 

AUTHOR INDEX 

Walsh, M. 

P226 

Walsh, M.N. 

P225 

Walsh, Mary N. 90, 138 

Wang, Chun-Li 

36, P391 

Wang, I-Wen 

P143 

Wang, Judy S.C. 

P096 

Wang, Mengjun 

P132 

Wang, Shao-Hua 

P092 

Wang, Wei 38 

Wang, Xiuhua 

P107 

Wang, Xiu-hua 

P025 

Wang, Y.C. 

P049 

Wang, Yan 

P038 

Wang, Yibin 99 

Ward, Tamra 36 

Wase, Abdul 

P200, P202 

Wasmund, Stephen L. 

P184 

Wasson, Lauren T. 

P201 

Watson, Robert A. 94 

Wawrzyniak, Andrew J. 

P271 

Wayne, PM 34 

Weaver, Cyprian 

P113 

Webb, R. Clinton 83 

Webster, Tracy 

P137, P138 

Webster, Tracy A. 

P148 

Weinhaus, Anthony 

P081 

Weinstein, Jessica E. 

P118 

Weinstock, Perry J. 94 

Weisshaar, Dana 

P316 

Wessler, Benjamin S. 

P280 

West, Ryenn L. 

P257 

Westlund, Randy 

P081, P188, P196 

Westrom, Sylvia 

P072 

Whalen, Erin J. 

P229, P233 

Whang, William 

P201 

Wharton, J. Marcu 41 

Whellan, David J. 28, 85, 135, 143 

White, Matthew S. 

P285 

White, Michel 

P092, P205 

White, Rodney A. 

P096 

Whittaker, Kerry S. 

P271 

Wiafe, Seth 

P266 

Widger, William 

P115 

Wiederkehr, Daniel 

P310 

Wiegand, Uwe 

P220 

Wilkoff, Bruce L. 47, 88, 135 

Williams, Celeste 

P139 

Williams, Paula 

P308 

Wilmer, Brian L. 

P180 

197

AUTHOR INDEX 

Wilmot, Ivan 

P351 

Win, Cho 

P063 

Winchester, Mark A. 40 

Winters, Gayle L. 

P352 

Wiste, Heather 

P138 

Wiste, Heather J. 

P137 

Witmer, Char 

P370 

Witteles, Ronald M. 

96, P353 

Wittstein, Ilan 

P321 

Wittstein, Ilan S. 

P118 

Wolf, Matthew J. 49 

Wolfe, Douglas 

P317 

Wolff, Andrew A. 

P231 

Won, Hoyoun 

P103, P326 

Wong, Vivian 

P035 

Woo, Gregory W. 

P346 

Woo, Mary W. 101 

Woo, Y. Joseph 

P161 

Wood, MJ 34 

Woollett, Ian F. 

P275 

Worku, Berhane 

P144 

Wu, Jia-Rong 

P273 

Wu, Joseph 39 

Wu, Justina C. 

P203 

Wu, Yuping 

P268 

Xu, Chun 

P059, P170 

Xu, Xiaolei 39 

Xue, Yang 

P334, P356 

Yadav, Jay 136 

Yamashita, Dennis 

P229 

Yancy, C. 

P226 

Yancy, C.W. 

P225 

Yancy, Clyde W. 

P211, P253 

Yang, James 

P127 

Yang, Tae 

P302 

Yang, Yanfei 

P185, P315 

Yao, David 

P082 

Yaroshinsky, Alex 34 

Yau, Raymond 

P072 

Yeh, Gloria 34 

Yee J 34 

Yeo, Poh Shuan Daniel 

P364 

Yeo, Seon Ju 

P109 

Yip, Gabriel 

P188 

Yokota, Takashi 

P090 

Yong, Patrick 

P204 

Yoo, Byung Su 

P347 

Yoon, Chang-Hwan 

P303 

Yoon, Junghan 

P347 

198 

AUTHOR INDEX 

Yoshikawa, Tsutomu 

P112, P340 

Youker, Keith A. 

P115, P122 

Youmans, Quentin R. 

P026 

Youn, Young Jin 

P347 

Young, James B. 

P211 

Yu, Anthony F. 

P038 

Yu, C.C. 

P049 

Yun, Soo-Hyun 

P098 

Zafar, Farhan 

P283 

Zaitoun, Heshan 

P260 

Zalawadiya, Sandip 

P252, P311, P330 

Zalawadiya, Sandip K. 

P300 

Zannad, Faiez 

35, P228, P236 

Zazzalli, Kathleen 

P199 

Zelin, Kathleen 

P192 

Zhang, Geng 

P163 

Zhang, Jing 

P052 

Zhang, Shi-Jiang 

P196 

Zhang, Xilong 

P196 

Zhang, Zach 

P239 

Zhao, Mingming 39 

Zhong, Jiuchang 

P043 

Zhong, Jiu-Chang 

P025 

Zichitella, Gina 

P331 

Zile, Michael R. 

99, 135, P071, P080 

Zinka, Elzbieta 

P270 

Zipse, Matthew M. 

P194 

Zisimos, Costas 

P265 

Zmily, Hammam 

P252, P300, P311, P330 

Zmily, Hammam D. 

P256 

Zolty, Ronald P099, P120, P121, P234, P239, 

P240, P274, P320, P323, P329, 

P332, P387 

Zsebo, Krisztina M. 34 

Zucker, Mark 

P321 

Zweibel, Steven 

P193 

199

HFSA 

Office 

Speaker 

Ready Room 

Scientific Sessions 

Press 

Room 

Registration 

Scientific Sessions 

San Diego AUTHOR Convention INDEX Center 

Notes 

Second Level 

(Exhibit Hall) 

200 

201

206 207

208

SAMSCA ® (tolvaptan) 

importance of SAMSCA to the mother. 

Pediatric Use: Safety and effectiveness of SAMSCA in pediatric patients have not been 

established. 

Geriatric Use: Of the total number of hyponatremic subjects treated with SAMSCA in clinical 

studies, 42% were 65 and over, while 19% were 75 and over. No overall differences in safety or 

effectiveness were observed between these subjects and younger subjects, and other reported 

clinical experience has not identified differences in responses between the elderly and younger 

patients, but greater sensitivity of some older individuals cannot be ruled out. Increasing age has 

no effect on tolvaptan plasma concentrations. 

Use in Patients with Hepatic Impairment: Moderate and severe hepatic impairment do not 

affect exposure to tolvaptan to a clinically relevant extent. No dose adjustment of tolvaptan is 

necessary. 

Use in Patients with Renal Impairment: Exposure and response to tolvaptan are similar in 

patients with a creatinine clearance 10-79 mL/min and in patients without renal impairment. No 

dose adjustment is necessary. Exposure and response to tolvaptan in patients with a creatinine 

clearance 2000 mg/kg. No mortality was observed in rats 

or dogs following single oral doses of 2000 mg/kg (maximum feasible dose). A single oral dose 

of 2000 mg/kg was lethal in mice, and symptoms of toxicity in affected mice included decreased 

locomotor activity, staggering gait, tremor and hypothermia. 

If overdose occurs, estimation of the severity of poisoning is an important first step. A thorough 

history and details of overdose should be obtained, and a physical examination should be 

performed. The possibility of multiple drug involvement should be considered. 

Treatment should involve symptomatic and supportive care, with respiratory, ECG and blood 

pressure monitoring and water/ electrolyte supplements as needed. A profuse and prolonged 

aquaresis should be anticipated, which, if not matched by oral fluid ingestion, should be replaced 

with intravenous hypotonic fluids, while closely monitoring electrolytes and fluid balance. 

ECG monitoring should begin immediately and continue until ECG parameters are within normal 

ranges. Dialysis may not be effective in removing tolvaptan because of its high binding affinity 

for human plasma protein (>99%). Close medical supervision and monitoring should continue 

until the patient recovers. 

PATIENT COUNSELING INFORMATION: As a part of patient counseling, healthcare providers 

must review the SAMSCA Medication Guide with every patient [see FDA-Approved Medication 

Guide (17.3)]. 

Concomitant Medication: Advise patients to inform their physician if they are taking or plan to 

take any prescription or over-the-counter drugs since there is a potential for interactions. 

Strong and Moderate CYP 3A inhibitors and Pg-p inhibitors: Advise patients to inform their 

physician if they use strong (e.g., ketoconazole, itraconazole, clarithromycin, telithromycin, 

nelfinavir, saquinavir, indinavir, ritonavir) or moderate CYP 3A inhibitors (e.g., aprepitant, 

erythromycin, diltiazem, verapamil, fluconazol) or P-gp inhibitors (e.g., cyclosporine) [see 

Dosage and Administration (2.4), Contraindications (4.4), Warnings and Precautions (5.5) and 

Drug Interactions (7.1)]. 

Nursing: Advise patients not to breastfeed an infant if they are taking SAMSCA [see Use In 

Specific Populations (8.3)]. 

For more information about SAMSCA, call 1-877-726-7220 or go to www.samsca.com. 

Manufactured by Otsuka Pharmaceutical Co., Ltd., Tokyo, 101-8535 Japan 

Distributed and marketed by Otsuka America Pharmaceutical, Inc., Rockville, MD 20850 

US Patent Nos.: 5,258,510 and 5,753,677. 

SAMSCA is a trademark of Otsuka Pharmaceutical Co., Ltd., Tokyo, 101-8535 Japan 

© 2010 Otsuka Pharmaceutical Co., Ltd. 

0708L-0023B Rev. 05/2009

COME TO BOOTH 309 

Get in touch with your 

Test your 

hyponatremia (HN) 

knowledge and 

receive a free 

educational tool.* 

*While supplies last 

Indication and Important Limitations 

• SAMSCA is indicated for the treatment of 

clinically significant hypervolemic and euvolemic 

hyponatremia (serum sodium 12 mEq/L/24 hours) can cause 

osmotic demyelination resulting in dysarthria, mutism, dysphagia, lethargy, affective changes, 

spastic quadriparesis, seizures, coma and death. In susceptible patients, including those with severe 

malnutrition, alcoholism or advanced liver disease, slower rates of correction may be advisable. 

Contraindications: Urgent need to raise serum sodium acutely, inability of the patient to sense 

or appropriately respond to thirst, hypovolemic hyponatremia, concomitant use of strong CYP 3A 

inhibitors, anuric patients. 

• Subjects with SIADH or very low baseline serum sodium concentrations may be at greater risk for 

too-rapid correction of serum sodium. In patients receiving SAMSCA who develop too rapid a rise 

in serum sodium or develop neurologic sequelae, discontinue or interrupt treatment with SAMSCA 

and consider administration of hypotonic fluid. Fluid restriction should generally be avoided during 

the first 24 hours 

• Dehydration and hypovolemia can occur, especially in potentially volume-depleted patients receiving 

diuretics or those who are fluid restricted. In patients who develop medically significant signs or 

symptoms of hypovolemia, discontinuation is recommended 

• Gastrointestinal bleeding in patients with cirrhosis: Use in cirrhotic patients only when the need to 

treat outweighs this risk 

• Avoid use with: CYP 3A inhibitors and CYP 3A inducers. Reduced dose of SAMSCA may be needed 

if used with P-gp inhibitors 

• Co-administration with hypertonic saline is not recommended 

• Monitor serum potassium in patients with levels >5 mEq/L and in those receiving drugs known to 

increase serum potassium 

Commonly observed adverse reactions: (SAMSCA vs placebo) thirst (16% vs 5%), 

dry mouth (13% vs 4%), asthenia (9% vs 4%), constipation (7% vs 2%), 

pollakiuria or polyuria (11% vs 3%) and hyperglycemia (6% vs 1%). 

Please see Brief Summary of FULL PRESCRIBING INFORMATION, 

including Boxed WARNING, on previous pages. 

©2010 Otsuka America Pharmaceutical, Inc. July 2010 0710M-0856

Download - Heart Failure Society of America

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?